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Abstract 
Advances in healthcare over the last 100 years has resulted in an ever increasing 
elderly population. This presents greater challenges for adequate systemic and 
oral healthcare delivery. With increasing age there is a natural decline in oral 
health, leading to the loss of teeth and ultimately for some having to wear denture 
prosthesis. It is currently estimated that approximately one fifth of the UK and US 
populations have some form of removable prosthesis. The microbiology of denture 
induced mucosal inflammation is a pivotal factor to consider in denture care 
management, similar to many other oral diseases of microbial influence, such as 
caries, gingivitis and periodontitis.  
 
Dentures support the growth of microbial biofilms, structures commonly known as 
denture plaque. Microbiologically, denture stomatitis (DS) is a disease primarily 
considered to be of yeast aetiology, with the literature disproportionately 
focussed on Candida spp. However, the denture surface is capable of carrying up 
to 1011 microbes per milligram, the majority of which are bacteria. Thus it is 
apparent that denture plaque is more diverse than we assume. There is a 
fundamental gap in our understanding of the bacterial composition of denture 
plaque and the role that they may play in denture related disease such as DS. This 
is categorised as inflammation of the oral mucosa, a disease affecting around half 
of all denture wearers. It has been proposed that bacteria and fungi interact on 
the denture surface and that these polymicrobial interactions lead to synergism 
and increased DS pathogenesis. Therefore, understanding the denture microbiome 
composition is the key step to beginning to understand disease pathogenesis, and 
ultimately help improve treatments and identify novel targets for therapeutic and 
preventative strategies.  
 
A group of 131 patients were included within this study in which they provided 
samples from their dentures, palatal mucosa, saliva and dental plaque. Microbes 
residing on the denture surface were quantified using standard Miles and Misra 
culture technique which investigated the presence of Candida, aerobes and 
anaerobes. These clinical samples also underwent next generation sequencing 
using the Miseq Illumina platform to give a more global representation of the 
microbes present at each of these sites in the oral cavity of these denture wearers. 
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This data was then used to compare the composition and diversity of denture, 
mucosal and dental plaque between one another, as well as between healthy and 
diseased individuals. Additional comparisons included denture type and the 
presence or absence of natural teeth. Furthermore, microbiome data was used to 
assess differences between patients with varying levels of oral hygiene. The host 
response to the denture microbiome was investigated by screening the patients 
saliva for the presence and quantification of a range of antimicrobial peptides 
that are associated with the oral cavity. Based on the microbiome data an in vitro 
biofilm model was developed that reflected the composition of denture plaque. 
These biofilms were then used to assess quantitative and compositional changes 
over time and in response to denture cleansing treatments. Finally, the systemic 
implications of denture plaque were assessed by screening denture plaque samples 
for the presence of nine well known respiratory pathogens using quantitative PCR.  
 
The results from this study have shown that the bacterial microbiome composition 
of denture wearers is not consistent throughout the mouth and varies depending 
on sample site. Moreover, the presence of natural dentition has a significant 
impact on the microbiome composition. As for healthy and diseased patients the 
data suggests that compositional changes responsible for disease progression are 
occurring at the mucosa, and that dentures may in fact be a reservoir for these 
microbes. In terms of denture hygiene practices, sleeping with a denture in situ 
was found to be a common occurrence. Furthermore, significant shifts in denture 
microbiome composition were found in these individuals when compared to the 
denture microbiome of those that removed their denture at night. As for the host 
response, some antimicrobial peptides were found to be significantly reduced in 
the absence of natural dentition, indicating that the oral immune response is 
gradually impaired with the loss of teeth. This study also identified potentially 
serious systemic implications in terms of respiratory infection, as 64.6% of patients 
carried respiratory pathogens on their denture. 
 
In conclusion, this is the first study to provide a detailed understanding of the oral 
microbiome of denture wearers, and has provided evidence that DS development 
is more complex than simply a candidal infection. Both fungal and bacterial 
kingdoms clearly play a role in defining the progression of DS. The biofilm model 
created in this study demonstrated its potential as a platform to test novel actives. 
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Future use of this model will aid in greater understanding of host: biofilm 
interactions. Such findings are applicable to oral health and beyond, and may help 
to identify novel therapeutic targets for the treatment of DS and other biofilm 
associated diseases.  
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1.1 Introduction 
Edentulousness is categorised as the loss of all natural teeth, which is an 
irreversible clinical condition that can be described as the ultimate marker of oral 
disease burden (Cunha-Cruz et al., 2007). It is also associated with socioeconomic 
factors, with higher prevalence reported in the poor and women (Bedos et al., 
2003). With the sheer numbers of individuals routinely wearing and using a denture 
then there are profound implications for care and management. Many ageing 
individuals will experience a general decline in oral health, with current estimates 
reporting the international prevalence of edentulism varies from 7 to 69% of the 
adult population (Felton et al., 2011). Within the US and UK around 20% of the 
population already wear some form of removable denture (Coulthwaite and 
Verran, 2007, Shulman et al., 2004), with 70% of UK adults aged 75 years and 
above falling into this category (Iinuma et al., 2014). Nonetheless, dentures 
provide much-needed assistance to the patients, through improved nutritional 
intake and aesthetic appearance, which generally enhance the patients’ quality 
of life. Though, as with any indwelling foreign body there are consequences, and 
these need to be managed accordingly to minimise denture-induced disease.  
 
This chapter provides a review of the current literature relating to denture 
research, including denture microbiology, immunology, and emphasises the local 
and systemic implications of wearing dentures. Furthermore, this will highlight 
the importance of utilising advanced molecular technology OMICs approaches, 
such as next generation sequencing (NGS), when investigating microbial associated 
disease. Some aspects of this chapter have been published in: 
 
O'Donnell, L. E., E. Millhouse, L. Sherry, R. Kean, J. Malcolm, C. J. Nile and G. 
Ramage (2015). "Polymicrobial Candida biofilms: friends and foe in the oral 
cavity." FEMS Yeast Res 15(7). 
 
E. Rosa (ed.), Oral Candidosis: Physiopathology, Decision Making, and 
Therapeutics, Candida Virulence Factors. Lindsay E. O’Donnell, Douglas 
Robertson and Gordon Ramage © Springer-Verlag Berlin Heidelberg 2015. 
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1.2 Denture Stomatitis 
1.2.1 Introduction 
Denture stomatitis (DS) refers to inflammation of the oral mucosa and pathological 
changes associated with denture surfaces adjacent to tissue (Jeganathan and Lin, 
1992). Approximately two thirds of individuals who wear removable complete 
dentures suffer from DS, though most individuals are asymptomatic (Gendreau and 
Loewy, 2011). With 15 million dentures wearers in the UK this is not an 
inconsequential disease (Coulthwaite and Verran, 2007). DS sufferers can 
experience pain, discomfort, a burning or itching sensation and sometimes 
disturbance of taste. DS is associated with microbial factors, primarily infection 
with Candida albicans (Budtz-Jorgensen E, 1975). Other terminologies are used to 
refer to DS including denture-related candidiasis or Candida-associated denture-
related stomatitis.  
1.2.2 Classification 
DS is diagnosed by clinical examination of inflammation or swelling of the mucosal 
tissues covered by the denture. The severity of DS is classified by the colour, 
texture, and overall appearance of the upper palate. The most frequently utilised 
scale of severity in the literature is known as Newton’s Types (NT), and is 
described by three variables (Fig 1.1) (Newton, 1962a): 
0- No inflammation (Healthy) 
1- Localised inflammation (reddened areas within the tissue)  
2- Diffuse inflammation (diffuse hyperaemia of tissues with denture) 
3- Granular inflammation (increased papillary regions and swelling) 
 
Although microbial factors play a major role in the inflammation of the palatal 
mucosa of DS patients; severity cannot always be attributed to the number of 
organisms present. Therefore, other factors such as poor fitting dentures and poor 
oral hygiene appear to play a crucial role (Coco et al., 2008b). 
  Chapter 1: Introduction 
4 
 
 
Figure 1.1:Newton’s Type scale for the classification of inflammation present 
in DS. 
 A) Localised inflammation, B) Diffuse inflammation and C) Granular inflammation 
(Gendreau and Loewy, 2011). 
 
1.2.3 Prevalence 
Prevalence rates of DS vary considerably amongst the studies conducted; these 
variations can be attributed to differences within the study populations assessed. 
Table 1 provides the prevalence rates of numerous DS studies conducted 
worldwide. A large proportion of these studies were undertaken in treatment 
clinics designed specifically for denture patients, thus this may bias results as 
these patients already had pre-existing problems with their dentures. 
Furthermore, this may explain the high prevalence rates found in the majority of 
the prosthetic clinic based studies, with 67% of studies indicating a prevalence 
rate >45% (Gendreau and Loewy, 2011). Other studies obtained their prevalence 
rates by analysing representative population samples, for example, the NHANES 
III survey looked at a representative US population. They found that of 33,994 
individuals, 3,450 wore removable dentures, 28% of which had DS (Shulman et al., 
2004). The remaining population based studies from Spain, Slovenia and Turkey 
reported DS occurrence between 14.7-19.6% (Garcia-Pola Vallejo et al., 2002, 
Kovac-Kovacic and Skaleric, 2000, Mumcu et al., 2005). Yet, one representative 
study based in Denmark was somewhat of an outlier as it revealed a prevalence 
rate of 65%. However, this was later attributed to poor denture hygiene and a high 
occurrence of Candida infection within this population (Budtz-Jorgensen E, 1975). 
Furthermore, two studies undertaken in Finland, one from a national sample 
(Mikkonen et al., 1984) and the other from a group of home living elderly residents 
(Nevalainen et al., 1997), found a DS prevalence rate of 48% and 35%, respectively. 
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Interestingly, the study based solely on the elderly population had a lower 
prevalence rate. However, this could perhaps be explained by the fact that 
according to the national sample, 44% of adults in Finland wear dentures, which 
is an unusually high number in comparison to 20% of the US population (Shulman 
et al., 2004). Highlighting the fact that variation in dental and denture practices 
across different cultures makes defining DS prevalence particularly complex.  
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Table 1.1: Prevalence of Denture Stomatitis from studies conducted worldwide. 
 (Gendreau and Loewy, 2011). 
Study Population 
/Country 
Year of 
sampling 
Age 
(years) 
# Denture 
wearers 
#  with 
DS 
Prevalence Rate 
% 
Diagnosis 
method 
Random USA 1988-94 59.2±0.5 3,450 963 28 Newton’s 
Random 
Denmark 
1975 74.5 463 291 65 NR 
Age-stratified, Random 
Finland 
1984 81 260 91 35 NR 
Age-stratified 
Random 
Germany 
1997 Y-39 
O- 69.5 
655 NR Y- 2.5 
O- 18.3 
WHO guidelines 
Representative 
Finland 
1989-91 NR 3,875 1860 48 NR 
Representative 
Turkey 
2005 NR 178 3 18.5 WHO guidelines 
Age-stratified 
Spain 
2002 54.3±13.5 102 20 19.6 NR 
Random  
Age-stratified 
Slovenia 
2000 25-75 163 24 14.7 NR 
Stratified  
Chile 
2003 65 to >75 574 198 34.5 WHO 
LTCF residents 
Denmark 
1987 64≥85 582 197 33.9 NR 
Elderly patients attending clinic 
Turkey 
2002 NR 70 31 44 Budtz-Jorgensen 
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Study Population 
/Country 
Year of 
sampling 
Age 
(years) 
# Denture 
wearers 
#  with 
DS 
Prevalence Rate 
% 
Diagnosis 
method 
LTCF 
Finland 
2004 83.3±8.1 106 26 25 NR 
Randomley selected LTCF 
UK 
2000 84.5±8.3 331 110 33.2 Budtz-Jorgensen 
All LTCF in Taubate 
Brazil 
2006 74.9±12.5 201 108 54 NR 
LTCF patients 
Belgium 
1996 85.6±6.9 146 104 71 Budtz-Jorgensen 
LTCF 
Canada 
1999 83.4±17.6 38 13 34.2 Newton 
Population –based 
Greece 
2005 65-99 222 33 14.9 Newton 
LTCF 
Brazil 
2008 66.7±10.2 59 26 44.1 Newton 
Population-based Rural 
Brazil 
2008 NR 146 85 58.2 NR 
Dental clinic 
Endentulous referral 
Canada 
1976-1983 24-90 200 34 17 NR 
Prothetic clinic 
Mexico 
2005 Mean 67 105 50 47.6 NR 
Volunteer Clinic 
Brazil 
2004 62±12.8 236 NR 42.4 NR 
Volunteer Clinic 
Turkey 
2006 45-81 234 130 55.5 NR 
Pros Clinic 
Jordan 
2002 18-100 
Mean 
65±10.1 
321 94 29 NR 
  Chapter 1: Introduction 
8 
 
Study Population 
/Country 
Year of 
sampling 
Age 
(years) 
# Denture 
wearers 
#  with 
DS 
Prevalence Rate 
% 
Diagnosis 
method 
Pros Clinic 
Turkey 
2009 60-85 310 111 35.8 Newton 
Pros Clinic 
UK 
2008 49-89 
Mean 73 
37 26 70.3 Newton 
 
Pros Clinic 
Turkey 
2008 36-82 70 49 70 Budtz-Jorgesen 
Pros Clinic 
Canada 
2007 Mean 64.5 40 31 77.5 Newton 
Folllow-up Clinic 1 year after 
denture 
2008 72.1±4.4 173 110 63.6 Newton 
Pros clinic 
Spain 
2009 40-87 100 45 45 Newton 
Pros Clinic 
Jordan 
2007 39-100 300 157 52 Newton 
LTCF: Long term care facility, Y:Youngest, O:Oldest, NR: Not reported, WHO: World health organisation 
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1.2.4 Aetiology 
DS aetiology can be described as multi-factorial, (Fig 1.2) (Wilson, 1998). These 
factors include poor fitting dentures which can lead to mucosal trauma, poor 
denture hygiene, continual wearing of dentures and microbial infection. 
Therefore, treating DS is complex given the many factors contributing towards the 
disease, yet hygiene and microbial burden are most predominantly associated with 
causing disease and thus are the major targets for treatment.  
 
 
Figure 1.2: Aetiological factors associated with denture health. 
 
DENTURE 
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1.2.4.1 Denture trauma 
Denture-induced trauma, primarily associated with poor fitting dentures, has been 
identified as a high risk factor for developing DS. Approximately one half of 
denture wearers with poor fitting dentures are thought to experience localised 
Newton’s type I inflammation (Mumcu et al., 2005, Frenkel et al., 2000, Kuc et 
al., 1999, Coco et al., 2008a). A study by Enammi et al (2008) compared DS 
incidence between elderly patients given new conventional dentures and those 
given two-implant overdentures. The overdentures reduced occlusal pressure on 
the mucosa and improved denture fit and stability. They concluded that the 
improved stability of overdentures caused less mucosal trauma and significantly 
reduced the likelihood of developing DS (Emami et al., 2008). Other studies imply 
that both trauma and Candida infection are responsible for disease pathogenesis, 
as it has been suggested that mucosal trauma induced by the denture increases 
the permeability of the epithelium, enhancing the ability of Candida to penetrate 
the mucosa (Cawson, 1965).  
 
 
1.2.4.2 Oral hygiene 
More severe forms of DS have been associated with poor hygiene in numerous 
studies. These studies reported that the majority of denture wearers rely on 
mechanical cleaning with a toothbrush as the sole denture cleaning method 
(Gendreau and Loewy, 2011). Poorly cleaned dentures allows for the colonisation 
of yeasts and bacteria, which form complex microbial communities known as 
biofilms, and if left unchecked may lead to inflammation of the oral mucosa 
(Kulak-Ozkan et al., 2002). Dikbas et al (2006) found that of 234 patients, only 
11.9% had clean dentures and showed a significant correlation between unclean 
dentures and occurrence of DS (Dikbas et al., 2006). Furthermore, Budtz-
Jorgensen and Bertram (1970) associated poor hygiene with increased Candida 
infection, mucosal trauma and inflammation (Budtz-Jorgensen and Bertram, 
1970). While in contrast, Cross et al (2004) demonstrated that despite 
maintenance of excellent denture hygiene over three years, 18% of subjects 
relapsed, indicating factors other than hygiene are involved (Cross et al., 2004). 
For example, dentures set up a barrier to natural mechanical cleaning by saliva 
flow; therefore it is important to give time for this natural mechanism to have an 
effect by removing the denture whilst sleeping. Nonetheless, sleeping with 
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dentures in situ is still a common occurrence. This can lead to the development 
of an anaerobic environment between the denture and mucosa, favouring the 
growth of more pathogenic microbes and has been related to increased risk of 
developing DS (Gendreau and Loewy, 2011).  
 
1.2.4.3 Salivary flow, medication and diet 
Other factors that can impact denture health include diet and medication, which 
can consequently have a significant impact on the patients’ salivary flow. Saliva 
plays an important role in maintaining physiological homeostasis within the oral 
cavity (Anil et al., 2016). It is involved in lubricating oral tissues, swallowing and 
speaking and humidifying the oral environment. It is estimated the normal salivary 
flow rate is approximately 0.3 mL/min at rest, which can increase up to more than 
3 mL/min when stimulated (Watanabe and Dawes, 1988, Watanabe et al., 1995). 
Xerostomia is the subjective feeling of a dry mouth which is a symptom associated 
with alterations to the quality and quantity of saliva and is often a consequence 
of poor health, certain medications or radiation therapy (Cassolato and Turnbull, 
2003). The implications of xerostomia include problems eating, diminished taste, 
mucosal infections and denture intolerance. Xerostomia is predominantly 
associated with the elderly population and can lead to major complications in 
their general health and well being (Anil et al., 2016). Xerostomia can cause 
alterations to the oral microbiome, which often results in the growth of acidogenic 
bacteria, as well as favouring growth of Candida spp (Samaranayake, 2011). The 
moisture created by saliva in the oral cavity, plays a role in retention of dentures 
by contributing towards the suction mechanism required to maintain stability. 
Thus without this stability dentures are likely to rub against palatial tissues 
causing sore spots and trauma to the mucosa (Edgerton et al.). Moreover, 
numerous widely used medications can cause xerostomia, such as simvastatin, 
lisinopril, omeprazole, Amlodipine etc. Thus, medications which induce 
xerostomia are a contributor towards denture associated disease and trauma.  
Diet is a factor which can be associated with DS and can be implicated as both a 
cause and effect of the disease. According to the literature the primary 
microbiological cause of DS is candidal infection. Candida spp (Pereira-Cenci et 
al., 2008). requires nutrients for survival, including a rich source of glucose. 
Therefore, a diet high in carbohydrates has been linked to increase candidal 
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growth and survival (Brown et al., 2014). Thus, in patients plagued by oral 
candidiasis a decreased intake of food high in sugars is recommended. 
Furthermore, diet can also be affected by DS in that those with pre-existing 
disease and sore inflamed mouths may have difficulty eating. If this continues 
without treatment, the patients’ nutritional intake could be compromised which 
could have more serious consequences on their general health and wellbeing.  
1.2.4.4 Smoking 
Many factors, as previously mentioned, can contribute towards the development 
of DS, and whether smoking can be included as one of these factors has been 
considered for many years. Several studies have shown that Candida oral carriage 
rate is significantly elevated in smokers when compared to non-smokers (Abu-
Elteen and Abu-Alteen, 1998, Willis et al., 1999, Crockett et al., 1992). The 
mechanism by which smoking increases Candida growth is not fully understood, 
however a proposed mechanism is that nicotine triggers the liver into releasing 
glycogen into the blood stream. This then elevates the blood sugar level, providing 
a source of nutrients for Candida, however, the blood sugar level is now too high 
so the liver releases insulin to bring it back down. This causes blood sugar to drop, 
which causes cravings for another cigarette, thus creating a vicious cycle (Soysa 
and Ellepola, 2005). Inhibition of the immune response in the oral cavity as one 
study demonstrated that chronic exposure of rats to nicotine inhibits the antibody-
forming response and this immunosuppression is due to impaired antigen mediated 
T cell signalling (Lee et al., 2012). Furthermore, nicotine is said to have a 
vasoconstrictve effect on blood vessels by stimulating the α1-adrenergic receptors 
was suggested as an explanation for the reduced recruitment of inflammatory cells 
to the oral cavity seen in smokers (Johnson et al., 1991). Therefore, specific 
mechanisms by which smoking affect host microbiology and immunology needs to 
be identified as it is a vital step toward finding therapeutic approaches required 
to manage oral diseases in smokers. 
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1.3 Denture Microbiology 
The oral cavity is one of the main portals of entry into the human host, and is 
resident to a rich and diverse microbial flora. It is an advantageous habitat for both 
prokaryotes and eukaryotes, despite being bathed in saliva, an important innate 
defence mechanism that is abundant in antimicrobial molecules. Moreover, it is 
thought that up to 108 microbes per millilitre of saliva are present (Guo and Shi, 
2013).  
 
The microbiology of denture induced mucosal inflammation is a pivotal factor to 
consider in denture care management, similar to many other oral diseases of 
microbial influence, such as caries, gingivitis and periodontitis. The overall smooth 
appearance of dentures, both visually and to the touch, can be misleading as on 
closer inspection microscopically the denture may contain tiny cracks and fissures, 
which provide excellent habitats for microorganisms. Dentures support the growth 
of microbial biofilms, structures also known as denture plaque. These biofilm 
communities dominate the denture surface, with up to 1011 microbes per milligram 
of denture plaque (Nikawa et al., 1998), benefiting from the varied topography 
associated with denture acrylics and resins (Ramage et al., 2004a). Complex 
polymicrobial consortia of bacteria and yeasts reside within the cracks, crevices 
and fissures, and within surface pores, which give the appearance of a lunar 
landscape at high magnification. The nature of the surface of the denture provide 
optimal conditions for oral biofilm formation given that the acrylic surface is non-
shedding and the reduced salivary flow, which means less exposure to immune 
factors (Barbeau et al., 2003). The acrylic surface of PMMA allows the salivary 
pellicle to form readily on the surface of the denture. The salivary pellicle coats 
the oral surfaces, dentures included, with a layer of proteins, carbohydrates and 
lipids to which the primary colonisers, Streptococci, Actinomyces etc. can adhere 
(Cavalcanti et al., 2016). The pellicle components on dentures vary per individual, 
yet the general level of immune factors such as IgG, IgA, lysozyme etc, bound were 
reduced when compared to the oral mucosa, thus, it is suggested that this may 
influence the microbial colonisation of the denture base (Gocke et al., 2002). Thus, 
this architecturally heterogeneous panorama provides structural stability and an 
environment protected from key innate immune defences, as well as 
chemotherapeutic agents and mechanical disruption methods (Verran et al., 2014).  
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1.3.1 Candida  
The prevalence of invasive fungal infections has risen significantly worldwide, and 
although over 600 fungal species are reported as human pathogens, Candida 
species are arguably the most frequently isolated and are the most important 
fungal cause of morbidity and mortality in humans. In fact, Candida species are 
considered the fourth most common cause of hospital acquired bloodstream 
infections in the US (Lass-Florl, 2009). Candida albicans is generally attributed as 
being the main causative agent of DS, and this form of oral candidiasis affects 
approximately 30-70% of denture wearers. In most instances C. albicans exists as 
a commensal in the oral cavity; however, if the host defences become 
compromised and if the conditions within the oral cavity become favourable for 
the growth and adhesion of the yeast, then the fungus can become pathogenic. 
Microbiologically, DS is a disease primarily considered to be of yeast aetiology, 
with the literature disproportionately focussed on C. albicans (Bagg et al., 2003, 
Coleman et al., 1997, Li et al., 2007, Redding et al., 2004). It is able to exist as a 
commensal in the oral cavity of 25-50% of the healthy population but can become 
pathogenic under optimal conditions (Dagistan et al., 2009a). Two morphological 
forms of Candida exist, yeast and hyphal. Candida species take on the circular 
yeast morphology, however, hyphae are formed as a germ-tube projections from 
the yeast cell, forming branches which are divided by septa into separate fungal 
units (Fig.1.3). The hyphal form is referred to as the more invasive form of the 
fungus, with an enhanced ability to adhere to and colonise the prosthesis surface 
and is frequently isolated in DS sufferers (Gendreau and Loewy, 2011).  
 
 
A            B 
               
Figure 1.3: The different morphological forms of C. albicans.  
C. albicans yeast morphology (A), C. albicans hyphal morphology (B). 
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1.3.1.1 Candida virulence factors 
The success of Candida species, and in particular C. albicans, as a human 
pathogenic yeast can almost solely be attributed to their extensive arsenal of 
virulence factors. These include phenotypic plasticity, the ability to adhere to 
host or biomaterial surfaces, biofilm formation and subsequent dispersion of yeast 
cells from these structures (Mayer et al., 2013). Collectively, these make up the 
principal pathogenic mechanism assisting in the survival of these pathogenic 
yeasts. 
 
1.3.1.1.1 Adhesion  
 
Before becoming symptomatic to an infection Candida species must first adhere 
to and colonise host cells or an abiotic substrate. The adhesion proteins of C. 
albicans have been intensely studied and the agglutinin-like sequence (ALS) 
proteins have been identified as the central players (Hoyer et al., 2008). There 
are eight known ALS proteins (ALS 1-7 and ALS9) and of these ALS3 has been 
identified as the most significant due to its vast up-regulation during infection and 
ability to bind cadherins on host cells and induce endocytosis of the pathogen 
(Murciano et al., 2012, Phan et al., 2007). Hyphal-associated GPI-linked protein 
(Hwp1) has been identified as another key candidal adhesion protein. Knock out 
(KO) mouse model studies have shown reduced infection in models of systemic 
candidiasis with these proteins (Sundstrom et al., 2002, Phan et al., 2007). 
Candida glabrata, has a lower adherence capacity to gingival cells when compared 
to C. albicans and Candida tropicalis, however it adheres to dentures at a two-
fold greater rate than C. albicans; indicating that it has a stronger affinity for 
binding to prosthetics materials. (Li et al., 2007). A caveat to this finding would 
be that the yeast morphology of C. glabrata would be associated with greater 
viable cell numbers due to the homogenous nature of the yeast growth, whereas 
intertwined hyphal elements that are more commonly associated with C. albicans 
may be quantitatively greater, yet conventional microbial culture leads to a 
profound underestimation. 
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1.3.1.1.2 Hyphal formation  
 
Pressure generated by the hyphae is thought to be the reason for its effective 
infiltration of epithelial cells (Gow et al., 2002). The mechanics behind hyphal tip 
pressure remain little understood (Brand, 2012). It has been proposed Candida’s 
penetrative nature is intrinsic and that they have been programmed to infiltrate 
any surface they contact. Hyphae have been shown to penetrate into silicone 
material despite a lack of any biological interaction with the surface (Leonhard et 
al., 2010). Directional hyphal growth, known as thigmotropism, can occur as a 
result of contact sensing with the cell surface and can lead the hyphae to 
weakened areas of the cell wall (Hube and Naglik, 2001, Gow et al., 1994). 
Characteristic thigmotropic behaviour has been demonstrated in C. albicans and 
Candida dubliniensis (Watts et al., 1998, Chen et al., 2011).  
 
1.3.1.1.3 Biofilm formation        
  
The attachment of fungal cells is closely followed by cell division, proliferation 
and the development of a biofilm (Fig. 1.4) (Kumamoto, 2002). The capacity of 
some Candida species to form biofilms is classed as a virulence factor; a biofilm 
is characterised as a structured microbial community attached to both a surface 
and one another surrounded by a protective extracellular matrix (ECM) (Costerton 
et al., 1995), and it is now believed that the majority of microorganisms utilise 
this form of growth. The encased structure of the mature biofilm provides 
protection by preventing the penetration of host immune factors and antifungals 
into the ECM when compared to planktonic cells (Ramage et al., 2009). C. 
albicans, Candida parapsilosis and Candida tropicalis all have the ability to form 
biofilms and have been associated with higher levels of morbidity than that of 
non-biofilm forming Candida species (Kumamoto, 2002).  
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Figure 1.4: Developmental stages of C. albicans biofilm formation.  
The attachment of fungal cells is closely followed by cell division and 
proliferation, thus establishing colonisation. The production of hyphal growth and 
ECM leads to mature stable biofilm architecture. The mature biofilm then 
disperses yeast cells, subsequently leading to the formation of new colonies and 
further biofilm development. 
 
Hyphal production is a requisite for the formation of stable 3-D architecture within 
mature biofilms. The biofilm structure is stabilised by filamentous growth, 
however, the matrix is not impenetrable as there are water channels that deliver 
essential nutrients to the cells, and the cells can also escape the matrix and seed 
to other areas initiating the spread of infection (Douglas, 2003). The ECM 
composition of C. albicans biofilms consists of carbohydrates, mainly β-1,3 glucan, 
proteins, phosphorus and hexoamines. Positive regulators of β-1,3 glucan such as 
glucoamylases (Gca1 and Gca2), glucan transferases (Bgl2 and Phr1) and exo-
glucanase Xog1, seem to play an integral role in protecting the fungal cells as the 
biofilm becomes more susceptible to antifungals when they are absent (Taff et 
al., 2012).  
 
Once a mature biofilm is fully established yeast cells can then disseminate out to 
other areas subsequently leading to the spread of infection. Therefore, the 
formation of a biofilm is a fundamental mechanism exerted by Candida species, 
which aids their success as a pathogen by providing a protective niche for these 
fungi to grow, proliferate and subsequently disperse whilst defending against 
potentially devastating assaults from the immune system. Furthermore, increasing 
evidence indicates that Candida does not act alone when colonising dentures and 
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infecting host mucosa as bacteria have been found to be incorporated into the 
denture biofilms of DS sufferers (Tournu and Van Dijck, 2012). 
 
                      
1.3.1.2 Mixed Candida infection  
C. glabrata, despite being unable to form hyphae or form successful biofilms, 
remains the second most commonly isolated Candida species in most reported 
cases of candidiasis (Li et al., 2007). Moreover, it is hypothesised that Candida 
spp., in particular C. glabrata benefit from C. albicans. There have been 
suggestions that DS pathology may be promoted by the synergistic interaction 
between these species within denture biofilms. Coco and colleagues (2008) first 
reported that C. glabrata and C. albicans were often co-isolated from patients, 
particularly those with severe inflammation (Coco et al., 2008a). C. glabrata, 
unable to form hyphae, forms structurally poor and unstable biofilms, yet is linked 
with disease. Consequently, it was hypothesised that C. glabrata uses C. albicans 
as a structural scaffold to gain entry into the host. Further studies have confirmed 
this, where C. albicans appeared to assist the invasive capacity of C. glabrata 
within an in vitro reconstituted epithelial biofilm model (Silva et al., 2011). The 
mechanism of this interaction remains unknown. This group has shown similar data 
with work in a reconstituted human vaginal epithelial model, where C. glabrata 
on its own caused minimal tissue damage, yet there was a significant increase in 
C. glabrata colonisation and invasiveness in combination with C. albicans (Alves 
et al., 2014). Thus, further studies using in vivo models are required to investigate 
the pathogenesis of DS where C. albicans and C. glabrata are co-isolated.  
 
1.3.2 Bacterial denture plaque 
It could be inferred from a rudimentary scan of the literature that there is a 
candidal bias in DS, with little else of microbial importance in the context of 
dentures. Though in both healthy and diseased individuals it is apparent that 
denture plaque is more diverse than assumed. The denture surface capable of 
carrying up to 1011 microbes per milligram (Nikawa et al., 1998). The majority of 
studies investigating the bacteria colonising dentures typically use culture based 
methods and therefore only study a limited number of culturable bacteria (Sumi 
et al., 2003, Ribeiro et al., 2012, Baena-Monroy et al., 2005, Theilade and Budtz-
Jorgensen, 1988). Streptococcus species are amongst the most predominant 
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microflora detected on dentures, with species including Streptococcus oralis, 
Streptococcus salivarius, Streptococcus sanguinus, Streptococcus mutans and 
Streptococcus mitis (Coulthwaite and Verran, 2007). Staphylococcus spp. are also 
commonly isolated from dentures using selective media, most frequently 
Staphylococcus aureus (Ribeiro et al., 2012, Sumi et al., 2003). However, with the 
advent of molecular technologies, recent studies have utilised methods such as 
polymerase chain reaction (PCR) and DNA-DNA hybridization to gain a more 
detailed insight into the microbial composition of denture plaque. Using PCR, 
Campos et al (2008) were able to identify bacterial phylotypes found on healthy 
dentures and how they differed to those identified on those with DS (Campos et 
al., 2008). Healthy dentures were predominantly represented by bacteria within 
the Streptococcus and Veillonella genera, whereas phylotypes unique to DS were 
mainly of Streptococcus, Atopobium and Prevotella genera. Moreover, DNA-DNA 
hybridization of denture plaque revealed the presence of Actinomyces spp., 
Porphyromonas gingivalis, Veillonella parvula, Neisseria mucosa and Eikenella 
corrodens (Teles et al., 2012, Sachdeo et al., 2008).  Of note, numerous studies 
have identified the presence of periodontal pathogens on dentures, or in the oral 
cavity of denture wearers, including, P. gingivalis, Fusobacterium nucleatum, 
Aggregatibacter actinomycetemcomitans, which were previously thought to 
disappear from the oral cavity with the complete removal of natural teeth 
(Fernandes et al., 2010, Yasui et al., 2012).  
 
Studies have shown that there is indeed a diverse denture microbiome consisting 
of various orally important bacterial species, many of which have been shown to 
co-aggregate with Candida species. Some of these bacteria include putative 
periodontal pathogens, including F. nucleatum, A. actinomycetemcomitans and P. 
gingivalis (Sachdeo et al., 2008, Yasui et al., 2012), though caries-associated 
species such as Streptococcus and Lactobacillus species appear to be more 
prominent (Teles et al., 2012), possibly through their ability to coaggregate with 
C. albicans hyphae (Bilhan et al., 2009, Ribeiro et al., 2012). Indeed, it has been 
reported that polymicrobial interactions between Candida and bacteria may lead 
to synergism and increased DS pathogenesis (Stacy et al., 2014). Indeed, oral 
microbiologists have devoted significant time and effort to distinguishing the 
importance of specific bacterial-bacterial interactions, while investigations into 
polymicrobial interactions have not received the same level of attention or rigour. 
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This has led to a gap in the literature regarding candidal-bacterial interactions 
within the oral environment. Some of these key interactions will now be discussed. 
 
1.3.3 Polymicrobial interkingdom interactions 
The vast majority of the studies looking at fungal-bacterial interactions only look 
at a few species in vitro in oversimplified conditions. This highlights the 
importance of contemporary sequencing techniques to gauge a comprehensive 
understanding of the complete oral microbiome in order to fully understand 
fungal-bacterial relationships (Kraneveld et al., 2012, Shirtliff et al., 2009). The 
importance of Candida within these complex communities is now slowly being 
discovered as a result of advances in genome sequencing (Nobbs and Jenkinson, 
2015). For example, microbiome analysis of the saliva from elderly Dutch patients 
showed that an increased candidal load led to dysbiosis in bacterial flora, 
excluding pathogenic anaerobic bacteria and favouring co-existence with oral 
streptococci (Kraneveld et al., 2012). Candida species have been isolated from 
various sites within the oral cavity which include both soft and hard tissues of 
biological and non-biological origin including, periodontal pockets, root canals, 
orthodontic appliances, enamel, dentures and mucosal surfaces (Arslan et al., 
2008, de Carvalho et al., 2006, Dongari-Bagtzoglou et al., 2009, Freitas et al., 
2014, Ramage et al., 2004b, Sardi et al., 2010). A moisture rich environment, 
sufficient nutrients, hyphal growth and the presence of commensal bacteria, are 
all involved in influencing successful C. albicans biofilm architecture and virulence 
(Bertolini et al., 2015). 
 
 
1.3.3.1 Candida and Streptococcus 
A large proportion of the primary colonisers of the oral cavity are comprised of 
streptococcal species (Moore et al., 1982, Syed and Loesche, 1978). Oral 
streptococci are classed as mitis group streptococci (MGS), which include S. mitis, 
S. oralis, S. gordonii, S. sanguinis and S. parasanguinis species (Kawamura et al., 
1995). MGS streptococci are conventionally associated with the early colonisation 
of dental surfaces, comprising between 60-80% of the flora (Diaz et al., 2012a). 
Moreover, studies using high throughput gene sequencing technology has revealed 
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them to also be principal colonisers of oral mucosal surfaces (Diaz et al., 2012a). 
Recent metagenomic studies looking at the complete oral microbiome found that 
as Candida load increased the bacterial genus bacilli increased, with streptococci 
contributing to 34% of this group. Increasing Candida load has been shown to 
decrease the pH, this correlates with streptococci spp. due to it being extremely 
acid-tolerant (Kraneveld et al., 2012).  
 
The relationship between streptococci and Candida is synergistic in nature, as 
advanced microscopy has shown streptococci interacting with Candida in both 
yeast and hyphal forms (Fig. 1.5) (Dutton et al., 2014).  C. albicans has evolved a 
mechanism allowing it to bind directly to MGS species, including S. oralis, S. mitis 
and S. gordonii (Jenkinson et al., 1990). Interactions via C. albicans hyphal cell 
wall protein Als3, and the streptococcal cell surface adhesins SspA and SspB 
(Holmes et al., 1996), proteins that belong to the antigen I/II polypeptide family 
are involved in adherence between these two species (Bamford et al., 2009). Direct 
binding of SspB and Als3 is required for bacterial-fungal adherence. 
 
 
 
Figure 1.5: Candida and Streptococcus species interactions. 
Streptococcus species are able to interact with Candida species in both the yeast 
morphology (A) and hyphal morphology (B) (Jenkinson and Douglas, 2002).  
 
 
C. albicans can support the survival of streptococci by reducing oxygen tension 
levels to that more suitable for streptococcal growth, as well as providing 
nutrients required for bacterial survival (Douglas, 2002). This interaction is 
bidirectional, as streptococci supply Candida with nutrients from the salivary 
pellicle, such as glucose and lactate, which the yeast exploits as a source of carbon 
(Holmes et al., 2006). Moreover, streptococci are aciduric bacteria and therefore 
  Chapter 1: Introduction 
22 
 
create an acidic environment via the fermentation of carbohydrates (Takahashi 
and Nyvad, 2011). Yet, Candida can grow and survive at a lower pH (<4.5) when 
co-colonised with streptoccoci, and the H2O2 produced by streptococci can induce 
oxidative stress, which encourages hyphal growth (Jenkinson et al., 1990, 
Nasution et al., 2008). Though, there are instances when this interaction can be 
detrimental to the host. Studies have shown that streptococci augment the 
persistence of Candida spp. Xu and colleagues (2014) established that co-infection 
with C. albicans and S. oralis led to a more severe inflammatory response when 
compared with the monospecies infection, which is due to an exaggerated up-
regulation of TLR2 dependant inflammatory genes (Xu et al., 2014, Dutton et al., 
2014).   
 
A significant component of a biofilm is the ECM, which provides protection against 
antimicrobials (Xu et al., 2014). The ECM of Candida biofilms is composed of β-
glucans (Gregoire et al., 2011), whereas the streptococcal biofilm ECM is chiefly 
comprised of α -glucans (Al-Fattani and Douglas, 2006, Taff et al., 2012). S. mutans 
utilises its ECM components by depositing α-glucans on the surface of hyphae to 
enhance adhesion to fungal cells (Gregoire et al., 2011). Furthermore, interaction 
between S. mutans and C. albicans is promoted by glucosyltransferase-derived ECM 
and expression of the S. mutans virulence gene gtfB (Falsetta et al., 2014). This 
study further demonstrated that Candida-derived β1,3-glucans contribute towards 
the ECM structure, at the same time fungal β-glucan and mannan present sites for 
gtfB binding. Additionally, β-glucans are found on the surface of hyphae as well as 
inside the matrix (Dongari-Bagtzoglou et al., 2009), therefore indicating that 
streptococci use these proteins to adhere to hyphal filaments. Together, this 
suggests the biofilm ECM may affect this synergistic behavior, favoring their co-
existence in the oral environment to the detriment of the host. 
 
Quorum sensing (QS) plays a significant role in the association between Candida 
and streptococci. The key QS molecule associated with C. albicans is farnesol, a 
tetraprenoid alcohol and a key intermediate in the sterol biosynthetic pathway in 
eukaryotic cells, its primary role is involved in the repression of hyphal growth 
and biofilm formation (Ramage et al., 2002). Yet, a study by Bamford et al (2009) 
has showed that S. gordonii can suppress farnesol induced inhibition of biofilm 
formation, via autoinducer 2 (AI-2). AI-2 is associated with the luxS gene, and 
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mutants of this gene were less effective at permitting hyphal formation, however, 
the mode of action has yet to be elucidated (Bamford et al., 2009). Farnesol also 
inhibits S. mutans biofilm formation and polysaccharide production (Koo et al., 
2003). From this and other studies it has been suggested that it may be used to 
control its competitiveness in mixed species biofilms and could be targeted as a 
chemotherapeutic strategy (Jeon et al., 2011). AI-2 is the chief QS molecule 
released by bacteria that allows inter-species communication (Vendeville et al., 
2005).  luxS streptococcal mutants are able to form monospecies biofilms, 
however, when co-colonised with C. albicans, biofilm formation becomes 
abrogated, suggesting this molecule is plays a role in cellular communication 
(McNab et al., 2003, Bamford et al., 2009).  
 
1.3.3.2 Candida and Lactobacillus 
The general consensus is that lactobacilli antagonise candidal species colonisation 
and growth, and is one of the main reasons they are included in probiotics (Young 
et al., 1956). Probiotics have proven to reduce candidal levels at various sites, 
including the oral cavity, bloodstream and urinary tract (Kumar et al., 2013, 
Mendonca et al., 2012). Initial studies suggested that lactobacilli decreased C. 
albicans levels via provision of nutrients for lactobacilli resulting in lactic acid 
production, thus hampering candidal growth through pH dependant inhibition. 
Evidence indicates that there is a close association between the both organisms, 
but to date the majority of data has come from studies into vaginal infection. The 
role played by lactobacilli in maintaining homeostasis at the vaginal mucosa 
originally came to light due to the occurrence of vaginal candidiasis during 
treatment with systemic antibiotics. The mechanistics behind Lactobacillus 
induced inhibition of Candida spp. growth and virulence are not yet fully 
understood, but perhaps the production of hydrogen peroxide contributes as it has 
been associated with anti-candidal activity, albeit in some strains of lactobacilli 
(Strus et al., 2005). Furthermore, one of the key virulence factors associated with 
Lactobacillus is its ability to produce antimicrobial proteins known as bacteriocins 
(Yang et al., 2014). Bateriocins have broad spectrum activity which can kill other 
closely related or non-related microbes but not the organism itself and are 
generally harmless to the human body. They are increasingly being used as a food 
preservative due to their antimicrobial effect against many food spoilage and 
pathogenic bacteria (Garsa et al., 2014). Their mechanism of action includes 
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binding to the main transporter of peptidoglycan subunits and preventing correct 
cell wall synthesis, as well as membrane insertion which leads to pore formation 
and ultimately cell death (Cotter et al., 2005). Therefore, it is possible that the 
release of bacteriocins by lactobacilli may be responsible for the antagonistic 
effect on Candida spp, however to date bacteriocins have not been directly linked 
to candidal inhibition. Thus, other interactions also contribute towards disease 
development, such as modulating the host response, in that lactobacilli cells have 
been shown induce the production of inflammatory cytokines when co-cultured 
with C. albicans (Martinez et al., 2009), potentially explaining the clearance of 
candidal infection.  
 
Yet, in spite of the overwhelming evidence that their relationship is antagonistic, 
there is some studies indicate that they may mutually benefit one another. 
Modulating the environmental pH to that of a more acidic environment is a 
common trait of lactobacilli as a result of producing lactic acid (Messaoudi et al., 
2013). This is generally considered a pathogenic mechanism due to the inability 
of other bacteria to tolerate a low pH. However, a low pH induces a stress 
response in Candida, leading to hyphal formation in certain species of oral 
Lactobacillus, specifically L. casei, which has been shown to stimulate C. albicans 
hyphal growth (Orsi et al., 2014).  Furthermore, Candida hyphae can co-aggregate 
and maintain lactobacilli levels in patients with more severe of oral disease (Bilhan 
et al., 2009). Thus, the induction of hyphae may be beneficial to lactobacilli as it 
can provide a stable scaffold to which the lactobacilli can adhere. Nonetheless, 
further investigation is essential to understand interactions in detail to establish 
the true extent of the dynamic relationship; given that the conceived antagonism 
may be specific to C. albicans. For example, Jiang et al (2015) demonstrated that 
only one of six probiotic Lactobacillus species had an inhibitory effect on C. 
glabrata growth (Jiang et al., 2015). This suggests that the interactions between 
Candida and lactobacilli may be dependent on the particular species they interact 
with.  
 
1.3.3.3 Anaerobic Gram-negative interactions 
The environment of subgingival plaque is highly anaerobic, favouring many 
obligate periodontal disease (PD) pathogens such as P. gingivalis, F. nucleatum 
and Prevotella intermedia. However, given the indeterminate association 
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between Candida spp and PD, then this remains a reasonably ignored area of 
research. Studies investigating interactions between C. albicans and P. gingivalis 
have produced contradictory results. P. gingivalis was shown to suppress Candida 
biofilm formation by reducing the number of viable yeast cells coincidental with 
an increasing P. gingivalis concentration (Thein et al., 2006). On the other hand, 
it was demonstrated that P. gingivalis induces germ-tube formation in C. albicans, 
leading to a more invasive phenotype, thus increasing the risk of infection (Nair 
et al., 2001).  Additionally, both microbes appear to demonstrate a mutually 
antagonistic effect on one another in relation to host cell adhesion, as P. gingivalis 
blocked the adhesion of C. albicans to buccal epithelial cells (Nair and 
Samaranayake, 1996), whilst the presence of C. albicans inhibited adhesion to 
gingival epithelial cells or gingival fibroblasts by P. gingivalis (Tamai et al., 2011). 
However, the same study also showed that pre-exposure of gingival epithelial cells 
and fibroblasts to C. albicans enhanced cell invasion by P. gingivalis. What is clear 
is that further studies are necessary to understand the interactions between these 
two microorganisms.  
 
Co-aggregation studies have shown that F. nucleatum has the ability to adhere to 
C. albicans species (Grimaudo and Nesbitt, 1997), as well as C. dubliniensis (Jabra-
Rizk et al., 1999). Although, the co-aggregation with C. albicans may be 
temperature dependant as when C. albicans was grown at 37°C, it did not adhere 
to F. nucleatum, yet the two species did co-aggregate when grown at 25°C and 
45°C (Jabra-Rizk et al., 1999). The mechanisms responsible for these interactions 
are unknown, however these observations suggest C. albicans and F. nucleatum 
interactions may play an important role in oral colonisation by yeasts.  
 
Thus, understanding the composition of denture biology is key to beginning to 
understand the complex microbial interactions. These interactions, whether 
synergistic or antagonistic in nature can result in enhanced pathogenicity, which 
can lead to local infection, yet on a more serious note, may contribute towards 
the development of a systemic infection. 
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1.4 Systemic implications of wearing dentures 
In recent years the systemic effect of oral bacteria has become increasingly 
apparent, as it is now implicated in numerous systemic diseases including 
rheumatoid arthritis, cardiovascular disease, kidney disease and respiratory 
infection (Pizzo et al., 2010, Farquharson et al., 2012). However, the majority of 
this evidence to date has primarily focused on the link between PD and systemic 
infections. Whereas, given that the composition of denture plaque is considerably 
understudied, there is little evidence on the systemic impact of denture plaque. 
 
1.4.1 Respiratory infection 
The 2010 Global Burden of Disease Study reported that lower respiratory tract 
infections; including pneumonia are the fourth leading cause of death worldwide 
(Lozano et al., 2012). Approximately 90% of deaths caused by pneumonia occur in 
those aged 65 and over, with one in 20 people over the age of 85 presenting with 
a new case of pneumonia every year, and with the increasingly ageing population 
more cases are likely to present (Torres et al., 2013). Poor oral hygiene has been 
connected to respiratory infection with common respiratory pathogens being 
identified within dental plaque, convincingly linking this with the development of 
pneumonia in intensive care patients and the dependant elderly (Sumi et al., 2007, 
Russell et al., 1999). 
 
Aspiration pneumonia (AP) is a clinical phenotype associated with the aspiration 
of oropharyngeal secretions into the lower respiratory tract (Raghavendran et al., 
2011). With advances in medicine people are living longer and thus an increasing 
number of these individuals are at risk of developing AP. As the majority of AP 
cases occur in individuals >65 years old, it means a large proportion of these 
people will have dentures (Falcone et al., 2012, Centre, 2011). While the 
constituents of dental plaque have been well established, the composition of 
denture plaque has been understudied and thus the extent to which respiratory 
pathogens may colonise the prosthesis is not yet fully understood. The few studies 
which have investigated the presence of respiratory pathogens within the oral 
cavity have prominently relied on standard microbial culturing methods for 
identification of the microorganisms (Sumi et al., 2007, Sumi et al., 2002). This 
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therefore calls for the opportunity to make use of advanced molecular techniques 
to give more accurate insight into the potential systemic consequences. 
 
1.4.1.1 Categories of Pneumonia 
Pneumonia is classified into either community acquired pneumonia (CAP) or 
hospital acquired pneumonia (HAP). Other than the place of infection, these two 
categories differ as the microorganisms involved in each case are distinct (Falcone 
et al., 2012).  
 
During the past decade hospitalisation rates due to pneumonia has increased by 
34% (Trotter et al., 2008). Currently CAP is the leading cause of death due to 
infection within Europe, and while the reported incidence of CAP varies from 
country to country, they all conclusively report an increased progression rate with 
increasing age (Torres et al., 2013). HAP is defined as occurring more than 48 
hours after admission to the hospital and can be divided into ventilator associated 
pneumonia (VAP) and non-ventilator associated pneumonia (Niederman, 2010). 
VAP develops 48 hours or more after intubation and has a mortality rate between 
17-50% and the cost of treating ventilated patients with pneumonia is significantly 
higher than those without (Lahoorpour et al., 2013).  
 
It is estimated within the next 30 years, 40% of adults will spend some time in a 
long term care facility (LTCF) before dying (El-Solh, 2011b). Institutionalised 
elders are a group at great risk of developing CAP, currently the incidence of 
pneumonia in nursing homes or LTCF’s is 0.3-2.3 occurrences every 1,000 resident 
care days (Muder, 1998). These individuals often have co-morbidities such as 
COPD, cardiovascular disease, diabetes and neurological disorders such as 
dementia, all of which increase their risk of developing pneumonia (Falcone et 
al., 2012). Thus this highlights the importance of gaining an improved 
understanding of the pathophysiology of this disease for prevention purposes 
which will markedly improve health care costs and clinical outcomes.  
 
1.4.1.2 Microbiology of pneumonia 
The microorganisms most commonly associated with CAP are Streptococcus 
pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, Chlamydia 
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pneumoniae, Moraxella catarrhalis, and Legionella spp. However, multi-drug 
resistant bacteria such as Pseudomonas aeruginosa, Enterobacteriaceae spp. or 
methicillin-resistant S. aureus (MRSA) are more frequently responsible for HAP 
(Falcone et al., 2012). Although the prevalence rates of these organisms vary 
amongst studies of elderly individuals with aspiration pneumonia, gram-negative 
bacilli are the predominant organisms (49 %), followed by anaerobic bacteria (16 
%) and S. aureus (12 %) (Mandell, 2009, Falcone et al., 2009, El-Solh et al., 2003). 
S. pneumoniae is the primary aetiological pathogen associated with CAP, with 
approximately 92 strains existing, all varying in their carriage rates, prevalence 
and pathogenicity (Blasi et al., 2012). The most commonly encountered strains 
are 3 (16.9%), 19 (10.7%) and 14 (7.5%). Strain 2 frequently causes invasive 
disease, Strains 3, 4, 6A, 6B, 7, 9N, 9V, 11, 12, 14, 15A, 15F, 16, 18C, 22, 23A, 
23B, 31, 33 and 35 are associated with fatality (Blasi et al., 2012).  
 
PD is suggested to cause increased levels of oral pathogens in the saliva which are 
subsequently aspirated into the lungs. In cases which involved anaerobic 
pulmonary infection, there was a significantly elevated level of periodontal 
pathogens, such as P. gingivalis, isolated from these patients when compared with 
age-matched controls, thus supporting a role between periodontal infection and 
anaerobic pulmonary infection (Paju and Scannapieco, 2007). Furthermore, 
although clinically infections caused by Fusobacteria are rare, these bacteria are 
associated with simple diseases such as aspiration pneumonia to more severe 
infections such as necrotizing pneumonia (Brook, 2004). Fusobacteria nucleatum 
is associated with causing the majority of these infections (Nohrstrom et al., 
2011). F. nucleatum is normally found as a commensal of the oropharyngeal, 
gastrointestinal and respiratory tract, yet has been shown to become pathogenic 
in those that frequently aspirate oropharyngeal contents (Bartlett, 2012). 
Aspiration of oropharyngeal contents is increased in those with impaired cough 
reflexes, difficulty swallowing and those that sleep whilst wearing their dentures 
overnight. 
 
1.4.1.3 Dentures and pneumonia 
As over 70% of individuals >75 years old either wear a partial or complete denture, 
and as men are now expected to live to the age of 78 and women to 82, there are 
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a significant number of denture wearers in the population who could be at risk of 
AP (Centre, 2011, Kyte and Gordon, 2009).  
 
Edentulous individuals are unlikely to suffer from pneumonia caused by 
periodontal pathogens; nonetheless these bacteria can persist in the mouths of 
edentulous subjects for extended periods of time after the extraction of all teeth 
(Fernandes et al., 2010, Danser et al., 1995).   Adequate oral and denture care 
procedures within nursing homes are rare, mainly due to the individual’s inability 
to perform sufficient oral care themselves, a lack of personnel designated to oral 
hygiene care, inadequate staff training and patient noncompliance (El-Solh, 
2011a). Nonetheless, several studies conducted into the effectiveness of oral and 
denture care in nursing home patients saw a reduction of respiratory infections in 
patients that began intense oral hygiene regimens. Yoneyama et al (2002) 
conducted a study with 417 patients in nursing homes; patients were selected 
randomly for the control or intervention groups (Yoneyama et al., 2002). The 
intervention group had their mouths cleaned after every meal and dental 
hygienists provided professional health care once a week, the control group were 
responsible for their own oral health care. Both groups had their dentures cleaned 
once a day by their care providers. The results found that the control group had 
significantly higher incidences of pneumonia than the intervention group. Similar 
studies also found that when professional oral care was provided the risk of AP 
was significantly lowered. Studies were carried out looking at patients with 
dysphagia and impaired cough reflex sensitivity by Yoshino et al (2006) and 
Watando et al (2004), respectively. Both studies saw a significant improvement in 
cough reflexes and swallowing reflexes in the intervention groups, reducing the 
risk of AP (Yoshida et al., 2006, Watando et al., 2004). Therefore, this evidence 
highlights the need to implement an oral hygiene programme within nursing homes 
and LTCF’s. A programme of oral health care consisting of tooth brushing after 
each meal, cleaning dentures once a day, and professional oral health care once 
a week, seems the best intervention to reduce the incidence of AP, and 
subsequently reducing the burden of the health care system. 
 
As with all diseases of microbial origin, particularly those of the mucosa where a 
diverse microbial habitat exists, this leads to difficulties in determining the 
causative organism. Currently, no complete assessment using NGS has been 
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performed for dentures and the associated mucosa, thus understanding the 
interkingdom interactions and systemic risk factors involved cannot take place 
without first knowing what is there in the first place. Therefore, improved 
techniques to dissect and characterise the microbial ecology are welcomed, such 
as the advent of NGS. 
 
1.5 Next generation sequencing 
1.5.1 Introduction 
Dr Fredrick Sanger began research into DNA sequencing in the early 1970’s after 
successfully publishing a methods describing RNA sequencing (Sanger et al., 1965, 
Barrell and Sanger, 1969, Brownlee et al., 1967). In 1977 Sanger published a paper 
demonstrating a successful method for sequencing DNA, now commonly known as 
the Sanger method (Sanger et al., 1977). The method involved a complex process 
by which DNA incorporated nucleotides with a slight modification, the addition of 
a 3’ hydroxyl group which blocks the addition of further nucleotides. Mixtures of 
DNA polymerase and the four unaltered nucleotides were mixed with a modified 
nucleotide either A, C, G or T. The fragments produced from these reactions were 
separated by size on polyacrylamide gels, the reactions containing the modified 
A, C G and T were run on separate adjacent lanes. The gels were dried and 
exposed to x-ray films and the fragments were then visually separated based from 
top to bottom (shortest to longest fragments) to generate the DNA sequence, thus 
was laborious and an extremely time consuming process (Sanger et al., 1977, 
Mardis, 2013). However, various improvements were introduced since its invention 
including the introduction of DNA synthesis chemistry, the advent of 
oligonucleotide primers and the use of longer and thinner polyacrylamide gels 
(Mardis, 2013). Nonetheless, despite these improvements none were sufficient to 
make this method scalable for high throughput sequencing needs.  
Throughout the years the process of DNA sequencing has become more 
sophisticated and advanced, and with that came the advent of NGS (Mardis, 2008). 
NGS allows the sequencing of large amounts of DNA rapidly and at substantially 
lower costs than previous methods, as previously it took over a decade to sequence 
the entire human genome, yet now with NGS technology it takes hours (Mardis, 
2013). These NGS platforms are opening doors for research allowing for the 
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investigation of genomes, microbiomes, ecological diversity and identification of 
unknown aetiological agents. Today there are several NGS platforms in use, the 
more predominantly used is the 454 sequencing platform and the Illumina 
sequencing platform (Li et al., 2014).  
1.5.2 Next generation sequencing methods 
1.5.2.1  454 sequencing 
The 454 platform was the first next generation sequencer to be introduced 
commercially in 2004 using a method known as pyrosequencing. This method 
generates DNA fragments from the original DNA strand. These DNA fragments are 
used to generate fragment libraries to which adapters (short DNA sequences) are 
added to the DNA blunt ends. The library fragments are then mixed with agarose 
beads with bound oligonucleotides sequences which are complimentary to the 
454-specific adapter sequences, thus each bead is associated with a single 
fragment. Beads are isolated into individual oil:water micelles containing PCR 
reactants for amplification of the fragments, producing approximately one million 
copies of each fragment. The beads are separated into individual wells on a 
picotitre plate, providing a set location were each sequencing reaction can be 
observed. Each fragment is then sequenced en masse. Enzyme mixtures which 
initiate the downstream pyrosequencing reaction are then added to the wells. The 
picotitre plate functions as a flow cell by which each specific nucleotide solution 
is added in a stepwise manner. In pyrosequencing the incorporation of a nucleotide 
initiates the release of a pyrophosphate molecule, which leads to a series of 
reactions, ultimately producing light by the enzyme luciferase. The amount of 
light emitted is proportional to the number of nucleotides incorporated, and thus 
the DNA sequence is generated (Mardis, 2008). 
454 sequencing was for a long time the standard method used for NGS sequencing 
due to its longer sequence reads and ability to assign taxonomy down to species 
level, and thus was the main competitor for other sequencing platforms such as 
Illumina (Mardis, 2013). However, in 2013 Rosche announced the withdrawal of 
the 454 platform due to its inability to compete with the ever evolving NGS 
platforms (Goodwin et al., 2016). The lengthy read length that comes with the   
454 platform leads to increased insertion and deletion errors. Homopolymer 
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regions are problematic with this platform as read accuracy is lost when more 
than 6 homopolymer bp are present (Loman et al., 2012, Forgetta et al., 2013). 
Whilst other platforms which use a similar method such as the Ion torrent have 
kept up with other rapidly evolving NGS platforms, the 454 has failed to keep up 
with yield or cost. The platform would not be fully discontinued until 2016 and 
thus current literature is still being published using this method, and thus it is still 
important to consider studies using the 454 method for comparison. 
1.5.2.2 Illumina sequencing 
As with the 454 platform a fragment library must be generated before sequencing 
can begin. The Illumina platform uses a chip-based bridge amplification procedure 
followed by sequencing synthesis using reverse terminator dye nucleotides, which 
takes place and occurs on the surface of an 8-channel oligo-derived flow cell. 
Adapters are annealed to the DNA fragments before they are introduced to the 
flow cell, which has oligonucliotides, complimentary to the adapters, already 
attached. Fragments attached to the oligonucleotides on the flow cell then 
undergo brigde amplification using DNA polymerase to generate clusters. Each 
cluster represents the same fragment sequence and produces approximately one 
million copies of each, which provides a fluorescent signal strong enough to be 
detected during nucleotide incorporation. Unlike the 454 platform, Ilumina 
introduces all four nucleotides simultaneously, as each base has a unique 
fluorescent label attached. A laser is then used to activate the fluorescent labels 
and the colour emitted is read. Each base contains a 3’-OH group to prevent 
incorporation of more than one nucleotide. After each cycle the 3’-OH group is 
chemically removed and the process is repeated, eventually generating the DNA 
sequence (Mardis, 2008). 
1.5.3 Sequencing the 16S gene 
Research into understanding microbial communities has been revolutionised by 
NGS, as we are now able to gain an in depth insight into the microbiome 
composition of various microbial communities. The majority of microbiome 
studies sequence the 16S rRNA gene, however the region within the gene that is 
sequenced varies from study to study. Bacterial rRNA 16S genes contain nine 
hypervariable regions (V1-V9), which express extensive sequence diversity across 
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bacteria (Van de Peer et al., 1996). Sections within these regions that are known 
to be species specific are often targeted as it allows for identification down to the 
species level. None of the hypervariable regions are able to differentiate between 
all bacterial species; therefore this led to numerous studies all comparing 
different variable regions. Chakravorty et al (2007) sequenced the different 
variable regions to compare the advantages of each region for the specific 
diagnostic goals required (Chakravorty et al., 2007). There results indicated that 
different variable regions were better than others for differentiating between 
certain genera. In terms of oral microbiome studies the most popular regions 
sequenced include the V1-V3 and V3-V4 regions (Liu et al., 2016, Kennedy et al., 
2016, Macovei et al., 2015, Yun et al., 2016, Harris et al., 2015, Johansson et al., 
2016). The V1-V3 region remains popular because it has been shown to produce 
an overall similar OUT profile as the V3-V4 when tested on the same samples, 
however the V1-V3 provides a greater phylotype richness and evenness which is 
thought to support a more representative assessment of the community (Zheng et 
al., 2015b). However, Kozich et al (2013) in a recent study set out to address 
problems associated with the MiSeq platform and attempt to improve the quality 
of data produced (Kozich et al., 2013). Comparison of three different sequencing 
regions V34, V4 and V45 found that surprisingly the shorter V45 region had a higher 
error rate than the V34 region. Interestingly however, the V4 region alone had a 
lower error rate than both the V34 and V45. Thus, they deduced that the fraction 
and length of sequences retained could be organised so that it is comparable to 
platforms with longer sequence reads (Schloss et al., 2011). Furthermore, the 
shorter V4 region is approximately 250 bp in length, therefore using the Miseq 
platform with the 500 bp read, gives almost complete overlap of the sequences 
and produces a lower error rate (Kozich et al., 2013). Therefore, the sequencing 
region of choice is ultimately dependant on whether a lower error rate or 
increased species richness is desired. 
1.5.3.1 Advantages and disadvantages of using the Illumina Miseq platform 
and alternatives 
Advances in the technology of these next generation sequencers has raised 
questions on which is the most suitable platform to use for in depth analysis of 
microbial communities. Traditionally he most commonly used platform was the 
454, however its inability to keep up with new advancing NGS platforms led to its 
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discontinuation. However, interest in other platforms such as Illumina continues 
to grow as the technology becomes more sophisticated and advanced (Gloor et 
al., 2010), yet it is essential that with these advancements comes improvement 
in sequencing quality as this cannot be sacrificed for an increased sequence 
output. Other factors which do need to be taken into account when selecting an 
NGS platform include cost, how many reads can you get per run and per pound, 
and also the length of the sequence because the longer the sequence the more 
accurate the assignment to a taxonomic group.  
The Illumina platform is able to generate the largest amount of sequencing data 
at the cheapest price (Caporaso et al., 2012). Currently up to 300 and 500 
nucleotide reads of sequence are obtainable from the HiSeq and MiSeq platforms 
respectively, which are split into two reads. The HiSeq platform has a substantially 
greater read depth and is more costly to run than the MiSeq, and is more commonly 
used for shotgun metagenomics. However, Miseq Illumina is more appropriate for 
16S rRNA gene sequencing due to its longer sequence reads (Caporaso et al., 
2012). Traditionally 454 was favoured over the Illumina platform because Illumina 
had trouble sequencing samples with low genetic diversity, however, the 
introduction of the phage PhiX into the DNA library, to increase the diversity 
corrected this problem, so with improved technology as little as 5% of the DNA 
library is comprised of PhiX (Kozich et al., 2013). Therefore, taking into account 
the shorter sequencing time, the increased read depth and considerably cheaper 
cost the MiSeq Illumina platform is able to cost-effectively produce high quality 
sequencing data and is currently considered the clear favourite NGS platform for 
large scale sampling.   
However, the Illumina platform is not without its limitations. One of the main 
drawbacks of this technology is the short sequence read lengths, as the majority 
of samples are unable to be assigned to the species level as most stop at the genus 
level. However, databases including the human microbiome project and the 
human oral microbiome project etc, these can be used alongside sequencing data 
to build an understanding of the microbial environment. Furthermore, another 
limitation of NGS sequencing, is contamination of samples from the DNA extraction 
kits used before sequencing, known as the ‘kit-ome’, however this is a problem 
which affects all NGS platforms and not specifically the Illumina. Studies have 
been conducted in which blank control that have been passed through the 
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extraction kits were sequenced and detected microbial contamination, all be it at 
a low biomass (Salter et al., 2014). Contaminating genera include Proteobacteria, 
Actinobacteria, Firmicutes, Bacteriodetes and Acidobacteria. Therefore, kit 
contamination can significantly influence the results of microbiome studies, and 
particular care should be taken for samples with a low biomass. The inclusion of 
negative controls for sequencing may help distinguish contaminating microbes 
from the samples and help limit false conclusions. 
As NGS continues to evolve, more and more sequencing platforms begin to emerge, 
other alternatives include the ion torrent, PacBio and Minlon platforms. The Ion 
torrent system, like the 454 involves sequencing by synthesis and is able to 
generate superior read lengths of approximately 400 bp (Goodwin et al., 2016). 
This platform involves works by detecting the H+ ions released as each nucleotide 
is incorporated and the change in pH is detected by a sensor. The change in pH is 
directly proportional to the number nucleotides integrated (Loman et al., 2012). 
Although facing similar drawbacks to the 454 such as insertion and deletion errors, 
the ion torrent has been able to keep pace with the rapidly changing NGS field. 
The PacBio system is the most commonly used long-read platform (Eid et al., 
2009). It involves fixing DNA polymerase to the bottom of the flow cell and allows 
the DNA strand to progress through zero mode waveguides (Levene et al., 2003). 
A laser records the colour of the emitted light as the labelled nucleotide is 
incorporated, the polymerase then cleaves the fluorophore before the next 
nucleotide is added. The PacBio system can generate read lengths of 10-15 kb, 
however it is not without its limitations as the long read length means a higher 
error rate, yet, PacBio provide a circular template which provides a level for error 
correction (Goodwin et al., 2016). Moreover, the MinION platform is a nanopore 
sequencer, which directly detects the DNA composition of ssDNA without the 
hybridisation or incorporation of nucleotides along a template DNA strand. 
Instead, DNA is passed through a protein pore which results in a shift in voltage 
through the pore, these voltage shifts are characteristic of a particular DNA 
sequence (Clarke et al., 2009). The advantages of MinION are that it can be run 
from a personal computer, is easily portable and is ideal for use in clinics when 
rapid responses are required. However, although there are few limitations as of 
the size of fragment that can be sequenced, the MinION has a large error rate. 
Nonetheless, improvements in the Chemistry involved are improving error rates 
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and read accuracy (Goodwin et al., 2015, Jain et al., 2015). Therefore, although 
of late the hugely successful Illumina instruments have dominated the NGS field 
and some technologies that could not keep up with the ever evolving technology 
have become casualties, new technologies continue to be developed, challenging 
Illumina for its place at the top.  
Moreover, whilst it cannot be argued that the advent of NGS has revolutionised 
these types of studies, whether it is investigating the microbiome, genome, 
metabolome etc, simply knowing what is there is not sufficient in terms of 
understanding the disease pathogenesis. The microbes are not always the sole 
players involved in disease; as the host can also play a role. Take PD for example, 
the over activation of the immune system is strongly associated with hard and soft 
tissue destruction. Thus, understanding the role of the host is crucial for 
investigating disease pathogenesis and the intricate interplay between the host 
and microbiome.  
1.6 Host response 
The host response at the oral mucosa has been thoroughly investigated in terms 
of dental related disease including gingivitis and PD (Millhouse et al., 2014), 
however there is a sufficient lack in understanding regarding the role of the oral 
mucosal immune response in terms of DS. As we have previously stated the 
literature is heavily biased towards Candida in terms of DS (Coco et al., 2008a, 
Davenport and Hamada, 1979, Iacopino and Wathen, 1992), therefore, studies in 
this area have focused on the protection during infection by Candida (Wei et al., 
2011, Yanez et al., 2011, Carvalho et al., 2012). The key factors involved are 
primarily associated with cell-mediated immunity. Microbial componants such as 
lipopolysaccharide and peptidoglycan are primarily recognised by pattern 
recognition receptors (PRRs) such as Toll-like receptors (TLRs) expressed on the 
host epithelium (Tietze et al., 2006). The binding of a PRR to its cognate Pathogen 
associated molecular pattern (PAMP) triggers a signalling cascade which can lead 
to the activation and modulation of the innate and adaptive immune responses, 
and production of antimicrobial mediators such as antimicrobial peptides (AMPs) 
including defensins, cathelicidins and defensins (Akira and Takeda, 2004). In terms 
of Candida, it is recognised by PRRs including Dectin-1,CR3, TLR2, TLR3 and TLR4 
on the host  oral epithelial cells (Yanez et al., 2011, Gasparoto et al., 2010, 
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Takahara et al., 2012). Dectin-1 and CR3 recognise β-glucans on C. albicans cell 
wall in both yeast and hyphal forms (Zheng et al., 2015a). The role of TLR2 and 
TLR4 is controversial as some studies have shown an upregulation during Candidal 
infection, yet others showed no differences in the epithelial cell cytokine profile 
when these receptors were blocked by antibodies (Weindl et al., 2007). However, 
intracellular TLR3 is activated in response to host cell invasion by C. albicans 
(Muller et al., 2007).In terms of DS, Gasparoto et al (2012) demonstrated that the 
expression of TLR2 on neutrophils is significantly reduced in elderly individuals 
with DS in comparison to younger controls with DS, suggesting that with the 
natural ageing of the immune system, PRRs gradually become deficient (Gasparoto 
et al., 2012).  
The immune cells normally involved in innate immunity of the oral mucosa include 
dendritic cells, macrophages and neutrophils, all of which drive adaptive immune 
responses involving T cells and B cells (Wei et al., 2011). In general it is accepted 
that CD4+ T cells of Th1/Th17 lineage responses are protective against candidal 
infection (Schaller et al., 2004, Pandiyan et al., 2011), whilst a Th2 response is 
detrimental (Clemons and Stevens, 2001). These CD4+ cells orchestrate the 
immune response by the release of inflammatory and anti-inflammatory 
cytokines. A study recently conducted by Rogers et al demonstrated that cytokines 
associated with a Th1/Th17 response were elevated within DS patients in 
comparison to healthy denture wearing controls, thus the appropriate response is 
being elicited (Rogers et al., 2013). However, there is a delicate balance between 
host immunity and pathogen growth as excessive Th1 and Th17 responses could 
also contribute to inflammation and tissue damage. Nonetheless, in spite of the 
evidence concerning host immune responses during Candida infection, limited 
studies have been undertaken regarding the local inflammatory response 
associated with DS, particularly in terms of the role of bacteria in this disease.  
Moreover, in addition to the cellular immune response and their related cytokines, 
there are other immune factors involved in maintaining healthy oral mucosa. A 
range of AMPs have been isolated within the oral cavity. They are classed as a 
major innate arsenal against microbes and have demonstrated effective 
protection against oral disease, including DS.  
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1.6.1 Antimicrobial peptides 
Cationic AMPs are small peptides that, by definition, exhibit some, often broad-
spectrum, antimicrobial activity. AMPs can protect against a wide variety of 
bacterial, viral, fungal and protozoan infections and as a result are often referred 
to as host defence peptides. They also play an important role in the innate immune 
system, promoting actions that protect against microbial infection (Andersson et 
al., 2016). AMPs are synthesised within granules of phagocytic cells or are secreted 
by epithelia (Gudmundsson and Agerberth, 1999). In humans and other mammals, 
there are sites within the body that are generally free of microorganisms (e.g. 
lung), yet other sites such as the oral cavity, are heavily colonised by 
microorganisms. The oral cavity and respiratory tract express a similar pattern of 
AMPs, and there has been an increased interest in the roles that AMPs have at 
these sites against conditions such as PD and cystic fibrosis (Devine, 2003). An 
increasing resistance of microbes to anti-microbial drugs has lead researchers to 
look for new approaches, with the outcome being an increase in studies into using 
antimicrobial peptides (AMP’s) as a potential new therapy (da Silva et al., 2012).  
 
1.6.1.1 Histatin 5 
Histatins in particular have shown strong antifungal properties predominantly 
against Candida biofilms and promisingly has a potent effect on fungal species, 
which show strong resistance to classic antifungals (Edgerton and Koshlukova, 
2000). There are three major histatins (Hst1, Hst3 and Hst5), yet histatin 5 has 
the most potent antifungal activity, with the ability to kill both yeast and hyphal 
forms of C. albicans (Xu et al., 1991). Histatin 5 gains entry into the cell by binding 
to the C. albicans cell wall proteins Ssa1/2 and glucans, it is then transferred into 
the cytosol via fungal polyamine transporters in an energy dependant manner (Puri 
and Edgerton, 2014). It is thought that histatins function by exerting action at 
microbial membranes leading to the loss of ions, primarily adenosine triphosphate 
(ATP) (Vylkova et al., 2007). Furthermore, histatin 5 induces the formation of 
reactive oxygen species (ROS) inside C. albicans cells and in the mitochondria, 
with high ROS levels correlating with increased cell death (Helmerhorst et al., 
2001). 
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The efficacy of histatin 5 in preventing adherence of Candida species to denture 
acrylic has been successfully demonstrated, as well as its ability to inhibit the 
adhesion of C. albicans to reconstituted human oral epithelium (RHOE) (Yoshinari 
et al., 2006, Edgerton et al., 1995, Moffa et al., 2015). Whilst C. albicans biofilms 
are highly susceptible to histatin 5, C. glabrata biofilms on denture surfaces are 
less susceptible, whilst planktonic C. glabrata cells are completely insensitive 
(Konopka et al., 2010). Therefore, similar to antifungal agents currently used 
clinically, histatin 5 is vulnerable to the resistant abilities of C. glabrata.   
 
1.6.1.2 LL-37 
Several studies have demonstrated that LL-37 assists in the initiation of the 
immune response by its ability to induce migration, chemotaxis and activation of 
innate immune cells (Diamond et al., 2009, Gordon et al., 2005). LL-37 is the only 
cathelicidin found in humans and becomes active when proteinase 3 cleaves the 
C-terminus to create an active 37 residue antimicrobial peptide (Sorensen et al., 
2001). This peptide was initially found within neutrophil granules but was later 
discovered in monocytes, T cells and the respiratory mucosa (Diamond et al., 
2008b). Like histatin 5, LL-37 has broad spectrum activity targeting Candida, 
Gram-positive and Gram-negative bacteria (Overhage et al., 2008, Dean et al., 
2011, Amer et al., 2010, Murakami et al., 2004, Wong et al., 2011). LL-37 contains 
several hydrophobic residues and is positively charged, these factors allow it to 
interact with negatively charged microbial membranes (Tsai et al., 2011a).  These 
electrostatic interactions can then either lead to the peptide being taken into the 
cell or the accumulation of enough peptides leading to the formation of a pore 
and the loss of cellular homeostasis (Brogden, 2005, Lee et al., 2011, Henzler 
Wildman et al., 2003).  
 
In terms of fungal interactions, LL-37 has been shown to block C. albicans adhesion 
to mucosal membranes by interacting with surface carbohydrates on the mucosal 
membrane. β-1-3 glucan is a major component of fungal cell membranes, and an 
interaction between related exo β-1-3 glucan, Xog1p, significantly decreases C. 
albicans adhesion to epithelium (Tsai et al., 2011b). Thus LL-37 could be utilised 
for detection of other cell wall components involved in Candida adhesion. As for 
bacterial interactions, LL-37 has been shown to prevent biofilm formation at low 
concentrations and at higher concentrations is able to destroy preformed P. 
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aeruginosa biofilms. Studies investigating LL-37-treated P. aeruginosa biofilms 
saw a down-regulation of quorum-sensing (LasI, rhlR)-controlled genes and an up-
regulation of type IV pili, which led to twitching of the bacteria and prevented 
adhesion to surfaces (Overhage et al., 2008, Dean et al., 2011). LL-37 also 
demonstrated an anti-biofilm effect against Francisella novicida (Amer et al., 
2010). Nonetheless, some bacteria have developed a resistance mechanism 
against LL-37, which involves the release of proteolytic enzymes to cleave the 
active form of the peptide (Sieprawska-Lupa et al., 2004).  
 
1.6.1.3 Alpha defensins 
Alpha defensins, or as they are more commonly known, human neutrophil peptides 
(HNP), are named so because they were first isolated from neutrophil granules 
(Yang et al., 2004). HNP 1-3 are abundant in the oral cavity, found in tissue and 
secretions including oral and salivary gland tissues as well as saliva and gingival 
crevicular fluid (Gorr and Abdolhosseini, 2011). The HNP’s all are similar in size 
and structure containing of between 29-35 amino acids, with only slight changes 
in composition distinguishing them (Kohlgraf et al., 2010).  
 
Increases in the level of HNP’s found in the oral cavity are seen in a number of 
oral diseases such as PD, lichen planus, Behcets disease and aphthous stomatitis 
(Kucukkolbasi et al., 2011). α defensins exert their antimicrobial effects by direct 
antimicrobial activity, by disrupting the cellular membrane or by inducing non-
oxidative killing in phagocytes (Dale and Krisanaprakornkit, 2001). HNP-1-3 have 
been shown to directly target oral bacteria including S. mutans, A. 
actinomycetemcomitans and P. gingivalis (Gorr and Abdolhosseini, 2011). One 
study investigating Escherichia coli found that HNP1-3 permeabilised the outer 
then the inner membrane, and upon breach of the inner membrane cellular 
homeostasis was compromised and DNA, RNA and protein synthesis ceased (Lehrer 
et al., 1989). However, the antimicrobial activity of HNP’s are not as potent 
against oral bacteria as beta defensins (Dale and Fredericks, 2005).  
 
1.6.1.4 Beta Defensins 
Beta defensins were originally found in the respiratory epithelium but were 
subsequently discovered to be expressed at most epithelial surfaces, suggesting 
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that they play an important role in protecting the epithelium against invading 
pathogens.  Three defensins are expressed by human oral epithelial cells (hBD 1-
3). Hbd-1 is expressed at low levels constitutively, however, hBD-2 and 3 have low 
expression but can be up-regulated upon stimulation by microbes or the immune 
system (Diamond and Ryan, 2011). Their mechanism of action is thought to 
directly target the microbial membrane (Hans and Madaan Hans, 2014). As β- 
defensins are positively charged, they target negatively charged areas of the 
microbial membrane, which for gram positive bacteria is lipoteichoic acid and for 
gram negative bacteria; lipopolysaccharide (LPS) (Weinberg et al., 1998, Hans and 
Madaan Hans, 2014). It is proposed that interaction with the membrane leads to 
peptide deposition and pore formation (Agawa et al., 1991).  
 
β- defensins have a broad spectrum of activity, as they possess antibacterial, 
antifungal and antiviral properties. In terms of the oral cavity, these peptides 
have been shown to be active against periodontal pathogens including, A. 
actinomycetemcomitans, F. nucleatum and S. mutans (Ji et al., 2010, Joly et al., 
2004, Song et al., 2009). Nonetheless, some oral pathogens have developed 
resistance to β- defensins, as P. gingivalis does not induce the expression of 
defensins (Krisanaprakornkit et al., 2000) and Treponema denticola suppresses 
the induction by interacting with the signal transduction pathway (Brissette et al., 
2008, Shin and Choi, 2010). As for Candida, studies of oral candidiasis showed an 
increased level of expression of β- defensins in the oral epithelium and that hBD2 
and hBD3 were more effective at killing C. albicans than hBD1 (Sawaki et al., 2002, 
Feng et al., 2005). However, hBD-1 has been shown to play an important role in 
preventing early infection by C. albicans, (Tomalka et al., 2015)  suggesting that 
hBD1 is required during early infection and hBD2 and hBD3 become involved later.  
 
1.6.1.5 Calprotectin 
Calprotectin, also known as calgranulin, is found to be constitutively expressed in 
several immune cells including neutrophils, monocytes, macrophages as well as 
epithelial cells (Nacken et al., 2003, Dale et al., 1985, Odink et al., 1987, 
Brandtzaeg et al., 1987). Its levels are elevated in saliva, plasma and synovial fluid 
during inflammation as a result of diseases such as PD (Nisapakultorn et al., 2001, 
Kido et al., 1999). Calprotectin exerts its antimicrobial activity by sequestering 
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metal ions, namely zinc. When released into an inflammatory environment, it will 
bind these ions, which are essential for microbial function, thus provides host 
defence by inhibiting microbial growth (Damo et al., 2013).  
 
In whole unstimulated saliva, calprotectin is found at levels around 22 mg/L (Cuida 
et al., 1995). It has been shown to confer protection against S. 
aureus, Staphylococcus epidermidis, and E. coli (Steinbakk et al., 1990). 
Moreover, in the oral cavity, calprotectin was shown to contribute towards the 
resistance of gingival epithelial cells to invasion with P. gingivalis (Nisapakultorn 
et al., 2001). In terms of its antifungal properties, higher levels of calprotectin 
were found in the saliva of patients with oral candidiasis than those without 
(Kleinegger et al., 2001). Furthermore, several studies have demonstrated its 
ability to inhibit C. albicans growth (Sohnle et al., 1996, Okutomi et al., 1998, 
Murthy et al., 1993). The recent phenomenon of neutrophil extracellular traps 
(NETs) has been an area of great interest in medical research and calprotectin has 
been shown to be one on the primary constituents released by these NETs (Urban 
et al., 2009). Urban et al (2009) demonstrated that calprotectin KO’s used in C. 
albicans mouse infection models completely lost their antifungal activity, 
demonstrating the importance of this peptide against fungal infection.  
 
1.6.1.6 Lactoferrin 
Lactoferrin is one of the few proteins which are expressed at all mucosal sites 
throughout the body and is found in saliva, nasal secretions, gastric secretions, 
tears, breast milk and amniotic fluid. It has been shown to demonstrate anti-
bacterial, anti-fungal and anti-viral properties (Farnaud and Evans, 2003). 
Traditionally lactoferrin was thought to play an indirect role in terms of its 
antimicrobial activity by sequestering iron which was essential for bacterial 
survival. However, it was then discovered that lactoferrin demonstrated 
bactericidal activity that was independent of binding iron. Interactions with 
bacteria are thought to happen through binding to the lipid A portion of LPS or 
lipoteichoic acid for Gram-negative and Gram-positive bacteria, respectively. This 
interaction occurs when positively charged lysine or arginine residues interact 
with negatively charged regions of the lipid A or lipoteichoic acid, resulting in 
disruption of the outer membrane and disturbs the membrane stability. In terms 
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of oral bacteria, the binding of P. gingivalis and A. actinomycetemcomitans to 
epithelial cells is blocked by iron saturated lactoferrin (Alugupalli and Kalfas, 
1995). Elevated levels of oral lactoferrin have been suggested as a marker of PD 
(Friedman et al., 1983, Adonogianaki et al., 1993). Several studies have 
demonstrated the effective anti-fungal activity of lactoferrin against Candida spp. 
(Lupetti et al., 2007, Andres et al., 2008, Al-Sheikh, 2009, Kondori et al., 2011, 
Velliyagounder et al., 2015). Moreover, Kobayashi et al (2011) saw interesting 
effects of synergism when using lactoferrin in combination with traditional 
antifungals fluconazole and itraconazole, on certain strains of C. albicans 
(Kobayashi et al., 2011). Thus, providing evidence of a new potential therapeutic 
for the treatment of candidiasis.  
Consequently, the importance of the immune system in controlling microbial 
growth around the denture environment cannot be understated. Given the 
relationship between the elderly and denture wear, then a depleted immune 
system in this patient group creates an increased risk of infection. Thus, given the 
increasing elderly population, due to medical advances, this emphasises the 
importance of understanding the host response of a disease, which affects a large 
proportion of the population, and thus alleviating the burden on the National 
Health Service (NHS). 
1.7 Conclusions 
It is clear by reviewing the literature that there is an extreme lack of investigation 
regarding the microbial composition of denture plaque. At present, those studies 
that have looked at denture microbiology have used less complex techniques such 
as culturing and standard PCR. Currently, to our knowledge, no group has made 
use of NGS technology in this context. In addition to this, understanding the innate 
arsenal of innate immune factors, such as AMPs, that are present within the oral 
environment of a denture wearer will further contribute towards understanding 
the pathogenesis of DS. 
1.8 Aims and hypothesis 
Denture biofilms are able to form on all surfaces of the denture, however it is 
those biofilms which form on the upper denture surface in direct contact with 
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palatal mucosa that are predominantly associated with denture related disease. 
Currently there is limited understanding of the role of bacteria in this disease. 
The aims of this study were therefore to:  
1) Investigate the microbiome of dentures and other tissues within the mouths of 
denture wearers using NGS technology  
2) Compare the microbiome of healthy and diseased individuals suffering from DS 
of varying severity 
3) Identify the potential systemic implications of the denture microbiome, in 
terms of respiratory pathogens colonising dentures  
4) To use the knowledge gained from the NGS to develop an accurate denture 
biofilm model the can be used for various applications including the testing of 
chemotherapeutics.  
5) To investigate the host response in relation to denture plaque by studying 
salivary AMPs in order to understand DS pathogenesis 
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2.1 Introduction 
Healthcare improvements in the last century have led to an increasingly elderly 
population. Worldwide, 810 million people are aged 60 years or over, which is 
predicted to increase to at least two billion by 2050 (22% of the entire global 
population) (Guzmán et al., 2012). In the EU alone the proportion of the 
population who are 65 years and older is predicted to reach 53% by the year 2025 
(Muenz, 2007). This demographic change will result in significant challenges for 
oral healthcare delivery to an increasingly aged population with declining oral 
health. As the population ages oral diseases become more relevant with respect 
to their local and systemic impact, which can have profound implications for 
healthcare provision (Griffin et al., 2012, Meurman and Hamalainen, 2006).  
 
The oral cavity is a complex environment that is continually exposed to numerous 
opportunistic microbial pathogens. These are kept in check by a robust arsenal of 
immune factors that maintain a healthy oral environment and prevent the 
development of disease. This arena has gradually become a key area of biomedical 
research, which has led to a greater understanding of the causes, pathogenesis 
and host response against oral disease, with the majority of research focussing on 
diseases affecting dentate individuals, such as gingivitis, periodontitis and caries. 
Conversely, there is relatively less research regarding denture related disease. 
Despite major improvements in oral health worldwide, recent estimates report 
that the rate of edentulouness still varies from 7 to 69% of the worlds adult 
population (Felton et al., 2011, Petersen, 2003), and in the US and UK populations 
around one fifth wear some form of removable denture (Coulthwaite and Verran, 
2007, Shulman et al., 2004). This continued high prevalence should convince 
researchers that there is a requirement to develop an understanding of the 
implications of dentures on oral health. Moreover, according to the literature, the 
key to understanding the role of dentures in oral health lies with the denture 
microbiology. As the majority of studies regarding denture related disease 
indicate a microbial cause, yet an in depth analysis of denture plaque microbiology 
has yet to be carried out. 
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Furthermore, focusing solely on clinical and microbiological indicators of dental 
disease may not fully reflect the problems people have with their dentures (Guyatt 
et al., 1989). Fiske and co-workers (1998) indicated that tooth loss and wearing 
dentures has broader psychosocial consequences than the obvious functional 
limitations (Fiske et al., 1998). Patient centred outcomes are increasingly being 
used to measure the impact of health and disease on quality of life (Wilson and 
Cleary, 1995), including the Oral Health Impact Profile–14 (OHIP-14) 
questionnaire, which was developed and validated based on Locker’s conceptual 
framework for assessing oral health (Locker, 1988, Locker et al., 2004). 
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2.2 Aims 
The aim of this chapter was to report patient demographic data in order to gain a 
clearer understanding of the patient cohort that will be included in this 
observational cross sectional study. Furthermore, to understand how patient 
demographics such as gender, health, denture type and hygiene affect both the 
basic denture microbiology and oral health related quality of life measures. The 
following key questions were investigated:  
 
 How are the patient demographics, including gender, health status, 
denture type and dentate status distributed proportionally? 
 Does denture stomatitis affect the qualitative microbiology on the denture 
surface? 
 Does the denture type alter the qualitative microbiology on the denture 
surface? 
 Does the presence of natural teeth alter the qualitative microbiology on 
the denture surface? 
 Do oral hygiene habits and practices alter the qualitative microbiology on 
the denture surface? 
 How does wearing dentures impact the oral health related quality of life of 
our participants? 
 Do certain oral hygiene habits and practices have an impact on oral health 
related quality of life? 
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2.3 Materials and Methods 
2.3.1 Patient recruitment 
131 denture wearing patients attending the University of Glasgow Dental School 
and Hospital were enrolled in the study. Patients that were attending the hospital 
had appointments to have new dentures made, which included healthy patients 
and those having trouble with their dentures. This therefore avoided the sample 
bias of only recruiting patients with denture associated problems. Convenience 
sampling was used based on the patient availability on recruitment days. Patients 
were recruited by a designated PhD student (self) or a research nurse. Patients 
were given a study information sheet (Appendix I), written informed consent 
(Appendix II) was obtained from all participants. Ethical approval for the study 
was granted by the West of Scotland Research Ethics Service (12/WS/0121). All 
patients wore full or partial removable dentures. A team of qualified dental 
clinicians were responsible for the collection of samples and the recording of 
clinical features (Appendix III). There was no age related exclusion criteria for this 
study. Newton’s classification method for DS was used to score the appearance of 
the patient’s palatal mucosa (Newton, 1962b). The following scores were applied; 
0= healthy mucosa, 1= pin-point hyperaemic lesions (localized erythema), 2= 
diffuse erythema (generalized simple inflammation), and 3= hyperplastic granular 
surface (inflammatory papillary hyperplasia).  For standardisation, all clinicians 
received training to calibrate scoring the extent of erythema. Patients were 
excluded from the study if they were pregnant, had previous radiotherapy for the 
treatment of head and neck malignancy, had been receiving 
antimicrobial/antifungal treatment, using prescription mouthwashes or had 
received immunosuppressant therapy within six months previous to sampling. 
 
2.3.2 Clinical sample collection 
Ethylene oxide sterilised swabs (Fisher Scientific, Loughborough, UK) were used 
to collect samples from the denture surface in contact with the palatal mucosa 
and the palatal mucosal surface covered by the denture. If any natural teeth were 
present the clinician took a plaque sample using a sterile dental probe, which was 
immediately placed into a 2 mL collection tube (Fisher Scientific) containing 
  Chapter 2: Patient Demographics 
50 
 
RNAlater® (QIAgen, Manchester, UK). Dentures were removed from the patients’ 
mouth and placed in sterile bags (Fisher Scientific) filled with 50 mL PBS (Sigma-
Aldrich, Dorset, UK), then placed in a sonic bath (Ultrawave, Cardiff, UK) and 
sonicated for 5 min at at 35 kHz to remove adherent denture plaque. The denture 
sonicate was then transferred to a 50 mL tube and centrifuged for 10 min at 3700 
x g, and the plaque pellet re-suspended in 2 mL of RNAlater® (QIAgen). Swab tips 
were removed and stored in RNAlater®. Denture plaque, dental plaque and swab 
samples were all stored at -80oC (Triple Red Lab Technology, Long Credon). In 
total, samples from 131 patients were collected, which included 131 denture 
swabs, 131 mucosal swabs and 79 dental plaque samples.  
 
 
2.3.3 Collection of clinical data and questionnaire  
Data on patient age, gender, smoking status and any history of recent 
antimicrobial medication were recorded on a clinical information sheet (Appendix 
IV). Patients were then asked to complete a questionnaire covering aspects of 
their routine oral hygiene regimens. Included within the questionnaire were 
questions from the OHIP – 14, which assesses seven dimensions of impact of oral 
conditions on people’s oral health related quality of life (OHRQoL), including 
functional limitation, physical pain, psychological discomfort, physical disability, 
psychological disability, social disability and handicap (Allen and McMillan, 1999). 
A 5-point Likert scale anchors each of the OHIP-14 questions. Each response was 
provided a score as follows; Never = 0, Hardly ever =1, occasionally = 2, Fairly 
often = 3, Very often = 4.  The sum of each patient’s questionnaire was calculated 
by adding the response for each question. The maximum possible score is 56. The 
greater the score the greater the impact on the patients oral health related 
quality of life. All patients were given a unique study code, which was used for 
subsequent analysis throughout the study to ensure the anonymity of the patients. 
 
2.3.4 Microbial quantification of denture sonicate 
Prior to centrifugation, 1 mL of the denture sonicate was used to prepare serial 
ten-fold dilutions ranging from 100 – 10-5 in phosphate buffered saline (PBS) [Sigma-
Aldrich, Dorset, UK]. Serial dilutions were then used to perform colony forming 
unit (CFU) counts standard using colorex Candida (E & O labs, Bonnybridge, UK), 
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colorex S. aureus (E and O labs), MacConkey (E & O labs) and BHI blood (E & O 
labs) agar plates. 100 μl of each serial dilution was spread across each of the 
plates. Colorex® Candida plates were incubated at 30oC for 72 hours and 
MacConkey, colorex S. aureus and BHI blood plates were incubated at 37oC for 24 
hours. Additional blood agar plates were maintained under anaerobic conditions 
(85% N2, 10% CO2 and 5% H2 [Don Whitley Scientific Limited, Shipley, UK]) at 37oC 
for 24 hours. Bacteria and Candida were quantified by counting colonies formed 
for each dilution and the average number of bacteria or Candida cells/mL was 
calculated. The quantity (cells/mL) for both bacteria and Candida were then 
calculated based on initial dilutions (multiplied 50 x in order to represent the 
original 50 mL of PBS in which the denture was sonicated).  
 
2.3.5 Candida species strain collection 
Candida isolates from dentures grown on Colorex® Candida plates were assigned 
a species based on the colour of the colonies, green for C. albicans, pink for C. 
glabrata and blue for C. tropicalis. Purity plates were made for each isolate on 
Sabouraud dextrose agar (SAB [Sigma-Aldrich, Dorset, UK]). All isolates were 
stored in Microbank® vials (Pro-Lab Diagnostics, Cheshire, UK) at -80oC until 
further use (Triple Red Lab Technology).   
2.3.6  Statistical Analysis 
Statistical analysis and graph production were performed using GraphPad Prism 
(version 4; La Jolla, CA, USA) or IBM SPSS statistics (version 21; Chicago, Il, USA).  
All data was normalised by log transformation and statistical analysis carried out 
on these values, as indicated by the mean and median values throughout the 
results section. The Mann-Whitney U test was used to test for differences between 
microbial culture data across patient demographic groups and hygiene categories 
as the data were not normally distributed. The Mann Whitney U test was also used 
to test for differences in OHIP scores in relation to oral hygiene, cleaning 
frequency and sleeping with or without a denture in situ. A Kruskal-Wallis test 
with Dunns post-hoc test was employed to compare differences when the groups 
were further split into healthy and DS groups to account for multiple pair-wise 
comparisons. 
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2.4 Results 
2.4.1 Patient Demographics 
Samples from 131 patients were included in this study, of which the primary 
demographics of these patients are shown in Table 2.1. The average patient age 
was 71.6 years (min: 33, max: 95), the patient age distribution is shown in Figure 
2.1, with an average denture age of 4.5 years (min: 0.2 max: 40). Females 
represented the majority of the population at 65%, with males contributing only 
35% (Fig 2.2A).  63% of participants were found to have healthy oral mucosa and 
the remaining 37% were diagnosed with DS of varying degrees of severity (Fig 
2.2B). Overall, 18.3% of the patients were current smokers, and when split into 
healthy and DS groups, smokers represented 13.4% and 26.5%, respectively.  The 
majority of participants wore a complete denture (67.9%), with the remaining 
32.1% wearing a partial denture (Fig 2.2C). The average number of teeth 
remaining was 5.6 for the population as a whole; the distribution of the number 
of remaining natural teeth is shown in Figure 2.3.  
 
Table 2.1: Patient demographics. 
Patient Demographics 
Healthy   
Denture induced stomatitis   
 grade 1 grade 2 grade 3 Total 
N 
82 
(62.6%) 
 
25 
(19.2%) 
14 
(10.7%) 
10 
(7.5%) 
49 
(37.4%) 
Male 
26 
(31.7%)  
11 
(44.0%) 6 (42.9%) 
3 
(30.0%) 
20 
(40.8%) 
Female 
56 
(68.3%) 
 
14 
(66.0%) 8 (57.1%) 
7 
(70.0%) 
29 
(59.2%) 
Mean Age 
Median Age 
72 
72  
69.0 
72 
69.6 
70 
64.4 
65 
68.2 
70 
Median  Denture Age 
 
3  4.4 3.6 6.2 4.5 
Complete dentures 
61 
(74.4%)  
16 
(64.0%) 
 
8 
(57.1%) 
4 
(40.0%) 
28 
(57.1%) 
Partial dentures 
21 
(25.6%)  9 (36.0%) 6 (42.9%) 
6 
(60.0%) 
21 
(42.9%) 
Mean natural teeth 
remaining 5.2  5.2 6.1 8.5 6.1 
Current smoker 
11 
(13.4%)  
5  
(20.0%) 
3  
(21.4%) 
5 
(50.0%) 
13 
(26.5%) 
       
  Chapter 2: Patient Demographics 
53 
 
 
Figure 2.1: Patient age distribution of denture wearers.  
The proportion of denture wearers in the study representing each age group.   
 
 
 
 
 
Figure 2.2: Patient demographics of the study cohort.  
Pie charts representing the key patient demographics proportionally for (A) 
gender, (B) health & disease, (C) denture type and (D) dentate status.  
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Figure 2.3: Frequency of natural remaining teeth in patient cohort.  
The participants were separated into groups based on the number of natural teeth 
they had remaining in their oral cavity.     
 
 
2.4.2 Oral hygiene practices 
The clinical and questionnaire data collected also gave an insight into patient oral 
hygiene habits and practices (Table 2.2). Clinicians classed participants as having 
excellent (16%), good (56.5%) or poor (27.5%) oral hygiene. However, when split 
into healthy and diseased, only 20.7% of healthy patients were classed as having 
poor oral hygiene, in comparison to 38.8% of DS sufferers. This difference is even 
more apparent within the most severe inflammation group, grade 3, where 50% of 
patients have poor hygiene. Denture cleaning habits indicate that 32.1% of 
participants clean their denture at least once a day, 45.8% clean twice per day 
and the remaining 19.8% more than twice per day. Yet when split into health and 
disease, no noticeable differences were observed. Sleeping with a denture in is 
commonplace amongst denture wearers, as for this study it was found that 44.3% 
slept with their denture in situ, 44.3% did not sleep with their denture in situ, and 
11.4 % sometimes slept with their denture in situ. When separated into health and 
disease, however, 57.2% were found to sleep with their dentures in situ compared 
to the 36.6% of those with a healthy palatial mucosa. 
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Table 2.2: Oral hygiene practices and DS. 
Denture Hygiene    Denture induced stomatitis 
 Healthy  grade 1 grade 2 grade 3 Total 
Excellent 16 (19.5%)  1 (4.0%) 2 (14.3%) 2 (20.0%) 5 (10.2%) 
Good 49 (59.8%)  13 (52.0%) 9 (64.3%) 3 (30.0%) 25 (51.0%) 
Poor 17 (20.7%)  11 (44.0%) 3 (21.4%) 5 (50.0%) 19 (38.8%) 
       
Denture cleaning     Denture induced stomatitis 
 Healthy  grade 1 grade 2 grade 3 Total 
Never 1 (1.2%)  0 0 0 0 
<once/day 1 (1.2%)  0 1 (7.1%) 0 1 (2.1%) 
once/day 24 (29.3%)  9 (36.0%) 6 (42.9%) 3 (30.0%) 18 (36.7%) 
twice/day 40 (48.8%)  10 (40.0%) 6 (42.9%) 4 (40.0%) 20 (40.8%) 
>twice/day 16 (19.5%)  6 (24.0%) 1 (7.1%) 3 (30.0%) 10 (20.4%) 
       
Sleeping with 
denture     Denture induced stomatitis 
 Healthy  grade 1 grade 2 grade 3 Total 
No 43 (52.4%)  9 (37.5%) 4 (28.6%) 2 (20.0%) 15 (30.6%) 
Yes 30 (36.6%)  13 (54.2%) 9 (64.3%) 6 (60.0%) 28 (57.2%) 
Sometimes 9 (11.0%)  3 (8.3%) 1 (7.1%) 2 (20.0%) 6 (12.2%) 
 
2.4.3 Frequency and impact of oral pain and mouth dryness of 
denture wearers 
Adjusting to wearing dentures is often a difficult experience, with many suffering 
pain and discomfort. Of the 131 patients assessed, 82 (62.6%) were currently 
experiencing some form of denture related pain (Table 2.3). Using a scale from 1 
(no pain) to 10 (Intolerable pain), the average pain score was 5.29, with the most 
common pain described as a dull ache. Separation into health and DS groups found 
50 (61%) and 32 (65.3%) participants experiencing pain, respectively. Moreover, 
the mean pain score reported was lower for DS group, 4.56, than the healthy 
group, 5.8. 
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Table 2.3: Participants experience of pain caused by dentures. 
  
Experiencing 
Pain 
mean pain 
score 
Most common type 
of pain 
Total 82 (62.59%) 5.29 Dull ache 
Healthy (n=82) 50 (60.97%) 5.80 Dull ache 
 Denture induced 
stomatitis (n=49) 32 (65.30%) 4.56 
Throbbing and dull 
ache 
 
The vast majority of study participants (66.5%) found that they were unaware of 
any dryness of the mouth. Only 19.8% felt that they had too little saliva, with 
13.7% feeling like they have too much saliva. Suffering from DS appeared to affect 
mouth dryness (Table 2.4).   
Table 2.4: Mouth dryness. 
  
Too little 
saliva 
Too much 
saliva Unaware 
Healthy (n=82) 13 (15.8%) 14 (17.1%) 
55 
(67.1%) 
Denture induced stomatitis (n=49) 13 (26.5%) 4 (8.2%) 
32 
(65.3%) 
 
2.4.4 Prevalence of Candida on dentures 
72% of patient’s dentures were colonised by Candida. The prevalence of Candida 
species isolated from dentures of healthy and DS patients is shown in Table 2.5.  
The overall prevalence of Candida was higher on dentures from DS sufferers (78%) 
when compared with their healthy counterparts (64%). At the species level C. 
albicans was more predominant on DS individuals’ dentures (76%), whereas for C. 
glabrata there were little differences in prevalence between health (41%) and 
disease (40%). Furthermore, the number of patients in which C. albicans and C. 
glabrata were co-isolated was also more common in DS sufferers (36%). 
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Table 2.5: Prevalence of Candida species isolated from dentures of healthy 
and diseased patients. 
 Candida spp. 
 
+ve 
C. albicans 
 
+ve 
C. glabrata 
 
+ve 
Mixed C. albicans / 
C. glabrata 
+ve 
Healthy n (%) 
n= 78 
50 (64) 32 (41) 
 
32 (41) 14 (18) 
DS n(%) 
n= 45 
35 (78) 34 (76) 18(40) 16 (36) 
 
2.4.5 Quantitative analysis of denture microbiology 
The bacterial and fungal load colonising the dentures of our participants was 
quantified. The quantity of aerobic and anaerobic bacteria and Candida residing 
on the denture surface was enumerated by counting CFUs from the denture 
sonicate. Figure 2.4 compares the average number of CFUs detected in healthy 
patients against those with DS. In terms of total bacteria (Fig 2.4A), participants 
with DS had significantly higher levels of bacteria on their dentures [Median: 8.5 
(min: 5.3, max: 9.65) v 9.17 (min: 6.52, max: 10.19), p<0.05]. No significant 
differences in the number of aerobic bacteria were determined (Fig 2.4B) [Median: 
8.11 (min: 4.11, max: 9.61) v 8.53 (min: 4.38, max: 10.13), p>0.05], but DS 
participants appeared to have significantly more anaerobic bacteria than their 
healthy counterparts (Fig 2.4C) [Median: 8.05 (min: 5, max: 9.31) v 8.91 (min: 
6.04, max: 9.64), p<0.05]. As for Candida, patients that carried Candida on their 
dentures had significantly elevated levels if they suffered from DS (Fig 2.4D) 
[Median: 5.27 (min: 2.7, max: 7.1) v 6.2 (min: 3.7, max: 8.11), p<0.01]. When 
stratified into species (C. albicans [Fig 2.4E] and C. glabrata [Fig 2.4F]), only C. 
albicans showed a significant difference between the groups [Median: 5.14 (min: 
2.7, max: 6.85) v 5.75 (min: 3.65, max: 7.19), p<0.01], [Median: 5.22 (min: 2.7, 
max: 7.1) v 5.43 (min: 2.7, max: 8.1), p>0.05] respectively. 
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Figure 2.4: CFU analysis of denture microbiology of healthy and DS patients. 
Denture sonicate was used to quantify bacteria and yeasts by plating out on blood agar and colorex Candida plates respectively.  Blood 
agar plates were stored under aerobic and anaerobic conditions.  Colorex Candida plates allowed for differentiation between C. albicans 
and C. glabrata species.  Colonies formed were quantified and total bacteria (A), total aerobes (B), total anaerobes (C), total Candida 
(D), total C. albicans (E) and total C. glabrata (F) were separated into healthy and DS groups and compared. Data represents median (* 
p<0.05, ** p<0.01). Statistical analysis was performed using a Mann Whitney test as data did not conform to a normal distribution.  
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Participants were then split into groups depending on denture type (complete or 
partial), and also on whether they had some or no natural teeth remaining 
(dentate or edentate). Total bacteria CFU and total Candida CFU was compared 
between denture types and no differences were found for bacteria (Fig 2.5A) 
[Median: 8.69 (min: 5.3, max: 10.19) v 9.12 (min: 6.15, max: 9.65), p>0.05]. In 
contrast, Candida levels were significantly elevated on complete dentures (Fig 
2.5B) [Median: 6.01 (min: 3.18, max: 8.11) v 5.18 (min: 2.7, max: 6.89), p<0.01]. 
As for dentate status, as with the denture type, bacteria levels showed no 
differences (Fig 2.5C) [Median: 8.77 (min: 5.30, max: 9.53) v 8.75 (min: 6.78, max: 
10.19), p>0.05], but Candida levels were significantly elevated in edentulous 
individuals (Fig 2.5D) [Median: 5.43 (min: 2.7, max: 7.1) v 5.89 (min: 3.18, max: 
8.11), p<0.05]. 
 
Figure 2.5: CFU analysis of denture microbiology based on denture type and 
presence of natural teeth. 
Denture sonicate was used to quantify bacteria and yeasts by plating out on blood 
agar and colorex Candida plates respectively. The average CFU counts were then 
compared between complete and partial dentures for bacteria (A) and Candida 
(B) and between dentate and edentate patients for bacteria (C) and Candida (D). 
Data represents median (* p<0.05, ** p<0.01). Statistical analysis was performed 
using a Mann Whitney test as data did not conform to a normal distribution.  
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The oral hygiene data shown in Table 2.2 was used to assess the impact of common 
oral hygiene habits and practices on denture microbiology. For ease of comparison 
the excellent and good oral hygiene participants were grouped together and 
compared against the poor oral hygiene group. The quantity of total bacteria (Fig 
2.6A) [Median: 8.69 (min: 5.3, max: 10.19) v 9 (min: 6.15, max: 9.65), p>0.05] 
and total Candida spp. (Fig 2.6B) [Median: 5.49 (min: 2.7, max: 7.19) v 6.01 (min: 
2.7, max: 8.11), p>0.05] was compared between good and poor oral hygiene 
groups, however, no differences were observed for either. 
As for cleaning frequency, as previous, in order to make comparison easier those 
that selected that they never clean their denture or cleaned it less than once per 
day were excluded (3 participants). Furthermore, those that cleaned their denture 
twice a day were combined with those that clean more than twice per day. 
However, comparison of total bacteria (Fig 2.6C) [Median: 9.34 (min: 7.87, max: 
9.85) v 9.61 (min: 7.24, max: 10.08), p>0.05] and Candida spp. (Fig 2.6D) [Median: 
6.23 (min: 2.7, max: 7.1) v 6.78 (min: 3.18,max: 8.11), p>0.05] indicated no 
differences between the groups.  
Finally, for the sleeping with or without a denture in situ category, those that said 
‘sometimes’, were grouped with those that said ‘yes’. Comparison of total 
bacteria (Fig 2.6E) [Median: 8.76 (min: 6.78, max: 9.65) v 8.81 (min: 5.3,max: 
10.19), p>0.05] and Candida (Fig 2.6F)  [Median: 5.83 (min: 2.7, max: 8.11) v 5.63 
(min: 3.18,max: 7.1), p>0.05] also revealed no significant changes for either. 
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Figure 2.6: Comparison of changes in denture microbiology as a result of oral 
hygiene practices. 
The denture sonicate was assessed by CFU analysis for differences in the quantity 
of bacteria and Candida, respectively for, hygiene status A) and B), denture 
cleaning frequency D) and E) and sleeping with a denture in situ G) and H). Data 
represents median. Statistical analysis was performed using a Mann Whitney test 
as data did not conform to a normal distribution.  
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2.4.6 OHIP and patient demographics 
 
The median OHIP sum for the study cohort was 17, ranging between 0 and 56. The 
healthy group’s median OHIP sum was 17.5, while the DS group score 16.2, which 
was not statistically significant (Kruskal-Wallis test 0.94). The stacked data of 
each patient’s response to the individual questions for the OHIP-14 questionnaire 
are shown in Figure 2.7. Of the 7 domains this cohort of patients most frequently 
(very often) experience physical pain, and psychological discomfort. Social 
disability and handicap was least (never) experienced out of the 7 domains.  
 
The overall OHIP score was calculated for each patient based on their answers 
from the OHIP-14 questionnaire. These scores were then used to compare between 
different patient demographic groups including gender, health and disease, 
denture type and the presence of teeth. Females had significantly higher OHIP 
scores than males, indicating that dentures have a bigger impact on their oral 
health related quality of life (Fig 2.8A) [Median: 13 (min: 0, max: 38) v 20 (min: 
0, max: 51), p<0.05]. The OHIP score for individuals with healthy mucosa was 
significantly higher than those with DS (Fig 2.8B) [Median: 17.5 (min: 0, max: 56) 
v 17 (min: 0, max: 51), p<0.01]. Participants wearing complete dentures had a 
significantly higher OHIP scores when compared with those with partial dentures 
(Fig 2.8C) [Median: 19 (min: 0, max: 56) v 10 (min: 0, max: 41), p<0.01]. 
Edentulous individuals also scored higher than dentate individuals (Fig 2.8D) 
[Median: 13 (min: 0, max: 51) v 21 (min: 0, max: 56), p<0.01]. 
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Figure 2.7: Frequency data stacked for each patient’s answer of the OHIP-14 questionnaire.  
Two questions each representing 7 domains of functional limitation, physical pain, psychological discomfort, physical disability, 
psychological disability, social disability and handicap were included in the OHIP-14 questionnaire. A Likert scale was used for each 
question, and the frequency by which patients gave a particular answer is shown for each question in this figure.  
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Figure 2.8: Patient demographics and the impact on oral health.  
Based on their answers to the OHIP-14 questionnaire, each patient was given an 
OHIP score. Scores ranged from 0-56. Overall OHIP score was compared across a 
range of different patient demographics including, gender (A), health & DS (B), 
denture type (C) and dentate status (D). Data represents median (* p<0.05, ** 
p<0.01). Statistical analysis was performed using a Mann Whitney test as data did 
not conform to a normal distribution.  
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2.4.7 Patient and denture hygiene habits and the OHIP 
The average overall OHIP score was measured and assessed to see if oral hygiene 
practices such as hygiene status, denture cleaning frequency and sleeping with a 
denture in situ had a significant impact on general oral health related quality of 
life. No significant differences in OHIP score were noted between those with good 
or poor oral hygiene (Fig 2.9A) [Median: 19 (min: 0, max: 51) v 12 (min: 0, max: 
56), p>0.05] Frequency of cleaning dentures (Fig 2.9B) [Median: 17 (min: 0, max: 
56) v 17 (min: 0, max: 51), p>0.05] or sleeping with denture in situ, (Fig 2.9C) 
[Median: 19 (min: 0,max: 51) v 10 (min: 0, max: 56), p>0.05]  did not appear to 
have a significant impact on oral health related quality of life. 
 
Each of the groups looking at patient and denture hygiene habits were further 
separated into healthy and DS groups, to investigate if disease status impacted 
oral health related quality of life when combined with poor oral hygiene habits. 
The presence and severity of DS appeared to have no effect on OHIP score when 
comparing hygiene status as no differences were detected between any of the 
groups (Fig 2.10A) Frequency of which dentures were cleaned each day did not 
appear to affect whether the patients were healthy or diseased (Fig 2.10B). 
Moreover, the findings indicated that the patients oral health related quality of 
life was unaffected by disease status when sleeping with a denture in situ (Fig 
2.10C). 
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Figure 2.9: The oral health impact of common oral hygiene practices.  
Overall OHIP score was assessed for differences between those with good or poor oral hygiene (A), those that clean their denture once or 
twice per day (B) and those that sleep with their denture in situ and those that do not (C). Data represents median. Statistical analysis 
was performed using a Mann Whitney test as data did not conform to a normal distribution.  
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Figure 2.10: The oral health impact of common oral hygiene practices on healthy and DS paients.  
Overall OHIP score was assessed for differences between healthy patients and those with DS. Healthy and diseased patient groups were 
further split into those with good or poor oral hygiene (A), those that clean their denture once or twice per day (B) and those that sleep 
with their denture in situ and those that do not (C) and assessed for differences that may be accounted for by disease status. Data 
represents median. Statistical analysis was performed using a Kruskal-Wallis test with Dunn’s post-test to compare all groups to each 
other.  
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2.5 Discussion 
Population growth and an increasingly elderly population is leading to a rising 
demand to deliver sufficient healthcare to the population. Those most often in 
need of healthcare are the elderly population, and they are most frequently 
associated with having declining oral health. The identification of associations 
between oral health and systemic diseases such as cardiovascular disease and 
pneumonia has led recently to an increase in research interest in this area (Inaba 
and Amano, 2010, Farquharson et al., 2012). Moreover, the population group most 
at risk of developing these diseases are the elderly population, i.e. those ≥70 years 
old. As greater than 70% of the population older than 75 years wear some form of 
removable prosthesis, it is possible that the associations being made between oral 
health and systemic disease may somehow implicate denture related hygiene and 
disease (Iinuma et al., 2015).  
 
Our patient cohort was comprised of predominantly females, which supports 
previous studies that found a higher prevalence of denture wearers are female 
(Bertakis et al., 2000). Furthermore, epidemiological studies have found an 
association with women and increased risk of DS (Kovac-Kovacic and Skaleric, 
2000, Nevalainen et al., 1997, Mikkonen et al., 1984). However, the reason why 
women seem to be more prone to developing DS is unknown.  
 
The prevalence rates of DS, varies considerably, with studies reporting rates of 
between 15% and 78% (Gendreau and Loewy, 2011). This large variation can be 
explained by the multifactorial aetiology of DS. Factors such as poor denture fit, 
poor hygiene, lack of access to dental care and smoking are just some examples 
that may contribute towards DS development (Gendreau and Loewy, 2011). The 
DS prevalence rate of 37.4%, reported in this study, falls somewhere in the middle 
of these two extremes and is similar to other studies conducted within the UK, 
which report rates of 33.2% and 27% (Zissis et al., 2006, Frenkel et al., 2000). 
Nonetheless, of the studies reporting DS prevalence rates, there are concerns that 
not all of them are of a representative population and thus their outcomes may 
not be a true reflection of the population. Furthermore, amongst these studies 
different scales are used to categorise DS, whilst the majority used either 
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Newton’s or Budtz-Jorgensen, which are similar and are therefore comparable, 
other studies do not report using any scales to grade DS. Consequently, 
inconsistencies across these studies most likely explains the large variation in 
reported prevalence rates (Gendreau and Loewy, 2011). 
 
This study reports both the proportion of complete denture wearers in comparison 
to partial denture wearers as well as dentate individuals compared to edentate 
individuals. The reasoning of this is because not all of the complete denture 
wearers were fully edentulous, as some had mandibular teeth remaining. This 
categorisation allows us to understand how denture type and the presence of 
natural teeth may differentially affect oral health and microbiology of denture 
wearers. Furthermore, this study reported that 67.9% of participants wore a 
complete dentures, which is a similar to the rate of 64.6% reported (Bilhan et al., 
2012). However, it is difficult to know if these figures are comparative to other 
denture studies as unfortunately the majority of studies failed to provide the 
information of whether dentures were complete or partial. As for natural 
dentition, this study demonstrated that 53.4% of participants were partially 
edentulous, with a range of 1- 28 natural teeth remaining. The loss of natural 
teeth has been shown to impact the denture wearer in several aspects of their 
lives such as, impairing their immune response (Davidopoulou et al., 2013), 
experiencing physical pain, social and psychological discomfort (Davis et al., 2000) 
and even compromising their nutritional status (Chauncey et al., 1984).  
 
The significance of understanding as much about our patients as possible cannot 
be underestimated, given the influence they can for example, have on denture 
microbiology. Microbial colonisation of the denture is considered the primary 
cause of denture related disease, yet there is a large gap in understanding its 
pathogenesis. This is because it is difficult to pinpoint exactly what a healthy or 
diseased denture microbiome should look like given the vast number of biological 
and environmental variables that can affect the microbial composition. Of the 
literature that exists, what is apparent is that there is need of a more in depth 
understanding of the bacterial microbiology, as traditionally the literature is 
disproportionally biased towards fungal microbiology (Altarawneh et al., 2013, 
Dagistan et al., 2009b, Iacopino and Wathen, 1992).  
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In this study, one of the key questions is to investigate how the denture 
microbiology varies between healthy individuals and those suffering from DS. The 
initial CFU analysis revealed that the total bacteria numbers were significantly 
higher in the DS group, yet in terms of aerobes and anaerobes only anaerobes 
showed a difference. This suggests that the development of disease is 
accompanied by a conversion to a more anaerobic microbial composition, yet 
whether this is a cause or effect of disease requires further investigation. The 
microbiological approach used here is limiting and therefore the use of selective 
media may have been more appropriate. However, in terms of identifying the 
specific species responsible for these changes, a more sophisticated technique 
such as high throughput gene sequencing may be more appropriate. Furthermore, 
these findings are reflective of disease progression in periodontal disease (PD). As 
PD progresses from health to disease, the microbial composition becomes 
increasingly comprised of anaerobic bacteria (Haffajee and Socransky, 2006).  
 
Our study identified a 72% prevalence of Candida species on dentures, of which C. 
albicans was the most predominant, and was the only species in which we saw a 
significantly higher CFU count in DS individuals. However, C. glabrata was also 
isolated in a high number of patients (40%), which is in line with studies showing 
the increasing emergence of this species, as it is currently responsible for 
approximately 13% of invasive candidosis cases (Pfaller et al., 2012, Lewis et al., 
2013, Klingspor et al., 2015, Coco et al., 2008a). In addition, the frequency of C. 
glabrata oral carriage rate has been shown to increase with age. Of particular 
interest was the number of patients in which both C. albicans and C. glabrata 
were co-isolated, this was high particularly amongst DS sufferers (35%). Recent 
studies have suggested that when co-cultured C. albicans and C. glabrata form a 
more pathogenic and invasive biofilm than either species alone, this may 
contribute to more severe cases of DS (Alves et al., 2014). However, despite 
showing that DS is more common in dentate individuals, we found significantly 
higher Candida CFU counts on edentate patients and complete dentures when 
compared to dentate and partial dentures, respectively. This may be due to the 
less diverse microbiome of the edentulous patients, as with fewer microorganisms, 
this opens up a niche for Candida spp. to colonise.  
 
  Chapter 2: Patient Demographics 
71 
 
Maintenance of oral hygiene is important to keep the number of microbes residing 
on the denture and in the mouth low in order to prevent disease development. 
Clinicians and dentists stress the importance of maintaining good denture hygiene, 
yet there is not currently a gold standard technique of what is the best method. 
Poor hygiene practices and habits are commonplace amongst denture wearers 
(Gendreau and Loewy, 2011). Yet, interestingly this study found no differences 
between groups for bacteria or Candida levels in the hygiene, cleaning frequency, 
or the sleeping categories. However, this may reflect limitations in the sensitivity 
of CFU analysis for quantifying microbes. Nonetheless, although there appears to 
be little change in the abundance of microbes, this is not to say that the 
microbiome composition had not altered. 
 
Additionally, focusing solely on the microbiology of dentures does not completely 
represent all the problems people experience with them. The use of the OHIP-14 
questionnaire has been shown to be extremely useful within this study in helping 
to identify key factors which may impact on oral health related quality of life 
(Allen and McMillan, 1999, Locker et al., 2001). Identifying these issues will help 
communication between patient and clinician during treatment as some of the 
patient related factors cannot be corrected by new dentures or hygiene regimens. 
The results of the OHIP-14 questionnaire show patients wearing dentures have a 
wide range of disorders impacting their daily lives. In particular physical pain and 
psychological discomfort was frequently reported. This is unlikely to be apparent 
from just a clinical examination, and is supported elsewhere (Jagger et al., 2006, 
Mericske-Stern, 1990).  
 
The OHIP data suggests that dentures have a greater impact on females oral health 
related quality of life than males. This maybe a true difference between genders, 
however, as females are reported to access health care and report problems more 
frequently than males, this may explain our findings particularly given that 69% of 
the study cohort was female (Bertakis et al., 2000). Interestingly, individuals with 
DS did not report to having a more difficult experience with their dentures than 
their healthy counterparts, thus emphasising the point that factors other than 
disease must be taken into account when assessing oral health. Furthermore, fully 
edentulous individuals with complete dentures have a worse experience with 
dentures than partially dentate individuals. This could be because participants 
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feel that their partial dentures are more stable as they are supported by the 
remaining natural teeth, and are therefore more likely to stay in place. Unstable 
dentures may cause discomfort, and the increased risk that they may fall out could 
lead to both social and psychological anxiety.  
 
In summary, understanding as much information regarding the study cohort is 
essential when undertaking such a comprehensive study. Looking at basic denture 
microbiology, we have shown that DS sufferers appear to have a more anaerobic 
microbiome, yet whether this indicates increased pathogenicity requires further 
study. Moreover, in terms of Candida species, the elevated levels of C. albicans 
in DS patients is unsurprising, however the increasing isolation of C. glabrata is 
interesting particularly given its association with antifungal resistance. 
Furthermore, using the OHIP-14 data we have demonstrated that other dentures 
can have an impact on several aspects of the patients’ life, and is not solely 
disease related. Therefore, we have highlighted the importance for future denture 
related studies not to solely focus on the biology, but also to take into account 
the physical and psychological factors which may be affecting the patients’ 
general oral health, in order to gain a more rounded understanding of the patient’s 
condition.  
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CHAPTER FINDINGS 
Anaerobic bacteria are significantly more abundant on the denture of DS sufferers. 
Candida is significantly more abundant on the dentures of DS sufferers, and at the 
species level this could be attributed to C. albicans. 
Edentulous individuals and complete denture wearers have significantly more 
Candida on their dentures. 
Hygiene status and common hygiene habits and practices did not alter the CFU 
levels of bacteria or Candida on dentures. 
Being fully edentulous and having a complete denture have a more negative 
impact on the individuals oral health related quality of life. 
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3 Defining the role of the oral microbiome of 
denture wearers
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3.1 Introduction 
Within the oral cavity, approximately 700 bacterial species have been identified 
using the human oral microbiome database (HOMD) (Chen et al., 2010). Given such 
a vast number of microbes, defining the composition of a ‘typical healthy’ oral 
microbiome is problematic as it is likely to be affected by a combination of both 
biological and environmental factors, each with the ability to alter the microbial 
composition. Furthermore, the addition of a prosthetic denture to the oral cavity 
will only further add to the complexity of understanding this environment. 
Ultimately, this means that each individual have their own unique oral 
microbiome.  
 
The primary disease condition that denture wearers suffer from is denture 
stomatitis (DS). Given that around one fifth of adults wear some form of removable 
denture prosthesis, this represents a large proportion of the population, and thus 
DS should be considered a disease of greater importance (Shulman et al., 2004). 
DS refers to inflammation of the oral mucosa and pathological changes associated 
with the wearing of dentures (Gendreau and Loewy, 2011), and can be classified 
according to the severity of inflammation using a scale first described by Newton 
(Jeganathan and Lin, 1992, Newton, 1962b). The aetiology of DS is related to a 
variety of factors including poorly fitting dentures causing trauma and biological 
factors such as poor salivary flow, smoking or antibiotic treatment, as well as 
microbial infection (Salerno et al., 2011).  
 
Despite the individuality of the oral microbiome certain oral diseases have a 
‘pattern’ of particular bacteria associated with the disease. In periodontal disease 
there appears to be a well defined ecological shift in the microbiome, affected by 
different environmental stressors (Socransky et al., 1998). However in terms of 
denture related disease, there is very little evidence of the microbial changes that 
occur when going from a healthy to diseased phenotype. Nonetheless, without 
firm evidence base DS is regarded as a disease of yeast origin, primarily Candida 
albicans. It affects approximately 30-70% of denture wearers (Gendreau and 
Loewy, 2011), with Candida spp. colonising the denture surface to form co-
aggregates with bacteria and other yeasts to build complex microbial communities 
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known as biofilms. The majority of literature in this area focuses solely on Candida 
spp. as the primary cause of infection, however, there is increasing evidence to 
suggest that this is very much a polymicrobial disease in which bacterial and yeast 
interactions play a role in disease pathogenesis (Morales and Hogan, 2010, Shirtliff 
et al., 2009). Several studies have isolated bacteria directly from the surface of 
dentures using standard microbial culturing techniques, primarily streptococci and 
staphylococci species (Sumi et al., 2002, Ealla et al., 2013, Daniluk et al., 2006, 
Sumi et al., 2003). However, culture based methods do not always give a 
comprehensive representation of the polymicrobial population, which can contain 
up to 1011 microbes per milligram of denture plaque (Nikawa et al., 1998). The 
advent of high throughput sequencing, however, has revolutionised our 
understanding of microbial ecosystems, and thus using this superior method we 
can for the first time gain an insight into the oral microbiome of denture wearers.  
 
Understanding the microbiome may not be so straightforward, as many factors can 
alter the composition, with denture hygiene thought to have a strong impact. 
Moreover, good denture hygiene practice is not always commonplace amongst 
denture wearers. This could be attributed to the fact that the majority of 
individuals are elderly, many of whom are institutionalised and are unable to 
implement or are simply unaware of the importance of maintaining good denture 
hygiene (Petersen and Yamamoto, 2005). Failure to clean the denture and oral 
cavity sufficiently can lead to an accumulation of bacterial and fungal plaque on 
the denture surface and is thought to be one of the main causes of denture-related 
disease. Therefore, understanding how key factors such as hygiene habits and 
practices can impact the composition, is crucial to gaining a more comprehensive 
picture of the microbiome. 
 
In addition to an incomplete understanding of the composition of denture plaque, 
we also have limited knowledge and understanding of the local host immune 
response. It has been established that the immune response is gradually impaired 
with increasing age (Muller and Pawelec, 2014, Castelo-Branco and Soveral, 2014), 
but with the addition of loss of natural teeth an even greater rapid decline in host 
protective responses in the oral cavity is reported (Davidopoulou et al., 2013). 
Antimicrobial peptides (AMP) including cathelicidin LL-37, histatins and defensins, 
which exhibit antimicrobial and immunoregulatory properties and protect mucosal 
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surfaces against pathogens, have been found to be present in saliva. However, no 
studies have yet investigated salivary AMPs in denture wearers and the potential 
role they may play in the protection against denture plaque. Thus, a more in depth 
investigation is required into the host-microbiome relationship in denture wearing 
individuals, which may help towards understanding the pathogenesis of DS. 
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3.2 Aims 
It is hypothesised that the oral ecology of natural and non-natural surfaces of 
denture wearers is affected by host related factors, which in turn affects disease 
outcomes. Therefore, the aim of this chapter was to carry out a detailed site-
specific analysis of the oral microbiome of denture wearers using high throughput 
16S rRNA gene sequencing technology, and to further this with respect to candidal 
load. A secondary aim was to investigate the relationship between denture plaque 
composition, oral disease and host related factors, including immunological and 
behavioural parameters. This is the first study to provide such a detailed microbial 
analysis of denture biofilms. The following key questions were investigated:  
 
 What is the oral microbial composition of the denture, mucosal tissue and 
dental plaque of a denture wearer? 
 Does the composition vary between sample sites, and if so, to what extent?  
 Is microbiome composition different between health and DS? 
 Does the presence of natural teeth or the denture type have an impact on 
the microbiome composition? 
 How does candidal load effect the composition of the microbiome?  
 Is there a relationship between host factors and microbiome composition? 
 How does denture hygiene effect the microbiome on the denture? 
 How does denture hygiene effect the microbiome of the mucosa? 
The data represented in this chapter has been published in: 
O'Donnell LE, Robertson D, Nile CJ, Cross LJ, Riggio M, Sherriff A, et al. The Oral 
Microbiome of Denture Wearers Is Influenced by Levels of Natural Dentition. PLoS 
One. 2015;10(9):e0137717. 
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Work from this chapter has been presented at the following conferences: 
 
L. O’Donnell, E. Zaura, B. Brandt, C. Nile, D. Robertson, G. Ramage. ‘Host 
microbiome interactions in the oral cavity of a denture wearer’. International 
Association for Dental Research (IADR), Boston, USA, March 2015.  
L. O’Donnell, E. Zaura, B. Brandt, C. Nile, D. Robertson, G. Ramage. ‘Microbiome 
Interactions in the Oral Cavity of a Denture Wearer’. British Society for Oral and 
Dental Research (BSODR), Cardiff, UK, September, 2015. 
 
 
Illumina sequencing and initial data sequencing analysis was carried out at the 
department of Preventive Dentistry, Academic Centre for Dentistry Amsterdam, 
University of Amsterdam and VU University Amsterdam, Amsterdam, the 
Netherlands. The key individuals involved at ACTA were Mark Buijs, who carried 
out DNA extractions, qPCR and sequencing and Egija Zaura and Bernd Brandt who 
were involved in the initial sequencing data analysis. My role was primarily in all 
the downstream analyses. 
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3.3 Methods 
3.3.1 Sample collection and processing 
Samples intended for 16S high throughput gene sequencing, which included the 
denture swab, mucosal swab and dental plaque sample, were collected as 
previously described (section 2.3.2). After collection, the samples were 
transferred to a category II laboratory for processing and storage at - 80 oC. Upon 
completion of sample collection 131 denture swabs, 131 mucosal swabs and 79 
dental plaque samples were transferred to the department of preventive 
dentistry, Academic Centre for Dentistry Amsterdam, VU University Amsterdam 
for DNA extraction and sequencing. 
3.3.2 DNA isolation of high throughput sequencing samples 
DNA was extracted from 131 denture swabs, 131 mucosal swabs, and 79 dental 
plaque samples. Dental plaque samples were centrifuged for 15 min @ 13,000 x g 
the supernatant was removed and the sample resuspended in 150 µl TE buffer. 
Swab samples were sonicated for 30 sec, and then the sonicated fluid was 
transferred into a deep well plate and centrifuged for 15 min at 13,000 x g. The 
precipitate was then resuspended in 150 µl TE buffer. All samples were then 
transferred to a plate with each well containing 0.25 ml of lysis buffer (AGOWA 
mag Mini DNA Isolation Kit, AGOWA, Berlin, Germany), 0.3 g zirconium beads 
(diameter, 0.1 mm; Biospec Products, Bartlesville, OK, USA) and 0.2 ml phenol. 
The samples were homogenized with a Mini-beadbeater (Biospec Products) for 2 
min. DNA was extracted with the AGOWA mag Mini DNA Isolation Kit. During the 
DNA extraction process not all samples had sufficient DNA to use for sequencing, 
therefore DNA from 108 denture samples, 87 mucosal samples and 63 dental 
samples remained for sequencing, collectively all these samples originated from 
123 patients. This process was carried out by Mark Buijs (ACTA).  
 
3.3.3 Quantitative PCR of high throughput sequencing samples 
Real time qPCR was performed to determine the concentration of DNA per sample. 
Primers and a probe for the 16S rRNA gene were used, (F: 
TCCTACGGGAGGCAGCAGT, R: GGACTACCAGGGTATCTAATCCTGTT Probe: 6FAM-
CGTATTACCGCGGCTGCTGGCAC-BBQ). As an internal control for PCR inhibition a 
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qPCR of PhHV (Phocid herpesvirus type 1 gB gene) was also performed as described 
by Watzinger et al (2004). The total reaction volume was 20 μl, including 3 μl of 
DNA. Reactions contained a 26PCR Probe Master Mix (Roche), for 16S rRNA, 7.5 
pmol primers and 3.8 pmol probe. For PhHV 1.8 pmol primers and 0.4 pmol probe 
of each primer was used. qPCR was carried out using the Light cycler LC480-II 
(Roche Diagnostics, Switzerland) under the following conditions: an activation 
step of 10 min at 95oC, followed by 50 cycles consisting of a denaturation step at 
95oC for 30 sec, an annealing step at 60oC for 30 sec, and an extension step at 
72oC for 30 sec. Bacterial 16S rDNA concentrations (CFU/mL) were determined 
from standard curves of E. coli K12 cultures. 
 
3.3.4 PCR amplification and Illumina sequencing 
Amplicon libraries of the V4 hypervariable region of the 16S rRNA gene were 
generated for each of the individual samples. PCR was performed using the 
forward primer 515F (GTGCCAGCMGCCGCGGTAA) and the reverse primer 806R 
(GGACTACHVGGGTWTCTAAT) (Caporaso et al., 2011). The primers included 
Illumina adapters and a unique 8-nt sample index sequence key (Kozich et al., 
2013). The amplification mix contained 2 units of Phusion HotStart II High fidelity 
polymerase (Thermoscientific), 1 unit Buffer Phusion HS II (5x), including 1.5 mM 
MgCl2 (Thermoscientific), 0.2 mM dNTP (Thermoscientific, Germany) and 1 µM of 
each primer. To each reaction 1 ng of DNA template was added. After 
denaturation (98oC; 30 sec), 35 cycles of denaturation (98oC; 10 sec), annealing 
(55oC; 30 sec), and extension (72oC; 30 sec) were performed. Individual amplicon 
libraries were analyzed for DNA content with the fluorescent Quant-iT™ 
PicoGreen® dsDNA Assay Kit (Invitrogen). The libraries were pooled in equimolar 
amounts. The amplicons were purified by means of the IllustraTM GFXTM PCR DNA 
and Gel Band Purification Kit (GE Healthcare, Eindhoven, the Netherlands). The 
quality and the size of the amplicons were analyzed on the Agilent 2100 (Santa 
Clara, CA, USA). The amplicon was sequenced in paired end mode on a MiSeq 
sequencing system (Illumina, Eindhoven, the Netherlands) with the v2 kit 
(Illumina) (Caporaso et al., 2012, Kozich et al., 2013). 
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3.3.5 Sequencing data analysis 
Reads were first quality filtered using Trimmomatic v0.32, (Bolger et al., 2014). 
Next, the reads were merged using fastq-join implemented in QIIME v.1.8.0 
(Bolger et al., 2014). Sequences were clustered into operational taxonomic units 
(OTUs) using USEARCH v7.01090 (Edgar, 2013), after being quality filtered with 
usearch (maxee 0.5). The representative sequence of each cluster was assigned a 
taxonomy using the RDP classifier (ref: Cole JR, Wang Q, Cardenas E, Fish J, Chai 
B, et al. (2009) The Ribosomal Database Project: improved alignments and new 
tools for rRNA analysis. Nucl Acids Res 37: D141–145. doi: 10.1093/nar/gkn879) 
(QIIME v.1.8.0) (Greengenes v13.8 97_otus set) with a minimum confidence of 0.8. 
All bioinformatics analysis was carried out by Bernd Brandt (ACTA).  
 
3.3.6 Candida CFU quantification 
The denture sonicate was processed and plated out onto Candida colorex agar 
plates, the colonies were counted and the abundance per mL was quantified, as 
previously described (section  2.3.4).  
 
3.3.7 ELISA testing 
Clarified saliva samples were used to assess the presence of AMPs within saliva by 
enzyme-linked immunosorbant assay (ELISA). ELISA kits for LL-37 (Hycult biotech, 
The Netherlands), Calprotectin (Hycult biotech), Lactoferrin (Hycult biotech), 
HNP1-3 (Hycult biotech), Histatin 5 (Stratech scientific, Suffolk, UK) and Beta 
defensin 1 (BD1) (Peprotech, London, UK) were used according to manufacturer’s 
instructions. Clarified saliva samples were diluted 1:5 in assay buffer (PBS, 0.5% 
BSA, 0.1% Tween20).  
 
3.3.7.1 LL-37, Calprotetin, Lactoferrin and HNP1-3 ELISA  
For the Hycult biotech kits, LL-37, Calprotectin, Lactoferrin and HNP1-3, all 
reagents within the kit were brought to room temperature (20-25oC) before use. 
Plates were pre-coated with capture antibody and therefore were ready for use 
directly from the kit. 100 μL of each sample and standards of known concentration 
were loaded into the plate provided in duplicate. Standard concentrations varied 
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depending on the peptide being detected. Plates were left to incubate for 1 h at 
room temperature. Contents were then discarded and washed with 200 μL of the 
wash buffer provided, this was repeated a further two times. 100 μL of diluted 
tracer antibody was added and the plate was incubated at room temperature for 
1 h. The plates were washed as previous and 100 μL of streptavidin-peroxidase 
was added. Plates were incubated for 1 h at room temperature and then washed. 
100 μL of 3,3’,5,5’-tetramethylbenzide (TMB) substrate was added and the plates 
were incubated in the dark for 30 min. The reaction was stopped by adding 100 
μL of the stop solution provided. Absorbance was read using a plate reader 
(FLUOstar Omega BMG Labtech, VA, USA) at 450 nm with a 650 nm wavelength 
correction. A standard curve was constructed by plotting the mean absorbance for 
each standard against the appropriate protein concentration and the R-squared 
calculated using a computer program (Omega analysis software, VA, USA). Results 
were calculated using a 4-parameter curve fit to determine the concentration of 
protein release in samples tested.  
 
3.3.7.2 Beta defensin 1 ELISA 
For the BD-1 ELISA, Capture antibody (1 μg/mL) was diluted in PBS to a 
concentration of 0.5μg/mL and 100 μL added to each well of a Nunc™ Maxisorp® 
flat bottomed microtitre plate (Fisher, Loughborough, UK). Plates were sealed and 
incubated overnight at room temperature. Contents were then discarded and 
washed 4 times with 300 μL of wash buffer per well. Plates were then blocked 
with 300 μL of the block buffer provided for 1 h at room temperature to block 
non-specific binding. Plates were washed as previously described (section 
3.3.7.1). Standards were serially diluted in diluent with concentrations ranging 
from 0 - 1 ng/mL. 100 μL of samples and standards were added to each well and 
incubated at room temperature for 2 h. Plates were washed and 100 μL of 
detection antibody, which had been diluted to a concentration of 0.5 μg/mL, was 
added. Plates were incubated for 2 h at room temperature and were washed as 
previous. The avadin-HRP conjugate was diluted 1:2000 in diluent and 100 μL was 
added to each well and left to incubate for 30 min at room temperature. Plates 
were washed and 100 μL of 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid 
(ABTS) substrate was added to each well. Colour development was monitored and 
absorbance was read using a plate reader (FLUOstar Omega BMG Labtech) at 405 
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nm with a 650 nm wavelength correction. Standard curves were prepared and 
results calculated as previously described (section 3.3.7.1).  
 
3.3.7.3 Histatin 5 ELISA 
All reagents were prepared for use as per manufacturer’s instructions. Plates were 
pre-coated with the capture antibody. 100 μL of samples and standards, were 
added to the appropriate wells with concentrations ranging from 800 to 0 ng/mL. 
Plates were sealed and incubated for 2 h at 37oC. Liquid was removed from each 
well but the plate was not washed. 100 μL of biotin-antibody was added to each 
well, which was then incubated for 1 hour at 37oC. Plates were washed with 200 
μL per well of the provided wash buffer, this was repeated a total of three times. 
100 μL of HRP-avidin was added per well, plates were sealed and incubated for 1 
h at 37oC. Plates were washed 5 times. 90 μL of TMB substrate was added to each 
well and incubated in the dark for 15-30 min. 50 μL of stop solution was added per 
well. The absorbance was read using a plate reader (FLUOstar Omega BMG 
Labtech) at 450 nm with a 570 nm wavelength correction. Standard curves were 
prepared and results calculated as previously described (section 3.3.7.1).  
 
3.3.8  Analysis of oral hygiene statistics 
The data collected from the clinical information sheet and oral health 
questionnaire was collected and analysed, as previously described (section 2.3.3). 
In order to assess the effect of denture hygiene on the microbiome, three 
categories were selected: 
1. Oral hygiene, classed as either good or poor.  
2. Frequency of denture cleaning. Participants were separated in two groups, 
those that cleaned their denture once per day and those that cleaned 
twice. 
3.  Sleeping with or without a denture in situ. Participants were separated 
into those that slept with their denture in situ and those that did not.  
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Patient demographics regarding oral hygiene status, denture cleaning frequency 
and denture sleeping habits are shown in table 2.2 of the patient demographics 
chapter 2. 
 
3.3.9 Statistical analyses 
The data set was randomly sub-sampled to 770 reads per sample (minimum 
number of reads per sample was 776) to include the maximum number of samples 
for analysis. OTU datasets were reduced by log2 transformation so as to carry out 
principal component analysis (PCA) and diversity statistics (Shannon diversity 
index and Dominance index). Analysis was carried out using PAST software 
(Hammer O, 2001). 
 
A one-way ANOVA test was applied to compare diversity statistics at oral 
microbiome sites using GraphPad Prism software (version 4; La Jolla, CA, USA). 
Principal componant analysis (PCA) was used to reduce the dimensionality of the 
OTU dataset.  258 items were entered into the PCA. A scree plot was used to 
determine how many components emerged. Factor loadings above 0.15 on a 
component were considered to have a strong association with that component and 
were deemed to be the most informative in describing the microbiome 
components. To determine if distinct clusters formed for each group on the PCA 
plots, new variables were created for each principle component by using the 
factor loadings as regression coefficients, producing a score for each sample. 
These scores were then used as outcome variables to compare between groups 
(using t-tests where appropriate- dentate/edentate and complete/partial 
dentures groups).  
 
The contribution of each bacterial class was calculated in terms of proportion to 
the overall sample and an unpaired T-test was used to compare health and DS and 
smoker and non-smoker groups.  Diversity statistics were compared via a t-test 
with GraphPad Prism v5. Spearman’s rank correlation was used to assess 
correlations between the abundance of individual bacterial classes or genera with 
the proportion of Candida spp. found on dentures (CFU counts), using SPSS version 
20.  
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Salivary concentrations of AMPs were compared between healthy and DS groups, 
dentate/edentate groups and complete/partial groups. Data were log transformed 
and analysed using a t-test with GraphPad Prism. Furthermore Spearman’s rank 
correlation was used to assess correlations between the abundance of individual 
bacterial classes or genera found on dentures with the concentrations of salivary 
AMPs. 
 
To visualize the relationships and associations of the microbiomes with 
environmental variables, canonical correspondence analysis (CCA) was applied. 
This form of analysis, carried out using PAST, allows the visualisation of OTU 
distribution and sample group distribution in relation to a number of 
environmental variables. Environmental variables included were Candida CFU 
counts and salivary concentration of a number of AMPs. The significance of each 
of the CCA axes was calculated by permuting the data 999 times. 
 
Candida CFU counts were compared between healthy and DS groups, 
dentate/edentate groups and complete/partial groups. Data were log transformed 
and analysed using a t-test with GraphPad Prism v5, as indicated by the mean and 
median values shown throughout the results section. 
 
The contribution of each bacterial class was calculated in terms of proportion to 
the overall sample, a Mann-Whitney test was used to compare between denture 
hygiene status, cleaning frequency and sleeping with denture in situ to determine 
statistical significance.  Diversity statistics used a Mann Whitney test to compare 
between the same groups. A Kruskall-Wallis test with Dunns post-hoc test was 
employed to compare differences when the groups were further split into healthy 
and DS groups to account for multiple pair-wise comparisons. 
 
 
3.3.10  Study Design  
The study was designed as a pilot study and was initially only powered to detect 
a biologically meaningful association between health and DS and microbiome 
composition, and therefore was not originally powered to detect differences 
between additional variables including, denture type, dentate status, Candida 
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spp. levels and salivary AMP levels. Thus, non-significant results between these 
variables are not necessarily absence of effect, but a result of not achieving the 
full sample size required.   
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3.4 Results 
3.4.1  Illumina sequencing output 
Illumina high throughput gene sequencing was carried out on 108 denture swabs, 
87 mucosal swabs and 63 of the dental plaque clinical samples that were 
collected. Across all of the samples 632 OTUs were identified, with an average of 
94 OTUs per sample (SD 39; min 25, max 254), 536 of which contained a minimum 
of 5 reads. The data was sub-sampled to 770 reads per sample in order to avoid 
bias of variable sample size. After sub-sampling 502 OTUs remained with an 
average of 46 OTUs per sample (SD 18; min 11, max 121). The samples were 
categorised into five main phyla which represented 99.6% of the reads: Firmicutes 
(40.6%), Actinobacteria (23%), Bacteriodetes (22.2%), Proteobacteria (9.8%) and 
Fusobacteria (4%). Samples were categorised into groups according to sample site: 
denture (n=108), mucosal (n=87) and dental (n=63), with 337, 414 and 306 OTUs 
identified, respectively.   
 
3.4.2 Oral microbiome by sample site  
Clinical samples were separated into groups according to sample site: denture 
(n=108), mucosal (n=87) and dental (n=63), with 337, 414 and 306 OTUs identified, 
respectively.  On average, denture samples had 42 OTUs (SD 14; min 13, max 87), 
mucosal 49 OTUs (SD 20; min 11, max 121) and dental 51 OTUs (SD 37; min 16, 
max 306) (Figure 3.1A).  Interestingly, denture plaque samples were found to have 
significantly less OTUs compared to dental, (p<0.01), and mucosal, (p<0.05), 
plaque. Figure 3.1B shows the relative abundance of bacterial taxa at the class 
level present in each sample type, and demonstrates considerable variation in 
taxonomic profiles between sites. Actinobacteria and Bacilli were the two 
predominant classes found at denture and mucosal sites, comprising 75.2% and 
66.4%, respectively, of the overall composition when combined. However, 
Actinobacteria and Bacilli only contributed only 30% to dental plaque. Diversity 
statistics applied across samples revealed that dental plaque is more diverse 
(Figure 3.2A) than both denture plaque (Mean: 2.35 v 2.89, p<0.001), and mucosal 
surfaces (Mean: 2.44 v 2.89, p<0.001), with less dominant taxa according to the 
dominance index (p<0.001) (Figure 3.2B.). 
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Figure 3.1: Microbiome composition of various sample sites in the oral cavity 
of denture wearers. 
108 denture swabs, 87 mucosal swabs and 63 dental plaque samples underwent 
pyrosequencing of the 16S hypervariable V4 region to determine the bacterial 
composition of denture, palatal mucosal and dental plaque. (A) Number of OTUs 
identified per sample at each sample site (B) Relative abundance of bacterial taxa 
at the class level per sample site. Data represents the mean (*p<0.05, *** p<0.001). 
Statistical analysis was performed using a one-way ANOVA with Bonferonni post-
test to compare all groups to each other.  
 
        
PCA was applied to reduce the multidimensionality of the dataset. Two primary 
principal components emerged from this analysis. On average, dental samples 
scored higher on PC1 than denture or mucosal samples (p<0.0001) (Fig 3.3A), 
indicating higher frequencies of Fusobacterium, Corynebacterium, Selenomonas, 
Campylobacter and Prevotella, and lower of Streptococcus and Rothia. 
Furthermore, when denture and mucosal samples were directly compared, 
denture samples had a higher average score on PC1 than mucosal samples 
(p=0.0006) (Fig 3.3B). This indicated higher frequencies of Lactobacillus, 
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Actinomyces, Atopobium and Scardovia, and lower frequencies of Streptococcus, 
Rothia and Haemophilus.  
 
 
Figure 3.2: Microbial diversity varies between sample sites in the oral cavity 
of denture wearers. 
The taxonomic diversity and dominance of each group was analysed and compared 
via a (A) Shannon Diversity Index and (B) Dominance Index.  Data represents the 
mean (*** p<0.001). Statistical analysis was performed using a one-way ANOVA 
with Bonferonni post-test to compare all groups to each other.  
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Figure 3.3: Principal component analysis of denture, mucosal and dental 
samples. 
PCA was applied to all sample types to reduce the multidimensionality of the data 
and to determine variances between (A) Denture, Mucosal and Dental groups and 
(B) Denture and Mucosal groups. For statistical analysis new variables were 
created for each principle component by using the factor loadings as regression 
coefficients, producing a score for each sample. These scores were then used as 
outcome variables to compare between groups using a two-tailed unpaired t test.  
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3.4.3 Dentate v Edentate and partial v complete denture 
microbiome 
Samples were separated into groups depending on denture type 
(complete/partial) and on the presence or absence of teeth (dentate/ edentate), 
and the microbiome were compared at the denture and mucosal sites.  PCA was 
applied to the data, and as previous, two main principal components emerged 
from this analysis. When comparing denture type on the denture samples (Fig 
3.4A), partial dentures scored higher on PC2 than complete denture samples 
(p=0.0073), revealing higher frequencies of Actinomyces, Haemophilus, 
Corynebacterium and Veillonella and lower frequencies of Lactobacillus and 
Streptococcus. Denture samples were then split into dentate and edentate groups 
(Fig 3.4B). Dentate samples scored higher along PC2 than edentate (p=0.0194), 
and as with the partial denture group, they had higher frequencies of 
Actinomyces, Haemophilus, Corynebacterium and Veillonella and lower 
frequencies of Lactobacillus and Streptococcus. At the mucosal microbiome 
partial dentures scored higher on PC1 than complete denture samples (Fig 3.4C) 
(p=0.0001), and showed higher frequencies of Actinomyces, Prevotella, 
Haemophilus and Neisseria and lower frequencies of Streptococcus, Lactobacillus 
and Jathinobacterium. No differences in scores were found between dentate and 
edentate samples (Fig 3.4D). 
 
The diversity of the same sample groups were compared and revealed that partial 
denture samples were significantly more diverse than those from complete 
dentures at both the denture (Mean: 2.29 v 2.52, p<0.05) and mucosal surfaces 
(Mean: 2.34 v 2.67, p<0.05], (Fig 3.5A and 3.5E). Furthermore, the dentate 
patients had a significantly more diverse microbiome than the edentate, (Fig 3.5C 
and 3.5G); these results were found at both the denture (Mean: 2.45 v 2.25, 
p<0.05) and mucosal surfaces (Mean: 2.6 v 2.25, p<0.05). In terms of microbial 
dominance of samples, the dominance index showed no significant differences 
between groups at the denture (Fig 3.5B and 3.5D) and mucosal surfaces (Fig 3.5F 
and 3.5H) for both complete/partial and dentate/edentate groups.  
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Figure 3.4: Principal component analysis comparing dentition status and 
denture type. 
Samples were separated into groups based on denture type, (complete or partial) 
and dentition status (dentate or edentate) and principal component analysis was 
applied to the data for the denture (A-B) and mucosal microbiome (C-D). For 
statistical analysis new variables were created for each principle component by 
using the factor loadings as regression coefficients, producing a score for each 
sample. These scores were then used as outcome variables to compare between 
groups using a two-tailed unpaired t test.
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Figure 3.5: Diversity statistics comparing dentition status and denture type. 
Samples were separated into groups based on denture type, (complete or partial) 
and dentition status (dentate or edentate) and the taxonomic diversity of each 
group was analysed and compared via a Shannon Diversity Index for the denture 
(A and C) and mucosal microbiome (E and G). Sample dominance was assessed by 
dominance index at the denture (B and D) and mucosa (F and H).  Data represents 
the mean (* p<0.05). Statistical analysis was performed using a two-tailed 
unpaired t test.  
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3.4.4 Health v Disease 
Based on Newton’s inflammation scores, patients were separated into health and 
DS groups, and their microbiomes analysed. When comparing the relative 
abundance (%) of bacterial classes between health and DS groups, there were no 
differences found in dental plaque (Fig 3.6A) (Appendix V) or when comparing 
genera (Appendix VI). Denture plaque showed significantly higher proportion of 
Bacteroidia (Mean: 2.97 v 5.18, p<0.05) and Clostridia (Mean: 8.65 v 11.24, 
p<0.05), in DS patients (Fig 3.6C) (Appendix VII), and when investigated at the 
genus level (Appendix VIII), further increases in the DS group could be attributed 
to Prevotella spp. (Mean: 2.81 v 4.85, p<0.01) and Veillonella spp (Mean: 6.40 v 
7.53, p<0.05), respectively. The mucosal microbiome showed an altered 
composition between health and disease, in classes Actinobacteria (Mean: 17.56 
v 23.83, p<0.05), Bacteroidia (Mean: 4.85 v 8.64, p<0.05), Clostridia (Mean: 8.17 
v 10.07, p<0.05) and Fusobacteria (Mean: 1.87 v 1.07, p<0.05) (Fig 3.6E) (Appendix 
IX). At the genus level an increase in Prevotella (Mean: 4.19 v 6.85, p<0.05) was 
seen in DS patients (Appendix X). PCA was applied to the data, and as previous, 
two primary principal components emerged from this analysis, which explained 
the largest proportion of variance within the data. Scores based on factor loadings 
were used to compare healthy and DS groups for dental, denture and mucosal 
samples to determine if they formed distinct clusters (Fig 3.6B, 3.6D, and 3.6F). 
No significant differences were found between health and DS along PC1 or PC2 at 
any of the sample sites. Furthermore, Shannon diversity index and dominance 
index statistics indicated that mucosal samples from DS patients were significantly 
more diverse (Mean: 2.27 v 2.69, p<0.01) (Fig 3.7E) with less dominant taxa (Mean: 
0.23 v 0.16, p<0.05) (Fig 3.7F) than their healthy counterparts. No differences 
were found in dental (Fig 3.7A-B) and denture plaque (Fig 3.7C-D). Further analysis 
of diversity was carried out by sub-grouping into mild inflammation (Newton’s 
grade 1) and severe inflammation (Newton’s grade 2&3); however, no differences 
that were statistically significant were observed. 
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Figure 3.6: Microbiome composition and principal component analysis of healthy and DS samples.  
The microbiome composition was assessed for differences between health and disease in (A) Dental Plaque, (C) Denture Plaque and (E) 
Mucosal Plaque at the class level. Principal component analysis was applied to the data for the dental (B), denture (D) and mucosal 
samples (F). Statistical analysis was performed using a two-tailed unpaired t test. For PCA, new variables were created for each principle 
component by using the factor loadings as regression coefficients, producing a score for each sample. These scores were then used as 
outcome variables to compare between groups using a two-tailed unpaired t test.  
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Figure 3.7: Diversity statistics comparing health and DS.  
The taxonomic diversity of health and DS groups was analysed and compared via 
a Shannon Diversity Index in (A) Dental Plaque, (C) Denture Plaque and (E) Mucosal 
Plaque. Sample dominance was assessed by dominance index in (B) Dental Plaque, 
(D) Denture Plaque and (F) Mucosal Plaque. Data represents the mean (* p<0.05, 
** p<0.01). Statistical analysis was performed using a two-tailed unpaired t test.  
 
 
 
 
 
 
 
 
 
 
 Chapter 3: Defining the role of the oral microbiome of denture wearers  
98 
 
3.4.5 Impact of smoking on the microbiome 
The dental, denture and mucosal microbiomes of smokers and non-smokers were 
compared to assess for any differences in composition and diversity. When 
comparing the relative abundance (%) of bacterial classes between health and DS 
groups, there were no differences found in dental plaque classes (Fig 3.8A) 
(Appendix XI) or genera (Appendix XII). Denture plaque showed no differences in 
terms of classes (Fig 3.8C) (Appendix XII), but showed significantly higher 
proportion of Atopbium (Mean: 27.03 v 1.18, p<0.001) and lower proportions of 
Selenomonas (Mean: 0.14 v 0.81, p<0.01) in smokers at the genus level (Appendix 
XIV). The mucosal microbiome found no differences at the class (Fig 3.8E) 
(Appendix XV) or genus levels (Appendix XVI). PCA was applied to the data, and as 
previously described, and two primary principal components emerged from this 
analysis for the dental (Fig3.8B), denture (Fig 3.8D) and mucosal (Fig 3.8F) 
microbiomes. No significant differences were found between smokers and non-
smokers along PC1 or PC2 at any of the sample sites. Furthermore, Shannon 
diversity index and dominance index statistics indicated that no differences were 
found at the dental (Fig 3.9A-B), denture (Fig 3.9C-D) and mucosa (Fig3.9E-F).  
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Figure 3.8: Microbiome composition and principal component analysis of smokers and non-smokers. 
The microbiome composition was assessed for differences between smokers and non-smokers in (A) Dental Plaque, (C) Denture Plaque 
and (E) Mucosal Plaque at the class level. Principal component analysis was applied to the data for the dental (B), denture (D) and mucosal 
samples (F). Statistical analysis was performed using a two-tailed unpaired t test. For PCA, new variables were created for each principle 
component by using the factor loadings as regression coefficients, producing a score for each sample. These scores were then used as 
outcome variables to compare between groups using a two-tailed unpaired t test.  
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Figure 3.9: Diversity statistics comparing smokers and non-smokers. 
The taxonomic diversity of smoker and non-smoker groups were analysed and 
compared via a Shannon Diversity Index in (A) Dental Plaque, (C) Denture Plaque 
and (E) Mucosal Plaque. Sample dominance was assessed by dominance index in 
(B) Dental Plaque, (D) Denture Plaque and (F) Mucosal Plaque. Data represents 
the mean. 
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3.4.6  Impact of Candida on the microbiome 
The impact of increasing Candida CFU on the bacterial microbiome of each 
individual was assessed at the denture and mucosal surfaces. A positive correlation 
was found between Candida CFU and Bacilli class on dentures (p=0.01; Spearman’s 
rho 0.387), but Candida CFU negatively correlated with Fusobacteria (p=0.01; 
Spearman’s rho -0.470) (Fig 3.10). This was reflected at the genus level with 
Lactobacillus (p=0.0001; Spearman’s rho 0.502) and Fusobacteria (p=0.025; 
Spearman’s rho -0.417). No significant correlations were found between bacterial 
classes and Candida on the mucosal surface when assessing the complete cohort.  
 
In addition to the effect of denture type and edentulism on microbiome 
composition and diversity, other factors were also important, including Candida 
CFU count. The average CFU Candida count found on dentures was significantly 
higher in individuals with a complete denture (Mean: 5.77 v 5.02, p>0.01) (Fig 
3.11A) and in edentate individuals (Mean: 5.86 v 5.25, p<0.05) (Fig 3.11B), when 
compared to partial dentures and dentate individuals respectively.  
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Figure 3.10: The impact of increasing Candida spp. CFU on the microbiome of the denture.  
At the denture site the relative abundance of bacterial taxa within each sample was measured against increasing Candida CFUs at the 
class level. Statistical analysis was carried out using Spearman’s rank correlation. 
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Figure 3.11: Abundance of Candida on dentures is affected by denture type 
and presence of natural teeth.  
The average CFU Candida counts found on dentures were compared between 
complete and partial (A) and dentate and edentate (B) patients. *p<0.05, 
**p<0.01. Statistical analysis was performed using a two-tailed unpaired t test.  
 
 
 
3.4.7  Antimicrobial peptide detection in the saliva of healthy and 
diseased patients 
The levels of each AMP were compared between healthy and DS groups, and only 
LL-37 showed significantly elevated levels in DS patients (Mean: 1.04 v 1.28, 
p<0.05) (Fig 3.12 A).  HNP 1-3, lactoferrin, calprotectin, Histatin 5 and BD1, 
showed no statistically significant differences between groups (Fig 3.12 B-F). 
Furthermore, certain salivary AMPs, namely LL37, HNP 1-3 and Histatin 5 all 
showed significantly higher concentrations in patients with partial dentures (Fig 
3.13 A-C), and also in dentate individuals (Fig 3.13 G-I). Calprotectin, Lactoferrin 
and BD1 all showed no differences between complete/partial (Fig 3.13 D-E) and 
dentate/edentate groups (Fig 3.13 J-L) (3.1).  
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Figure 3.12: Concentrations of salivary AMPs increases with severity of 
inflammation.  
The salivary concentrations of (A) LL37, (B) HNP1-3, (C) Lactoferrin, (D) 
Calprotectin, (E) Histatin 5 and (F) BD1 were compared between healthy and 
diseased individuals. Data represents the mean (*p<0.05). Statistical analysis was 
performed using a two-tailed unpaired t test.  
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Figure 3.13: Concentration of salivary AMPs is affected by denture type and 
presence of natural teeth 
The average AMP concentrations found in saliva was compared between complete 
and partial (A - F) and dentate and edentate (G - L) for LL37, HNP 1-3, Histatin 5, 
Calprotectin, Lactoferrin and BD1 respectively. Data represents mean (*p<0.05, 
**p<0.01, **p<0.001). Statistical analysis was performed using a two-tailed 
unpaired t test.  
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Table 3.1: Patients screened for salivary antimicrobial peptides. 
AMP (n)  Healthy 
 n (%)  
DS  
n (%)  
Dentate  
n (%)  
Edentulous 
 n (%)  
Partial  
n (%)  
Complete  
n (%)  
LL37 (103)  64 (62) 39 (38) 66 (64) 37 (36) 63 (61) 40 (39) 
Lactoferrin (125)  81 (65) 44 (35) 68 (55) 57 (45) 40 (32) 85 (68) 
Calprotectin (124)  81 (65) 43 (35) 67 (54) 57 ((46) 41 (33) 83 (67) 
HNP 1-3 (116)  74 (64) 42 (36) 63 (54) 53 (46) 79 (68) 37 (32) 
BD1 (100)  65 (65) 35 (35) 54 (54) 46 (46) 65 (65) 35 (35) 
Histatin 5 (40)  27 (68) 13 (32) 25 (63) 15 (37) 23 (58) 17 (42) 
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3.4.8  Impact of AMP’s on the microbiome 
Next, we investigated the impact of the AMPs on the denture and mucosal 
microbiome. The relative abundance of bacterial classes and genera for the 
complete patient cohort was compared against salivary levels of each AMP. 
However, no significant AMP/bacterial correlations were found at the denture or 
mucosal surface. The AMP saliva concentration was also compared against 
increasing Candida CFU, but again no significant correlations were identified. 
Nonetheless, CCA analysis was performed and demonstrated that at the mucosal 
microbiome distinct clusters formed and showed that the dentate group related 
stronger to the AMPs (Fig 3.14).  
 
 
 
Figure 3.14: Cannonical Correspondence Analysis of the denture microbiome. 
CCA biplot allowing visualisation of dentate and edentate samples, represented 
by dots, in relation to environmental factors, including Candida CFU and salivary 
AMPs, which are represented by vectors. The variability in the samples was 
explained on axis 1 with 26.5% and on axis 2 with 19.3%.  
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3.4.9  Impact of oral hygiene on the denture microbiome 
The Shannon diversity and Dominance index were employed to compare the 
diversity and dominance of the denture microbiome for the different patient and 
denture hygiene practices (Fig 3.15). As for hygiene status, no statistical 
significance was observed between good and poor hygiene groups in terms of 
diversity (Fig 3.15A) [Median: 2.36 (min: 0.79, max: 3.46) v 2.49 (min: 1.53, max: 
3.54), p>0.05] or dominance (Fig 3.15B) [Median: 0.17 (min: 0.06, max: 0.73) v 
0.14 (min: 0.05, max: 0.37), p>0.05]. Whether dentures were cleaned once or 
twice per day appeared to have no effect on the diversity (Fig 3.15D) [Median: 
2.44 (min: 0.96, max: 3.46) v 2.37 (min: 0.79, max: 3.54), p>0.05] or dominance 
(Fig 3.15E) [Median: 0.16 (min: 0.06, max: 0.66) v 0.15 (min: 0.05, max: 0.73), 
p>0.05] of the denture microbiome, this also applied to sleeping with or without 
a denture in situ, (Fig 3.15G) [Median: 2.49 (min: 0.96, max: 3.54) v 2.35 (min: 
0.79, max: 3.08), p>0.05] and (Fig 3.15H) [Median: 0.14 (min: 0.05, max: 0.66) v 
0.17 (min: 0.06, max: 0.73), p>0.05], respectively.  Comparison of the average 
bacterial class proportion between the groups revealed few changes other than 
elevated levels of Alphaproteobacteria [Median: 0 (min: 0, max: 50.52) v 0.13 
(min: 0, max: 30.65), p<0.05], at the denture in those with poor oral hygiene 
(Fig.3.15C) (Appendix XVII). In addition, comparison at the genus level showed 
elevated levels of Scardovia [Median: 0 (min: 0, max: 16.75) v 0.32 (min: 0, max: 
27.27), p<0.05] in the poor hygiene group (Appendix XVIII). As for cleaning 
frequency, only a few significant changes in bacterial classes were identified 
between groups, including an increase in Bacilli [Median: 18.57 (min: 0.39, max: 
81.95) v 32.34 (min: 0.91, max: 96.92), p<0.01] in those that clean twice a day 
(Fig.3.15F) (Appendix XIX), no differences were found in terms of genus (Appendix 
XX). The denture microbiome of those that slept with their dentures in situ had 
significantly higher levels of Bacteroidia [Median: 2.6 (min: 0, max: 40.65) v 1.49 
(min: 0, max: 12.34), p<0.05] Clostridia [Median: 14.94 (min: 0.13, max: 41.17) v 
4.42 (min: 0.26, max: 21.43), p<0.001] Elipsonproteobacteria [Median: 0 (min: 0, 
max: 1.56) v 0 (min: 0, max: 0.26), p<0.05] and Fusobacteria [Median: 1.04 (min: 
0, max: 11.04) v 0.26 (min: 0, max: 4.42), p<0.001], and significantly lower levels 
of Bacilli [Median: 21.3 (min: 0.91, max: 86.88) v 34.61 (min: 0.39, max: 82.86), 
p<0.01] and Betaproteobacteria [Median: 0.39 (min: 0.39, max: 18.05) v 1.36 
(min: 0.91, max: 17.66), p<0.05] (Fig.3.15I) (Appendix XXI). As for the genus, 
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elevated levels of Actinomyces [Median: 23.44 (min: 0, max: 83.25) v 10.58 (min: 
0.39, max: 86.88), p<0.05], Leptotrichicia [Median: 0.58 (min: 0, max: 9.22) v 
0.13 (min: 0, max: 3.64), p<0.001], Nessieria [Median: 0.13 (min: 0, max: 8.70) v 
0.26 (min: 0, max: 16.62), p<0.01] and Veillonella [Median: 6.36 (min: 0, max: 
41.17) v 3.05 (min: 0, max: 20.39), p<0.01] were seen in those that sleep with 
their dentures in situ, as well as decreased levels of Haemophilus [Median: 0.39 
(min: 0, max: 20.13) v 0.78 (min: 0, max: 36.62), p<0.05], Rothia [Median: 2.21 
(min: 0, max: 40.26) v 8.38 (min: 0.13, max: 67.27), p<0.001] and Streptococcus 
[Median: 13.64 (min: 0, max: 86.62) v 25.65 (min: 0, max: 80.91), p<0.05] 
(Appendix XXII). 
 
The impact of disease regarding patient and denture hygiene practices was further 
assessed by separating each group into healthy and DS sufferers. Diversity and 
dominance was assessed across the hygiene status, cleaning frequency and 
sleeping with the denture in situ categories, however, no statistically significant 
changes were noted between any of the groups, across any of the categories (Fig 
3.16). Changes in the average abundance of each bacterial class were compared 
between the healthy and DS groups (Fig 3.17). No significant changes were 
detected across the groups within the hygiene category for any classes of bacteria. 
Within the cleaning category, there was a significant reduction in the level of 
Fusobacteria [Median: 2.08 (min: 0, max: 70.52) v 1.04 (min: 0, max: 14.42), 
p<0.05] between both healthy groups when the denture was cleaned twice per 
day, this was also seen between the healthy (once) group and the DS (twice) group 
[Median: 18.57 (min: 0, max: 70.52) v 1.04 (min: 0, max: 20.13), p<0.05]) (Fig 
3.17B). As for sleeping with a denture in situ, the abundance of Clostridia was 
significantly lower in healthy individuals that do not wear their denture whilst 
sleeping when compared to healthy individuals that sleep with their denture in 
situ [Median: 14.29 (min: 0.26, max: 41.17) v 4.03 (min: 0.26, max: 21.43), 
p<0.01] as well as diseased individuals that sleep whilst wearing their denture 
[Median: 4.03 (min: 0.26, max: 21.43) v 12.47 (min: 0.13, max: 36.75), p<0.001] 
(Fig 3.17C).  
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Figure 3.15: Comparison of changes in the denture microbiome as a result of oral hygiene practices.  
The microbiome was assessed for differences in taxonomic diversity and dominance of denture plaque for hygiene status (A -B), denture 
cleaning frequency (D -E) and sleeping with a denture in situ (G -H). Differences in denture microbiome composition for hygiene status 
(C), denture cleaning frequency (F) and sleeping with a denture in situ (I) was also compared. Data represents the median. Statistical 
analysis was performed using a Mann Whitney test as data did not conform to a normal distribution.  
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Figure 3.16: Comparison of changes in diversity of the denture microbiome as 
a result of oral hygiene practices. 
The microbiome was assessed for differences in taxonomic diversity and 
dominance of denture plaque, healthy and diseased patient groups were further 
split based on hygiene status (A-B), denture cleaning frequency (D -E) and sleeping 
with a denture in situ (G -H). Data represents the median. Statistical analysis was 
performed using a Kruskall-Wallis test with Dunn’s post-test to compare all groups 
to each other. 
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Figure 3.17: The effect of disease status on the denture microbiome as a result 
of oral hygiene practices. 
The microbiome was assessed for taxonomic differences in denture plaque, 
healthy and diseased patient groups were further split based on hygiene status 
(A), denture cleaning frequency (B) and sleeping with a denture in situ (C). 
Statistical analysis was performed using a Kruskall-Wallis test with Dunn’s post-
test to compare all groups to each other. 
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3.4.10  Impact of oral hygiene on the mucosal microbiome 
Differences in the diversity and dominance of the mucosal microbiome were 
assessed using the Shannon diversity index and dominance index for each of the 
patient and denture hygiene categories being measured (Fig 3.18). Comparison of 
good and poor oral hygiene at the mucosa revealed that those with poor oral 
hygiene have a significantly more diverse mucosal microbiome than those classed 
as having good oral hygiene [Median: 2.25 (min: 0.62, max: 3.81) v 2.66 (min: 
1.49, max: 4.15), p<0.05]) (Fig 3.18A). Furthermore, the poor hygiene group had 
significantly less dominant taxa than the good hygiene group [Median: 0.18 (min: 
0.04, max: 0.73) v 0.12 (min: 0.03, max: 0.42), p<0.05] (Fig 3.18B). Cleaning 
dentures either once or twice per day appeared to have no significant effect on 
the diversity [Median: 2.50 (min: 0.75, max: 3.81) v 2.34 (min: 0.62, max: 4.15), 
p>0.05] (Fig 3.18D) or dominance [Median: 0.14 (min: 0.04, max: 0.65) v 0.18 
(min: 0.03 max: 0.73), p>0.05] (Fig 3.18E) of the mucosal microbiome.  The 
mucosal microbiome was also unaffected by sleeping with a denture in situ in 
terms of diversity [Median: 2.31 (min: 0.62, max: 4.15) v 2.41 (min: 0.87, max: 
3.29), p>0.05] (Fig 3.18G) or dominance [Median: 0.18 (min: 0.03, max: 0.69) v 
0.17 (min: 0.06, max: 0.73), p>0.05] (Fig 3.16H). Bacterial class abundance levels 
showed no significant variation between groups in terms of hygiene status (Fig 
3.18C) (Appendix XXIII), yet in terms of genera Bifidobacterium [Median: 0 (min: 
0, max: 15.84) v 026 (min: 0, max: 5.71), p<0.01], Kingella [Median: 0 (min: 0, 
max: 0.78) v 3.9 (min: 0, max: 1.43), p<0.01] and Scardovia [Median: 0 (min: 0, 
max: 0.52) v 0.13 (min: 0, max: 6.10), p<0.001] were significantly elevated in 
those with poor hygiene (Appendix XXIV). No differences were seen at the class 
(Fig 3.18F) (Appendix XXV) or genus (Appendix XXVI) levels for cleaning frequency. 
However, sleeping whilst wearing a denture revealed significantly elevated levels 
of Bacteroidia [Median: 6.95 (min: 0, max: 37.92) v 3.9 (min: 0, max: 15.19), 
p<0.05], Coriobacteria [Median: 0.39 (min: 0, max: 6.23) v 0.13 (min: 0, max: 
3.51), p<0.05], Epsilonproteobacteria [Median: 0.19 (min: 0, max: 1.82) v 0.13 
(min: 0, max: 0.91), p<0.05] and Fusobacteria [Median: 1.17 (min: 0, max: 7.27) 
v 0.26 (min: 0, max: 6.88), p<0.01] (Fig.3.18I). Elevated levels of the genera 
Leptotrichicia [Median: 0.71 (min: 0, max: 7.27) v 0.13 (min: 0, max: 6.49), 
p<0.05] and Rothia [Median: 7.27 (min: 0.65, max: 50.52) v 5.65 (min: 0, max: 
28.70), p<0.05] were found in those that sleep with their denture in situ (Appendix 
XXVIII). 
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As previous, the groups within the hygiene, cleaning and sleeping categories were 
further separated into healthy and DS groups to investigate the impact of disease. 
Microbiome diversity and dominance were compared for each category. The 
diversity of the mucosal microbiome was significantly higher in the poor hygiene 
group with DS when compared to the healthy group with good hygiene [Median: 
2.23 (min: 0.62, max: 3.44) v 2.92 (min: 1.49, max: 4.15), p<0.05] (Fig 3.19A); 
however no significant changes in dominance were detected (Fig 3.19B). Neither 
diversity (Fig 3.19C) nor dominance (Fig 3.19D) showed significant variation 
between groups in the cleaning frequency category, this also applied to sleeping 
with the denture in situ (Fig 3.19E-2F).  There were no significant changes were 
observed when comparing the abundance of individual classes of bacteria across 
the healthy and DS groups within the hygiene (Fig 3.20A), cleaning (Fig 3.20B) or 
sleeping categories (Fig 3.20C). 
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Figure 3.18: Comparison of changes in the mucosal microbiome as a result of oral hygiene practices. 
The microbiome was assessed for differences in taxonomic diversity and dominance of mucosal plaque for hygiene status (A) and (B), 
denture cleaning frequency (D) and (E) and sleeping with a denture in situ (G) and (H). Differences in mucosal microbiome composition 
for hygiene status (C) denture cleaning frequency (F) and sleeping with a denture in situ were compared (I). Data represents the median 
(* p<0.05). Statistical analysis was performed using a Mann Whitney test as data did not conform to a normal distribution.  
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Figure 3.19: Comparison of changes in diversity of the mucosal microbiome as 
a result of oral hygiene practices. 
The microbiome was assessed for differences in taxonomic diversity and 
dominance of mucosal plaque, healthy and diseased patient groups were further 
split based on hygiene status (A) and (B), denture cleaning frequency (C) and (D) 
and sleeping with a denture in situ (E) and (F). Data represents the mean 
(*p<0.05). Statistical analysis was performed using a Kruskall-Wallis test with 
Dunn’s post-test to compare all groups to each other.  
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Figure 3.20: The effect of disease status on the mucosal microbiome as a result 
of oral hygiene practices. 
The microbiome was assessed for taxonomic differences  in mucosal plaque, 
healthy and diseased patient groups were further split based on hygiene status 
(A), denture cleaning frequency (B) and sleeping with a denture in situ (C). 
Statistical analysis was performed using a Kruskall-Wallis test with Dunn’s post-
test to compare all groups to each other. 
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3.5 Discussion 
Improving oral health has become a primary focus in medical research, and thus 
significant amount of time and money has been spent on investigating the 
pathogenesis and prevention of oral disease (Petersen et al., 2005, Petersen, 
2003). This is driven because of the increasing associations between oral health 
and systemic diseases, which includes rheumatoid arthritis, cardiovascular disease 
and respiratory disease (Inaba and Amano, 2010, Farquharson et al., 2012). 
However, this research has focused primarily on dental-related disease, whereas, 
denture-related disease, a problem affecting a large proportion of the ever-
increasing elderly population (Divaris et al., 2012, Griffin et al., 2012), has been 
relatively understudied. Moreover, the oral cavity is a complex anatomical 
structure and the presence of prostheses, such as a denture, may influence the 
ecological balance within the oral cavity. Therefore, a detailed investigation was 
required to gain a more in depth understanding of the oral microbiology of a 
denture wearer.  
 
Historically, denture-related research has a disproportionate focus on yeast 
associated infection (Dagistan et al., 2009a, Pereira-Cenci et al., 2008, Coco et 
al., 2008a), yet there is a distinct lack in understanding of the bacterial 
microbiome within the oral cavity of the denture wearer. The majority of studies 
investigating DS focus primarily on the role of Candida spp. (Pereira-Cenci et al., 
2008, Gendreau and Loewy, 2011), however, given that up to 1011 microbes are 
capable of colonising the denture surface (Nikawa et al., 1998), then it is likely 
that bacteria also play a role in disease. Other studies have investigated the 
bacterial composition of denture plaque, however, these studies have been 
limited by the method of investigation, such as culturing and DNA-DNA 
hybridisation, which limit the number of bacterial species that can be identified 
(Lamfon et al., 2005, Campos et al., 2008, Sumi et al., 2003, Sachdeo et al., 2008, 
Teles et al., 2012). For example, Campos et al (2008) used PCR and identified 82 
bacterial species, this however only made up approximately 50% of the bacterial 
flora detected in the samples, as the remainder were not-yet cultivated 
phylotypes, and thus remained unidentified (Campos et al., 2008). This study 
however has for the first time used detailed high-throughput 16S rRNA gene 
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analysis of the oral microbiomes of a range of denture wearers, which gives a more 
comprehensive and global representation of the bacterial microbiome.  
 
We first assessed the bacterial microbiome of three independent sites from the 
oral cavity of denture wearers, the denture, the palatal mucosa and dental 
plaque. Comparing the relative abundance of bacterial classes at the different 
sites showed the more diverse nature of the dental plaque in comparison to the 
denture and mucosal sites, both of which were predominantly composed of two 
classes, Actinobacteria and Bacilli. This result is unsurprising as both 
Actinobacteria and Bacilli are associated with being amongst the primary 
colonisers within the oral cavity, particularly Actinomyces and Streptococcus 
species (Wade, 2013, Aas et al., 2005, Diaz et al., 2006). The diversity statistics 
further substantiated this finding, showing that the dental microbiome was 
significantly more diverse and less dominant than both the denture and mucosal 
microbiome. These results are supported by a recent study comparing biofilms 
forming on natural teeth against those forming on denture teeth, which 
demonstrated that biofilms forming on natural teeth develop quicker and have a 
more abundant proportion of species present (Teles et al., 2012). The PCA analysis 
plots indicated distinct groups formed in which denture and mucosal groups 
clustered together and away from the dental group, thus indicating not only are 
they distinct in terms of diversity, but also compositionally separate. Moreover, 
direct comparison of denture and mucosal groups indicates that they also form 
their own distinct groups, and the reason for them clustering together previously 
was likely because of their similarity to one another as opposed to the dental 
microbiome. The different anatomical locations of these microbiomes likely 
explains these differences, as the adherent surfaces and surrounding environment 
of dental plaque may be more suitable for the growth of a more diverse range of 
microorganisms (Zaura et al., 2009a). For example, saliva is an important source 
of nutrients for microbes in the oral cavity (Humphrey and Williamson, 2001), 
however, the presence of a denture, acts as a barrier, thus with reduced nutrients 
available, fewer organisms can form a sustainable niche. 
 
This study has shown that the presence of natural dentition has a profound impact 
on the composition and diversity of the oral microbiome of a denture wearer. In 
terms of diversity, both the denture and mucosal microbiome is significantly more 
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diverse in dentate patients compared to edentate and in those with partial 
dentures versus those with complete. This suggests that this increased microbial 
diversity is not restricted to the anatomical sample site of the tooth, but also 
appears to affect the entire oral cavity. Patients included in this study that still 
had natural teeth remaining, ranged from 1 to 28 teeth, yet despite this wide 
range, PCA analysis indicated that they formed distinct groups from one another, 
indicating that even the presence of only one tooth is sufficient to have a profound 
impact of the microbiome composition. Distinct groups formed for the denture 
microbiome of both the complete/partial and dentate/edentate groups; however, 
for the mucosal microbiome distinct groups could only be distinguished between 
denture types. This could simply be a result of lack of statistical power, which is 
likely, given the similarity to the complete/partial PCA plot. Nonetheless, the lack 
of obvious groups between dentate and edentate samples at the mucosa could 
perhaps be explained by the nature of the surface. As we have already shown, the 
microbiome composition within the oral cavity is very much dependant on the 
location, therefore as the mucosal surface is biotic, microbes in contact are likely 
to be exposed to pathogen recognition receptors (PRRs) or host defence peptides 
of the epithelial cells (Diamond et al., 2008a, Bingle and Gorr, 2004, Dickinson et 
al., 2011). As many of the dentate associated bacteria are not traditional 
commensals, they may have a limited ability to colonise such a niche as well as 
the potential to initiate an immune response (Signat et al., 2011, Kinane et al., 
2008). Dentures, on the other hand are an abiotic surface, therefore biofilms from 
dentate individuals forming on this surface are likely to have less exposure to host 
defences and thus bacteria may grow unimpeded and have sufficient time to 
develop into a compositionally distinct plaque microcosm. 
 
One of the primary aims of this study was to identify any compositional changes 
in the microbiome between health and disease. However, no significant 
differences were shown between the two groups in dental plaque in terms of 
abundance of bacterial classes or diversity. Denture plaque revealed a number of 
notable changes between health and disease, with significantly higher proportions 
of Prevotella and Veionella species found in denture stomatitis sufferers.  These 
bacteria are more commonly associated with natural dentition, which suggests 
that DS microbiomes have a composition more comparable to that of dental 
plaque, however it could be due to the fact that the majority of our DS sufferers 
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had some natural dentition remaining. The virulence of both Prevotella and 
Veillonella species are well known in terms of oral disease, more specifically PD 
(Millhouse et al., 2014). In PD, Prevotella intermedia intitiates the production of 
degradative proteinases, including matrix metalloproteinases and proinflammtory 
cytokines by host cells, all of which contributes to the destruction of host tissues 
(Guan et al., 2009). Furthermore, P. intermedia has demonstrated resistance to 
antibiotics including penicillins, cephalosphorins and tetracyclines, thus 
elimination of this particular organism may be critical for disease prevention 
(Kulik et al., 2008, van Winkelhoff et al., 1997). P. intermedia is found throughout 
the oral cavity at healthy sites, and studies have shown that the profile of 
cytokines and proteins released by the bacteria is site dependant, which suggests 
that the environmental conditions have a strong influence on the behaviour of this 
particular bacteria (Kuboniwa et al., 2012). Moreover, the environment on the 
upper surface of the denture, in direct contact with the mucosa is and cut off 
from the antimicrobial effects of saliva, may support the pathogenicity of P. 
intermedia and enhance DS. Thus, this merits further investigation, in which the 
incorporation of P. intermedia into a denture biofilm model would be beneficial 
to assess its virulence. As for Veillonella, it is not generally considered a pathogen 
in the oral cavity, however it is implicated in oral disease due to its role as an 
intermediary in the development of periodontal biofilms by supporting the growth 
and attachment of the red complex bacteria, that are responsible for disease 
(Millhouse et al., 2014).   
 
Furthermore, at the mucosa, bacterial classes Actinobacteria and Bacteroidia also 
increased significantly in DS patients, further strengthening this hypothesis. A 
study supporting these findings by Campos et al (2008) investigated the microbial 
biofilm communities of denture stomatitis sufferers (Campos et al., 2008). They 
found 32 bacterial phylotypes that were unique to denture stomatitis biofilms, a 
large proportion of which fell under the genera Atopobium (16%) and Prevotella 
(11%), both of which fall into the classes Actinobacteria and Bacteroidia, 
respectively. Moreover, the mucosal microbiome of DS individuals is significantly 
more diverse with less dominant tax than their healthy counterparts, unlike the 
dental or denture microbiomes. Thus these results suggest that the compositional 
changes that are responsible for disease progression are occurring at the mucosa. 
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However, whether these changes are cause or effect of disease is an area that 
merits further investigation.  
 
We have established that the presence of natural teeth alters the composition and 
diversity of the microbiome, and our results suggest that the DS microbiome 
contains increased proportions of microbes more commonly associated with a 
dentate status. Therefore, we looked at the ratio of dentate to edentate within 
the health and DS groups and we found that both groups were equally represented 
within the health category (50%); however, the dentate group made up a 
considerably larger proportion of the DS category, (61%) than the edentate (39%). 
Therefore, this may explain why we are seeing higher levels of these, normally 
dentate-associated microbes, within the microbiomes of DS individuals. Within the 
DS group it is likely that dentate and edentate individuals form two distinct 
biofilms, both with pathogenic and invasive potential, however, given that the 
majority of those with severe inflammation had teeth (67%), the presence of 
natural teeth may exacerbate denture stomatitis infection, creating a more 
pathogenic biofilm than those found in the edentulous.   
 
Denture related disease is almost always attributed to infection with C. albicans, 
however, given the vast range of bacterial species identified on dentures and the 
surrounding mucosa in this study; it is unlikely that the infection can be attributed 
solely to Candida spp. Correlation analysis was carried out to investigate the 
affect of increasing Candida load (CFU counts) on the bacterial microbiome both 
at the class and genus level. At the denture and mucosal microbiome, there was 
a positive correlation with the class Bacilli and a negative correlation with 
Fusobacteria at the denture, these findings are in line with Kraneveld et al (2012), 
where they identified the similar correlations when analysing the effect of 
increasing Candida load on the salivary microbiome of the elderly (Kraneveld et 
al., 2012). At the genus level, these correlations could be attributed to 
Lactobacillus species. This finding was surprising as the majority of literature 
regarding these species, indicates that they have an antagonistic relationship (Orsi 
et al., 2014).  The mechanisms by which Lactobacillus inhibits growth of Candida 
spp. are not fully understood, investigations have suggested production of 
hydrogen peroxide by lactobacilli leads to anti-candidal activity. Furthermore, 
lactobacilli can modulate the host response, up-regulating cytokines when co-
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cultured with C. albicans, which could be associated with the clearance of 
candidal infection. Nevertheless, denture-wearing patients have been shown to 
have higher levels of Lactobacillus species in their saliva, but they are more 
commonly isolated in the saliva of DS sufferers (87%) in comparison to healthy 
controls (65%) (Bilhan et al., 2009). Yet, in spite of the vast evidence of an 
antagonistic interaction, certain species of oral Lactobacillus (namely L. casei) 
have demonstrated a stimulatory effect on C. albicans hyphal growth (Orsi et al., 
2014).  Furthermore, it has been shown that Candida hyphae can co-aggregate 
with lactobacilli and sustain their levels in patients with advanced oral diseases 
(Bilhan et al., 2009). Nonetheless, most of these studies have focused on 
Lactobacillus spp. inhibitory effects on C. albicans, but their inhibition of other 
Candida species such as C. glabrata has proven less effective, as Jiang et al (2014) 
demonstrated that only 1 of six probiotic Lactobacillus species used in the study 
had an inhibitory effect on C. glabrata growth (Jiang et al., 2014).  
 
Furthermore, it could be suggested that what is missing from this study is a control 
group of healthy non denture wearers to which the microbiome can be compared. 
Whilst this particular control group would be beneficial in terms of observing 
differences in the mucosal and dental microbiome, it would be impossible for the 
denture. The key purpose of such a group would be to attribute changes observed 
to the presence of a denture, however, this study has shown, numerous factors 
such as the presence of natural teeth, sleeping with a denture in, oral hygiene 
etc. can all contribute towards changes in the microbiome composition. This, 
makes understanding how the denture affects the microbiome composition 
increasingly complex. Unfortunately, the nature of this study did not allow for 
collection for such a patient cohort, primarily due to time constraints, costs and 
ethics.  Nonetheless, we are able to use data from previous literature looking at 
the healthy microbiome.  Comparison of our mucosal and dental microbiome data 
to other literature, showed several of the same genera which predominate within 
the healthy oral microbiome including, Streptococcus, Actinomyces, Rothia, 
Veillonella, Fusobacterium, Haemophilus, Porphyromonas Prevotella, 
Corynebacterium etc (Aas et al., 2005, Jenkinson and Lamont, 2005, Tuomanen, 
2005, Zaura et al., 2009b). Interestingly, our data found that Lactobacilli are one 
of the predominating genera the oral cavity of denture wearers, yet does not seem 
to be the case for the ‘healthy’ oral microbiome. Therefore, this again draws 
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attention to the role of lactobacilli in the oral cavity, emphasising the need for 
further investigation into its role in the mouth of denture wearers.  
   
As well as the microbial interactions in the oral cavity of denture wearers, we 
were also interested in gaining a wider understanding of the host-microbial 
interactions. From the range of AMPs measured, only LL37 showed any significant 
increases between health and inflammation. This could be explained by the fact 
that the majority of those with inflammation (66%) were in the dentate category, 
whereas the healthy group were predominantly edentate (95%), and as studies 
have shown the concentration of salivary AMPs declines with the loss of natural 
teeth (Davidopoulou et al., 2013). However, gaining a true understanding of 
salivary AMP concentration is more difficult with an elderly population, as the vast 
majority take one or more types of oral medication, many of which have been 
shown to cause xerostomia and thus there is the potential that they may affect 
salivary AMP concentrations (Visvanathan and Nix, 2010). Yet, to our knowledge 
the direct implication of oral medication on AMP production has not yet been 
elucidated.  
 
Furthermore, the method of collection and handling of saliva samples has to be 
carefully considered when measuring the levels of a specific protein, as factors 
such as saliva flow rate, site of sampling or sample storage can all impact the 
protein concentration (Sjogren et al., 2006).  For example, Sjogren et al (2006) 
took to normalising salivary measurements of a specific protein with the total 
protein concentration in order to control for changes in saliva flow, which can 
alter the concentration of particular analytes. However, others regard this method 
as inconclusive due to the complexity of individual protein secretion from the 
different saliva glands (Bishop and Gleeson, 2009, Brandtzaeg, 2007). Moreover, 
consistency of sample location is imperative due to the inconsistency of some 
salivary proteins at different locations. Several studies have shown differences in 
the concentration of specific proteins between different types of saliva including, 
whole saliva, pure parotid saliva and residual saliva (Brennan and Fox, 2000, Ruhl 
et al., 2004, Lee et al., 2007). Therefore, the current recommendation is 
collection of whole (mixed) saliva, which was collected in this study, in order to 
minimise differences in composition seen at different locations and saliva sources. 
Additionally, some proteins are very sensitive to degradation at room 
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temperature, therefore aliquoting samples before immediate freezing is 
recommended to avoid continuous freeze-thawing which can be detrimental to 
the samples (Groschl, 2008). Thus, although measuring protein levels within saliva 
is an extremely useful technique, it is not without its caveats and therefore 
preventative measures should be taken to ensure accurate interpretation of 
results.  
 
In order to identify any potential relationships or associations between AMPs and 
the microbiome, correlation analysis was carried out. Each AMP was correlated 
with the denture and mucosal microbiome at both the class and genus level. 
However, no significant correlations were identified. Nonetheless, this is not to 
say that the AMPs are not interacting with specific microbes, it is more likely due 
to their broad spectrum activity (Radek and Gallo, 2007). Furthermore, Bals et al 
(2000) stated that establishing the individual contribution of an AMP to host 
defence is extremely difficult due to the complexity of the environment and host-
microbial interactions (Bals, 2000), as we have clearly demonstrated from the 
data described herein. 
 
Moreover, in terms of the microbiome, simply understanding “what is there?” is 
not enough; other factors need to be taken into account, both biological and 
environmental. Certain ‘habits’ are commonplace amongst denture wearers, such 
as poor maintenance of denture hygiene or wearing a denture whilst sleeping 
(Kulak-Ozkan et al., 2002). Habits such as these may lead to the accumulation of 
plaque, and could subsequently lead to infection of the mucosa or the aspiration 
of microbes. Furthermore, they may provide the ideal environment to alter the 
microbial composition (dysbiosis), leading to the accumulation of fungi and 
bacteria associated with a diseased phenotype.  Therefore, understanding how 
these factors can affect our microbiome and in turn impact on our general oral 
health both physically and psychologically, should be taken into account, as their 
impact may lead to more severe consequences than denture stomatitis.  
 
Poor oral hygiene unfortunately is common place amongst denture wearers, more 
often than not a result of poor knowledge of the correct hygiene practices and 
products available (de Castellucci Barbosa et al., 2008). Poor hygiene leads to the 
accumulation of plaque, subsequently increasing the complexity and diversity of 
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the microbiome, which supports our findings of a more diverse microbiome, with 
less dominant taxa at the mucosa. This result reflects findings previously shown 
in this chapter whereby significant differences in diversity between healthy and 
diseased patients were only detected at the mucosal. Therefore, as suggested 
previously, compositional changes related to health/hygiene occur at the mucosal 
site, but again further investigation is required to determine if these changes are 
a cause or effect of poor hygiene.  The lack of differences in microbial composition 
and diversity between those with good and those with poor oral hygiene is 
surprising, particularly given the abundant evidence demonstrating a link between 
poor oral hygiene and the development of oral diseases, e.g. gingivitis, PD, 
candidiasis, etcetera (Pihlstrom et al., 2005, Akpan and Morgan, 2002, Darwazeh 
et al., 2010, Loe, 2000). Yet, it is possible that the lack of changes is due to the 
environment, as an edentulous oral cavity is less diverse than that of a fully 
dentate individual. Therefore, it is not to say that there are no significant changes 
occurring, it likely that in a less complex environment the changes occurring are 
more subtle and perhaps less likely to lead to a pathogenic outcome. 
 
We have previously shown that there are significant differences in the microbiome 
between healthy and diseased individuals in terms of microbial composition and 
diversity, at the mucosal surface in particular. Therefore, we were interested to 
know if having denture related disease induces changes in the microbiome in terms 
of oral hygiene. As currently within each group there is a mixture of healthy and 
DS patients, which may account for the lack of difference seen. However, further 
separating the groups into healthy and DS with good or poor oral hygiene would 
allow us to rule out any changes that were a result of disease rather than poor 
hygiene. In terms of this study, having DS indicated that any changes induced by 
poor oral hygiene were not affected by disease, however, we remain cautious 
before making a definite conclusion, given the complexity of the relationship and 
strong correlation between disease and poor oral hygiene.  
 
In terms of denture cleaning frequency, only a few notable changes were observed 
on the denture. Those that cleaned twice a day had increased levels of Bacilli in 
comparison to those that cleaned only once. This is likely due to colonization of 
streptococcal species, which are the main primary colonizers in the oral cavity 
(Moore et al., 1982, Syed and Loesche, 1978), and thus would be more apparent 
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on the denture surface of those that clean twice per day as they will likely have 
fewer microbes already on the denture surface. However, a recent study suggests 
that it is the method of cleaning employed which is a more important factor in 
altering microbial abundance and composition, rather than the frequency (Duyck 
et al., 2016). Therefore, given these findings, it begs the question, is maintaining 
a strict hygiene regimen as important as we have been led to believe? 
 
Sleeping with a denture in situ poses several risks, including choking and 
developing aspiration pneumonia (Iinuma et al., 2015). Removing dentures at 
night provides the opportunity for cleaning, e.g. soaking dentures overnight in an 
anti-microbial solution, whereas sleeping with them in simply allows for further 
accumulation of plaque (Duyck et al., 2016). Given the unique site of dentures, in 
direct contact with the mucosa, the accumulated plaque on the denture surface 
has greater opportunity to colonise and subsequently infect the mucosa if not 
removed. In this study, a number of notable changes in the abundance of several 
bacteria were found across both the denture and mucosa. Common to both were 
increases in Bacteroidia, Epsilonproteobacteria and Fusobacteria. The role of 
Bacteroidia in the oral cavity is well documented as Porphyromonas, Prevotella 
and Tannerella genera are all included within this class. In terms of periodontal 
disease, the most pathogenic organisms involved are the red complex bacteria, P. 
gingivalis, P. intermedia and T. forsythia (Socransky et al., 1998). Therefore, 
sleeping with a denture in situ may be causing an increase in these pathogenic 
bacteria and may contribute towards the increased diversity seen at the mucosa 
of DS individuals. Genera that have the potential to be pathogenic and fall under 
the Epsilonproteobacteria class include Helicobacter and Campylobacter. Within 
our samples no Helicobacter was detected, however Campylobater was detected 
at the denture, mucosal and dental sites. Campylobacter species are classed into 
two groups, zoonotic and human oral species (Lee et al., 2016). The zoonotic 
pathogens include C. jejuni and C. coli which primarily causes gastroenteritis in 
humans.  The human oral species include C. curvus, C. rectus, C. gracilis, C. 
concisus, C. showae and C. ureolyticus which naturally colonise oral cavity as 
commensals. However, these oral species have been linked with periodontal 
disease and have more recently been associated with intestinal disease (Kaakoush 
and Mitchell, 2012, Macuch and Tanner, 2000). Thus, there is potential that these 
normally harmless commensal species could play a role in DS, and requires further 
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investigation. However, the role of Fusobacteria within the oral cavity is well 
documented (Aas et al., 2005), which is most commonly the PD pathogen F. 
nucleatum (Dzink et al., 1988). However, whether the increasing levels of this 
microorganism can be associated with the development of DS disease remains 
unknown. Moreover, upon the denture surface the most notable change was the 
increase in Clostridia on those sleeping with their denture in situ, this pattern was 
also apparent even when the groups were separated into healthy and DS. 
Nonetheless, the DS ‘no’ group levels, although still lower in comparison to the 
‘yes’ groups, were slightly elevated, suggesting that disease is also contributing 
towards increasing Clostridia. Therefore, this further supports the theory that 
changes in the microbiome cannot be pinpointed to a single cause, and that 
various factors are responsible for shaping the microbiome.   
 
16S genomics is not without its limitations and can present numerous challenges 
(Sharpton, 2014). Amplicon sequencing does not always produce accurate 
estimates of the sample diversity, as the genomic loci sequenced may represent 
some taxa better than others(Human Microbiome Project, 2012). Furthermore, 
sequencing errors that are commonly introduced during PCR, can lead to incorrect 
sequences that may be rejected, therefore potentially losing important taxa 
(Wylie et al., 2012). The conserved nature of the 16S locus means that sequences 
can be shared between distantly related taxa, and could result in the 
overestimation of community diversity (Acinas et al., 2004). Moreover, amplicon 
sequencing is limited to identifying taxa for which the genetic sequences are 
known, but also by the sequences which are available in the genome databases, 
which affects how well the diversity of a community is interpreted (Langille et 
al., 2013). One of the main limitations of this study is that the majority of OTUs 
detected have only been identified up to genus level. Therefore, this will make it 
more difficult to decide on the correct species to include in devising an 
appropriate biofilm model of DS. However, given the vast number of studies 
regarding the composition of the oral microbiome, there is already an excellent 
understanding of the bacterial species normally found in the oral cavity based on 
the genera we have identified (Wade, 2013, Zaura et al., 2009a).  Nonetheless, 
16S rRNA sequencing essentially only gives an insight into the composition of the 
community, yet fails to give us an understanding of the biological functions and 
interactions associated with the microbes that are present. Shotgun 
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metagenomics is an emerging NGS technique which avoids the limitations found 
with standard 16S sequencing whilst providing an insight into the composition as 
well as the biological functions of a community (Sharpton, 2014). With this 
technique all DNA within the sample is degraded into tiny fragments and 
sequenced, reads are then sampled from the 16S taxonomically informative 
genomic loci, and from coding sequences that deliver insight into the biological 
functions of the sequenced genome. Although shotgun metagenomics is limited in 
its sequencing depths, and this sis where 16S genomics has an advantage. 
However, with the ever adapting NGS technologies it is likely vast improvements 
in the read depth of this technology will improve. Thus, the progression towards 
sequencing methods which provides a more in depth interpretation of the 
microbial environment seems the most probable and logical outcome for future 
sequencing studies.  
 
In conclusion, given the complexity of the oral environment, comprehending the 
intricate interactions of this ecosystem is a difficult task, and the addition of a 
denture further adds to the complexity. However, this study has taken a 
significant step forward towards understanding this environment. With a detailed 
knowledge of the microbial composition, research in this area can progress 
further, with a more in depth focus on how these organisms interact with one 
another as well as the host, allowing us to develop meaningful biofilm models of 
denture plaque. Moreover, going forward it would be useful to look at longitudinal 
dynamic changes of the denture microbiome and its effect on oral health.  
 
From this study we can conclude that the bacterial microbiome composition of 
denture wearers is not consistent throughout the mouth and varies depending on 
sample site. Moreover, dental plaque is unsurprisingly more diverse than denture 
plaque and the mucosal microbiome, and with this we have shown that the 
presence of natural teeth has a significant impact on the overall microbial 
composition. Furthermore, the findings from this study do suggest that 
maintaining good oral hygiene and hygiene practices do not appear to have as 
strong an influence on altering the microbial composition as we had previously 
assumed. Yet, the lack of differences are not necessarily absence of evidence, it 
may simply be due to the fact the this was originally designed as a pilot study and 
not designed to take into account additional factors such as hygiene.  
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We have deduced that there are a vast number of environmental variables with 
the potential to alter this environment, which ultimately means that the oral 
microbiome of each denture wearer is unique to the individual. Nonetheless, with 
the detailed knowledge we have gained from this study we can achieve a better 
understanding of the pathogenesis of denture related disease and which will aid 
towards the development of potential therapeutics.   
 
CHAPTER FINDINGS 
The bacterial microbiome composition of denture wearers is not consistent 
throughout the mouth and varies depending on sample site.  
The dental microbiome is more diverse than the denture and mucosal microbiome. 
The presence of natural teeth has a significant impact on the overall microbial 
composition.  
Evidence suggests that the compositional changes responsible for disease 
progression are occurring at the mucosa. 
Individual AMPs do not appear to have a direct implication on specific bacteria the 
microbiome composition. It is likely their antimicrobial effects are broader 
spectrum. 
Sleeping with a denture in situ leads to a shift in the microbial composition of 
denture plaque. 
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4 Developing a Denture Biofilm Model
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4.1 Introduction 
The role and clinical significance of fungal-bacterial interkingdom interactions 
within the oral cavity is of growing interest, with particular emphasis on how they 
impact disease (Sumi et al., 2002, Ealla et al., 2013). In the context of DS the 
majority of research has to date focused on how C. albicans is the causative 
microbial agent (Budtz-Jorgensen, 1970, Gendreau and Loewy, 2011, Johnson et 
al., 2012, Pereira-Cenci et al., 2008).  Despite this, recent data indicates that 
approximately 10-fold more bacteria than yeasts colonise the surface of dentures 
(Chapter 2). This has led to the development of denture biofilm models of 
polymicrobial composition, though these tend to either be limited to 2-3 
organisms or rely on clinical samples of unknown inocula (Yassin et al., 2016, 
Cavalcanti et al., 2015). Therefore, to fully understand the impact of multi-
species biofilm consortia on denture wearers and their impact on denture 
cleansing (Li et al., 2010, Coulthwaite and Verran, 2008, Urushibara et al., 2014), 
then there is a clear requirement to develop clinically relevant in vitro defined 
multi-species denture biofilm. 
Poly(methyl) methacrylate (PMMA) is the primary denture material of choice, 
though this has an uneven surface that results in a heterogeneous topography in 
which yeasts and bacteria can co-colonise, forming biofilms and escape from 
denture cleansing therapies (Li et al., 2010, Mendonca e Bertolini et al., 2014, 
Ramage et al., 2012). Investigations to determine the optimal method for cleaning 
dentures have focussed on the various physical and chemical cleansing techniques, 
both individually and in combination. Yet, most of these techniques evaluate 
treatment over a short period of time and therefore do not accurately simulate 
an optimal denture routine clinically (Felton et al., 2011, Pavarina et al., 2003, 
Pellizzaro et al., 2012). Daily denture cleansing treatment of Candida biofilms has 
been previously investigated and found that despite a significant reduction in 
viable C. albicans cells, a residual reservoir of yeast cells remained, resulting in 
ineffective cleansing (Faot et al., 2014, Freitas-Fernandes et al., 2014, Ramage 
et al., 2012). A limitation to these studies was using a single species biofilm model, 
as this is unreflective of the denture polymicrobial environment. Therefore, the 
development of a multispecies denture model that will give a more accurate 
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reflection of the impact of daily denture cleansing is paramount. Microbiome 
analysis of denture plaque, described in chapter 3, has shown that there are 
several key bacterial taxa represented in both health and disease. Therefore, 
denture plaque biofilms containing these taxonomic groups would provide a 
clinically relevant model for research into health, disease and potential 
therapeutics.  
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4.2 Aims 
We hypothesised that the composition of the denture biofilm changes over time 
and as a result of denture cleansing treatments. Therefore, the aims of this 
chapter were to develop a multispecies biofilm model that was representative of 
a denture environment using the microbiome compositional data, and assess the 
effectiveness of various denture cleansing treatments. The following key 
questions were investigated:  
 
 Is there a difference in model denture biofilm viability and biomass under 
different atmospheric conditions? 
 What proportion/composition of the overall biofilm does each individual 
species contribute? 
 Is combinational cleansing and brushing more effective than intermittent 
cleansing over a time course? 
 Is there a difference in viable biofilm composition post-treatment? 
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4.3 Materials and Methods  
4.3.1 Growth and standardisation of denture biofilm 
microorganisms 
Laboratory strains were selected to be included within this denture biofilm model 
based on microbiome data from this chapter 3. The organisms selected for the 
model were therefore Streptococcus mitis NCTC 12261, Streptococcus 
intermedius ATCC 27335 and Streptococcus oralis ATCC 35037, which were grown 
and maintained at 37 oC on colombia blood agar (CBA [Oxoid, Hampshire, UK]) in 
5 % CO2. C. albicans 3153A was maintained on Sabouraud’s dextrose agar (Oxoid) 
at 30 oC for 48 h. Actinomyces naeslundii ATCC 19039, Veillonella dispar ATCC 
27335, were maintained at 37 oC on fastidious anaerobic agar (FAA [Lab M, 
Lancashire, UK]) under anaerobic conditions (85% N2, 10% CO2 and 5% H2, [Don 
Whitley Scientific Limited, Shipley, UK]). Rothia dentocariosa DSM 43762 was 
maintained on CBA (Oxoid) at 37 oC under aerobic conditions. Lactobacillus casei 
DSM 20011 and Lactobacillus zeae DSM 20178 were both grown and maintained on 
MRS agar (Oxoid) in 5% CO2.  
An overnight broth of C. albicans was grown in yeast peptone dextrose (YPD 
[Sigma-Aldrich]) for 18 h at 30 oC. S. mitis, S. intermedius and S. oralis were grown 
in tryptic soy broth (TSB [Sigma-Aldrich, Dorset, UK]) supplemented with 0.6% w/v 
yeast extract (Formedium, Hunstanton, UK) and 0.8 % w/v glucose (Sigma-
Aldrich). V. dispar, A. naeslundii and R. dentocariosa were grown in 10 mL of brain 
heart infusion (BHI [Sigma-Aldrich]) broth. L. casei and L. zeae were grown 
overnight in MRS broth (Oxoid). Cultures were grown for 24 to 48 h at 37 oC as 
necessary, washed by centrifugation and resuspended in phosphate buffered 
saline (PBS [Sigma-Aldrich]). All cultures were standardised and adjusted to a final 
working concentration of 1 x 107 cells/mL, in artificial saliva (AS), for downstream 
biofilm studies. 
4.3.2  Development and standardisation of a denture biofilm 
model 
In order to assess the optimum developmental conditions, biofilms were grown 
under both 5% CO2 and anaerobic conditions. In order to standardise the biofilms, 
cell viability, biomass and composition were assessed via alamar blue, crystal 
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violet (CV) and qPCR, respectively. Microbes were grown in AS, of which 
components included, porcine stomach mucins (0.25% w/v), sodium chloride 
(0.35% w/v), potassium chloride (0.02 w/v), calcium chloride dihydrate (0.02% 
w/v), yeast extract (0.2% w/v), lab lemco powder (0.1% w/v), proteose peptone 
(0.5% w/v) in ddH2O (Sigma-Aldrich). Urea was then added independently to a 
final concentration of 0.05% (v/v).  
4.3.2.1 Developing the denture biofilm 
S. mitis, S. intermedius, S. oralis and C. albicans were standardised in AS to 1 x 
107 cells/mL and  200 μL was added to each well on a 96 well plate (Corning, NY, 
USA) The plate was then incubated at 37 oC in 5% CO2 or anaerobic conditions for 
24 h. Following incubation, the supernatant was removed. Standardised A. 
naeslundii, V. dispar, R. dentocariosa, L. casei and L. zeae were added to the 
plate containing the previous four organisms and incubated at 37oC in 5% CO2 or 
anaerobic conditions for 24 h. Biofilms were incubated for a further 4 days at 37oC 
in 5% CO2, or under anaerobic conditions, with spent supernatants removed and 
replaced with fresh AS daily.  
4.3.2.2 Denture biofilm cell viability 
Following biofilm development, biofilms were washed in PBS to remove any non-
adherent cells. Biofilm viability was then assessed using the AlamarBlue® viability 
assay. 10% alamarBlue® (Invitrogen, Paisley, UK) was added to the biofilms prior 
to incubation for 4 h in the dark at 37oC in 5% CO2 (Kirchner et al., 2012). The 
alamarBlue® is a colorimetric assay whereby an oxidation/reduction reaction 
occurs resulting in a colour change based upon cellular metabolic activity. 
Resazurin is the active ingredient of alamarBlue® that is reduced in the 
mitochondria of viable cells to produce resorufin, observed by a blue to pink 
colour change. Following incubation, the absorbance was read at 570 nm and the 
reference wavelength at 600 nm. The percentage reduction in viability was 
calculated according to the manufacturer’s instructions. To calculate the 
percentage viability the following calculation was used: 
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[(ε0X)λ2Aλ1 – (ε0X)λ1Aλ2 / (εRED)λ1A’λ2 – (εRED)λ2A’λ1] x 100 
 
λ1 = 570 nm λ2 = 600 mn 
 
(ε0X)λ2 = 117,216, (ε0X)λ1 = 80,586, (εRED)λ1 = 155,677, (εRED)λ2 = 14,652 
 
Aλ1 = OD reading for test well, Aλ2 = OD reading for test well 
 
A’λ1 = OD reading for negative control, A’λ2 = OD reading for negative control 
 
For each experiment this was performed in triplicate on three separate occasions. 
 
 
4.3.2.3 Denture biofilm biomass quantification using crystal violet 
Once the alamar blue assay was completed, biofilms were washed twice with PBS 
to remove any residual AlamarBlue® and left overnight to dry. Biomass was 
quantified with 0.05% w/v CV solution was added to each biofilm and incubated 
at room temperature for 20 min to allow uptake of the dye. Following incubation, 
the CV solution was discarded and the biofilms were washed with running tap 
water to remove any unbound dye, and 100 μL of 100% ethanol applied to destain 
each biofilm. The contents of the wells were mixed thoroughly by pipetting and 
transferred to a new 96 well flat-bottom microtitre plate for measurement. The 
biomass was quantified spectrophotometrically by reading absorbance at 570 nm 
in a microtitre plate reader (FluoStar Omega, BMG Labtech International, 
Ringmer, East Sussex, UK). All absorbance values were blank corrected based upon 
the negative control where no biofilms were formed. Each isolate had four 
replicates and biomass measured on three separate occasions.  
4.3.2.4 Quantitative analysis of denture biofilm formation 
For quantitative analysis of denture biofilms, the microbes were grown and 
standardised in AS, as previously described in section 4.3.1. 1 mL of AS containing 
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1 x 107 cells/mL of each microorganism was added to each well of a 24 well plate 
(Corning, NY, USA) containing polymethylmethacrylate (PMMA) 13 mm2 discs 
(Chaperlin and Jacobs Ltd, Surrey, UK].  The plate was then incubated at 37oC in 
5% CO2, or under anaerobic conditions, as previously described. The 9 species 
denture biofilms were then stored at -80oC until required. 
4.3.2.4.1 DNA extraction of denture biofilms 
 
Following biofilm development discs were gently washed with PBS to remove any 
non-adherent cells. Biofilms grown on PMMA discs were sonicated at 35 kHz 
(Ultrawave) for 10 min in 1 mL PBS to remove the biomass (Ramage et al., 2012). 
DNA was extracted from the biofilms using the QIAamp DNA mini kit, as per 
manufacturer’s instructions (Qiagen, Crawley, UK). The biofilms in PBS were 
centrifuged for 10 min at 10,000 g, then the supernatant discarded and the pellet 
was re-suspended in 180 μl of ATL buffer supplemented with 20 μL of proteinase 
K. Samples were incubated at 55oC for 20 minutes, and the mixture was 
transferred to a new tube containing 250 mg of sterile acid-washed glass beads of 
0.5 mm and 0.1 mm diameter (Thistle Scientific, Glasgow, UK). The tubes were 
vortexed for 3 × 30 s on a Mini-BeadBeater, (Sigma-Aldrich, Gillingham, UK), at 
the maximal speed, while intermittently being placed on ice. Samples were 
centrifuged for 10 min at 5 000 g and the supernatant was transferred to a fresh 
microcentrifuge tube. 200 μL of buffer AL was added to each sample and mixed 
by pulse-vortexing for 15 s, and then incubated at 70oC for 10 min. 200μL of 100% 
ethanol was added to the sample, and mixed by pulse-vortexing for 15 s. It is 
essential that the sample, Buffer AL, and the ethanol are mixed thoroughly to 
yield a homogeneous solution. The mixture was then transferred to the QIAamp 
Mini spin column and centrifuged at 6000 g for 1 min. The QIAamp Mini spin column 
was placed in a clean 2 ml collection tube and the filtrate was discarded, then 
500 μL of buffer AW1 was added to the spin column and centrifuged at 6000 g for 
1 min. The QIAamp Mini spin column was placed in a clean 2 ml collection tube 
and the filtrate was discarded, then 500 μL buffer AW2 was added to the spin 
column and centrifuged at full speed (20,000 x g) for 4 min. The QIAamp Mini spin 
column was placed in a clean 1.5 ml microcentrifuge tube tube and 50 μL buffer 
AE was added to the column. The samples were incubated at room temperature 
for 1 min, and centrifuged at 6000 g (8000 rpm) for 1 min. DNA was quantified 
using the NanoDrop™ ND-1000 spectrophotometer (Labtech International). 
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4.3.2.4.2 Nucleic acid quantification  
 
DNA was quantified using the NanoDrop™ ND-1000 spectrophotometer (Labtech). 
AE buffer was used as a reference before the DNA was quantified and 
concentrations were recorded in ng/μL. Samples with a 260/280 nm ratio of 1.8 
to 2.2 were deemed to be of high quality and were used for subsequent PCR 
reactions. DNA was stored at -20oC until required. 
 
4.3.2.4.3 Preparation of DNA for denture biofilm standard curves 
 
Serial 10-fold dilutions of the 1 x 108 cells/mL cultures were prepared ranging 
from 1 x 108 cells/mL to 1 x 103 cells/mL. Each dilution was centrifuged for 10 
min a 10,000 g. The supernatant was removed, making sure to avoid disturbing 
the pellet. DNA was extracted using the QIAmp mini DNA extraction kit (Qiagen, 
Manchester,UK) as previously described. DNA quality and quantity was then 
quantified by NanoDrop® (ThermoScientific, Loughborough, UK), as previously 
described (section 4.3.2.4.2).  
 
4.3.2.4.4 qPCR of denture biofilms 
 
Real-time quantitative PCR (qPCR) was then performed to determine the total 
number of cells for each species found in the biofilm. Briefly, 1 μL of extracted 
DNA was added to a mastermix containing 10 μL SYBR® GreenER™ (Life 
Technologies, Paisley, UK), 7 μL UV-treated RNase-free water and 1 μL of 10 μM 
forward/reverse primers for each bacterial/fungal species. Primers were either 
taken from published literature or designed using the web-based GenScript real-
time PCR primer design software (https://www.genscript.com/ssl-
bin/app/primer). Primer sequences were checked for specificity to each target 
organism using the NIH-BLAST database. PCR amplification efficiencies of all 
primer sets were optimised prior to gene expression analysis, with efficiencies 
ranging from 90-110%. Details of the oligonucleotide primers (Eurogentec, 
Southampton, UK) used in this study are listed in Table 4.1. The thermal profile 
used consisted of 50oC for 2 min, 95oC for 2 min followed by 40 cycles of 95oC for 
3 s and 60oC for 30 s using the step one plus real-time PCR unit (Applied 
Biosciences, UK). Biological replicates were analysed in duplicate. Melting curve 
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analysis was performed for all primer sets to ensure a single peak, which was 
indicative of primer specificity. A standard curve was run on each qPCR plate 
alongside the samples. Ct values were then used to approximate the number of 
corresponding colony forming equivalents (CFE’s). 
 
 
Table 4.1: Primer sequences for denture biofilm species. 
Target Primer sequence (5’-3’) Reference 
16S F – CGCTAGTAATCGTGGATCAGAATG 
R – TGTGACGGGCGGTGTGTA 
 
18S F – CTCGTAGTTGAACCTTGGGC 
R – GGCCTGCTTTGAACACTCTA 
 
Streptococcus spp. F – GATACATAGCCGACCTGAG 
R – CCATTGCCGAAGATTCC 
(Periasamy et al., 
2009) 
A. naeslundii F – GGCTGCGATACCGTGAGG 
R – TCTGCGATTACTAGCGACTCC 
(Periasamy et al., 
2009) 
R. denticariosa F –GGGTTGTAAACCTCTGTTAGCATC 
R – CGTACCCACTGCAAAACCAG 
(Uchibori et al., 2012) 
V. dispar F – CCGTGATGGGATGGAAACTGC 
R – CCTTCGCCACTGGTGTTCTTC 
(Periasamy and 
Kolenbrander, 2009) 
L. casei F –TGCACTGAGATTCGACTTAA 
R – CCCACTGCTGCCTCCCGTAGGAGT 
(Desai et al., 2006) 
L. zeae F – TGCATCGTGATTCAACTTAA 
R – CCCACTGCTGCCTCCCGTAGGAGT 
(Desai et al., 2006) 
 
4.3.3 Sequential treatment of complex biofilms 
For sequential treatment of complex denture biofilms, growth in 5% CO2 was 
selected as the optimal growth conditions. Biofilms were prepared in a 24 well 
plate containing PMMA discs, as previously described. Following biofilm 
development, each disc was gently washed with 1 mL of PBS to remove any non-
adherent cells. To demonstrate sequential combinational denture cleansing 
techniques were more advantageous than intermittent treatment, multispecies 
biofilms were treated daily over the course of 5 days, as illustrated in Figure 4.1. 
Treatments were either combinational therapy of brushing with hard water (HW) 
followed by a 3 min denture cleanser (DC) for 5 consecutive days or daily brushing 
with intermittent DC on day 1 and day 5 only.  
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For brushing treatments, toothbrushes containing HW were brushed 5 times across 
the surface of the PMMA disc containing the complex biofilm. This was based on 
the surface area and average time of denture brushing, as previously described 
(Ramage et al., 2012). For combinational treatment, brushing with HW was carried 
out before denture cleanser (DC) treatment (3 min). For treatment with the DC 
polident, PMMA discs containing multispecies biofilms were placed in a sterile 
beaker containing 150 mL of 375 ppm HW before the denture tablet was added, 
initiating treatment. PMMA discs were removed from the beaker and placed in a 
24 well plate containing 1 mL of Dey-Engley neutralising broth (Sigma-Aldrich) and 
incubated for 15 min anaerobically. This ensured complete inactivation of the 
compound before microbiological analysis. Untreated controls were maintained in 
1 mL HW during the treatment stage and served as a positive control. Blanks 
containing no inoculum were also included. Experiments were carried out in 
triplicate and on three separate occasions.  
4.3.3.1 Biofilm viability and analysis by colony forming units (CFU) 
CFU analysis was performed as a measure of how active each treatment was 
against the complex denture biofilms. Following treatment and neutralisation, 
PMMA discs were sonicated at 35 kHz for 10 min to remove the biomass, as 
previously described in section 4.3.2.4.1 (Ramage et al., 2012). 200 μl of sonicate 
was then transferred to a fresh microcentrifuge tube and ten-fold serial dilution 
in PBS were prepared from 100 to 10-6. The Miles and Misra technique was 
employed in which 20 μL of each serial dilutions were plated in triplicate on BHI 
+ 10% blood plates and incubated aerobically and anaerobically at 37oC for 48 h 
(Miles et al., 1938). In addition, samples were also plated on SAB agar and 
incubated at 30oC for 48 h. The number of colonies were counted and represented 
as total aerobes, total anaerobes and total yeasts. 
4.3.3.2 Differentiation of total and live cells within biofilms 
Viability of the treated biofilms was also assessed using live dead PCR in order to 
enumerate the definitive and relative composition of the biofilms, a technique 
that has been shown to differentiate viable and dead cells from various oral 
bacteria biofilms (Alvarez et al., 2013, Sanchez et al., 2014, Sanchez et al., 2013, 
Sherry et al., 2016).  This method is based upon propidium monoazide (PMA), a 
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DNA-intercalating dye that is able to bind to DNA following exposure to a halogen 
light source (Nocker et al., 2006). Binding can only occur in dead cells or those 
with compromised membrane integrity, as PMA is unable to permeablise cell 
membranes (Sanchez et al., 2014). This covalent bonding prevents downstream 
amplification in quantitative PCR (qPCR) and therefore only live cells can be 
detected.  
Samples were prepared as previously described by Sanchez et al (2014), with some 
modifications (Sanchez et al., 2014). In brief, the sonicated biofilm samples had 
50 μM of PMA added to each sample and were incubated in the dark for 10 min to 
allow uptake of the dye. All samples, PMA positive and negative, were then 
exposed to a 650 W halogen light for 5 min.  Samples were centrifuged at 10000 g 
for 10 min and the supernatants discarded. DNA was extracted using the QIAamp 
DNA mini kit (Qiagen), as previously described in section 4.3.2.4.1. No PMA 
controls were also included for each sample to determine total biomass. The 
extracted DNA underwent quality checks using the NanoDrop spectrophotometer 
(Fisher Scientific) as previously described in 4.3.2.4.2. Quantitative PCR was then 
carried out and standard curves were prepared as previously described in section 
4.3.2.4.3, to quantify total and live bacteria and fungi within the biofilm. Primer 
sequences are shown in table 4.1. 
4.3.3.3 Scanning electron microscopy 
Scanning electron microscopy (SEM) was performed on the 9 species biofilms 
grown on PMMA discs. Following maturation, biofilms were carefully washed with 
PBS and their respective treatments were employed, as previously described 
(section 4.3.3) Biofilms were carefully washed with PBS and then fixed with a 
fixative solution containing 2% para-formaldehyde, 2% gluteraldehyde and 0.15 M 
sodium cacodylate, and 0.15% w/v alcian blue (pH 7.4) and left in solution for 18 
h. The fixative was carefully discarded and replaced with 0.15 M sodium 
cacodylate buffer and stored at 4oC until processing. Samples were then prepared 
for SEM as previously described (Erlandsen et al., 2004). Samples were washed 3 
× 5 min with 0.15 M cacodylate to ensure all gluteraldehyde had been removed. 
Samples were then treated with 1% osmium tetroxide solution containing 0.15 M 
sodium cacodylate (1:1) and incubated in the fume hood for 1 h. Samples were 
rinsed 3 × 10 min with distilled water and then treated with 0.5% uranyl acetate 
Chapter 4: Developing a denture biofilm model 
143 
 
and incubated in the dark for 1 h. Uranyl acetate was removed from the samples 
and quickly rinsed with water before a series of dehydration steps were carried 
out. Two 5 min rinses of 30, 50, 70 and 90% alcohol were followed by 4 × 10 min 
rinses of absolute and dried absolute alcohol. Hexamethyldisilazane (HMDS) was 
used to dry the specimens by soaking the samples for 5 min before transferring to 
a plate containing fresh HMDS. All samples were then placed in a dessicator 
overnight to allow evaporation of any residue and drying. The specimens were 
then mounted and sputter-coated with gold in an argon filled chamber, and then 
viewed under a JEOL JSM-6400 scanning electron microscope. Images were 
assembled using Photoshop software (Adobe, San Jose, CA, USA). 
4.3.4 Statistical Analysis 
Data distribution, graph production and statistical analysis were performed using 
GraphPad Prism (version 5; La Jolla, CA, USA). After assessing whether data 
conformed to a normal distribution, One-way Analysis of Variance (ANOVA) and t 
tests were used to investigate significant differences between independent groups 
of data that approximated to a Gaussian distribution. A Bonferroni correction was 
applied to the p value to account for multiple comparisons of the data. Any non-
parametric data was analysed using the Mann-Whitney U-test or the Kruskal-Wallis 
test with a Dunn’s post-test to assess differences between independent sample 
groups. Statistical significance was achieved if P<0.05. 
  
Chapter 4: Developing a denture biofilm model 
144 
 
                          
Figure 4.1: Sequential treatment of denture biofilm protocol.  
PMMA discs were placed in 24 well plates for biofilm culture. Biofilms were treated daily with brushing and denture cleansing for 5 days 
or were brushed every day with denture cleansing on day 1 and day 5. Untreated controls were maintained in artificial saliva during 
treatments. 
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4.4 Results 
4.4.1 Development and standardisation of a denture biofilm 
model 
Using data from the microbiome analysis of denture plaque (chapter 3), the 
contribution of each genera was determined and averaged across the 108 patient 
samples that were sequenced. The ten most abundant genera found within 
denture plaque were calculated (Table 4.2). Actinomyces was most predominant, 
contributing to 26.97% of the overall biomass, followed by Streptococcus (23.5%), 
Rothia (10.09%), Lactobacillus (7.31%), Veillonella (6.85%), Prevotella (3.62%), 
Haemophilus (2.38%), Scardovia (2.12%), Bradyrhizobium (1.39%) and 
Bifidobacterium (1.09%). Based on these data, species that contributed to less 
than 5% of the overall biomass were not selected to be included in the denture 
biofilm model. Nine species were selected to be included in the denture biofilm 
model, C. albicans, S. mitis, S. oralis, S. intermedius, A. naeslundii, V. dispar, R. 
dentocariosa, L. casei and L. zeae. These particular species were selected based 
on literature and previous work by our lab, as they are commonly found species 
within the oral cavity for each genera (Chen et al., 2010, Millhouse et al., 2014). 
 
 
 
 
 
 
 
 
Chapter 4: Developing a denture biofilm model 
146 
 
Table 4.2: Most abundant genera found within denture plaque from the 
microbiome analysis. 
                   
The denture biofilms were tested under different growth conditions, either 
anaerobic or 5% CO2 in order to determine under which conditions there was 
optimal biofilm biomass and viability. In terms of biomass, there were no 
significant difference between 5% CO2 or anaerobic growth (Mean: 0.53 v 0.44, 
p>0.05) (Fig 4.2A). Under both growth conditions there was high biofilm viability, 
and no significant differences observed (Mean: 78.33 v 87.18, p>0.05) (Fig 4.2B). 
Therefore, given the similarity in biomass and viability, growing biofilms in 5% CO2 
was chosen as the preferred growth conditions when preparing biofilms hereafter.   
The composition of the denture biofilm was assessed to determine the individual 
species contribution to the biofilm using qPCR. Figure 4.3A shows the number of 
bacterial cells detected for each species, regarding CFE. Therefore, in terms of 
the overall proportion each species contributes to the biofilm, Streptococcus 
species were by far the most predominant, comprising up 49.2% of the biofilm (Fig 
4.3B). This is then followed by A. naesundii (33.6%), V. dispar (11.9%), L. zeae 
(2.9%), R. dentocariosa (1.9%), C. albicans (0.98%) and L. casei (0.39%). 
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Figure 4.2: Biofilm formation and viability of multi-species denture biofilms 
under alternate growth conditions. 
 Multi-species denture biofilms were grown on Thermanox™ coverslips within 24 
well plates with AS media changed daily for 4 days. Upon biofilm maturation and 
development, biofilm formation was measured using a crystal violet assay (A) and 
metabolic activity was measured using the alamarBlue® assay (B). All samples were 
assayed in triplicate, on three separate occasions. Data represents the mean. 
Statistical analysis was performed using a Mann Whitney test as data did not 
conform to a normal distribution. 
 
 
Figure 4.3: Individual species contribution to the denture biofilm. 
DNA was extracted from mature biofilms for quantification of each species using 
SYBR® GreenER™ based qPCR. Standard curves were prepared for each species and 
values were extracted for each sample, based on Ct values. The contribution of 
each individual species is shown as the number of cells detected for each species 
(A) and as a proportion of the biofilm (B). All samples were assayed in triplicate, 
on three separate occasions. Data represents mean ± SD. 
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4.4.2  Quantitative analysis of a denture biofilm after daily 
combinational treatment 
Longitudinal analysis of the effect of daily denture cleansing treatments on 
denture biofilms was carried out over the course of 5 days. Three groups were 
included, untreated biofilms as a positive control (UN), daily brushing followed by 
denture cleansing (BR+DC) and intermittent denture cleansing whereby brushing 
was carried out each day with the denture cleanser only used on day 1 and day 5 
(BR) (Figure 4.1). These treatments were selected based on patient denture 
cleaning habits and previous studies, however, the majority only looked at the 
effects of these denture cleaning treatments over a short period of time, and thus 
a more longitudinal study was required to investigate the long term effects (Felton 
et al., 2011, Pavarina et al., 2003, Pellizzaro et al., 2012).  
Total aerobic and anaerobic bacteria, and total yeasts, were initially quantified 
using CFU analysis. Both total aerobes (Fig 4.4A) and anaerobes (Fig 4.4B) 
remained relatively stable across the 5 days in terms of CFU/ml for the untreated 
group, with aerobes showing only a small decrease from 1.52 x 108 to 1.02 x 108 
CFU/mL and anaerobes a slight increase from 1.72 x 108 to 1.85 x 108 CFU/mL. 
For the intermittent brushing treatment (BR), bacteria were undetectable on day 
1, but saw a steady increase from day 2 to day 4, before declining again on day 5; 
a pattern also observed for both aerobes and anaerobes. As for the daily cleansing 
treatment, no CFUs were detectable on any day for either aerobes or anaerobes. 
Total yeast levels, in the UN group saw a decline over the five day time course, 
going from 5.43 x105 to 2.63 x 105 CFU/mL (Fig 4.4C). For the BR group, no yeasts 
were detectable on day 1, but there was a sharp increase to 5.01 x 104 CFU/mL 
on day 2, this remained steady until day 4 before becoming undetectable again on 
day 5.  
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Figure 4.4: Daily CFU counts of bacteria and yeasts post treatment. 
Multispecies complex biofilms were grown on PMMA for 7 days, as previously 
described. Biomass and viability of total aerobes (A), anaerobes (B) and Candida 
(C) was assessed by CFU. All testing was carried out in triplicate and on three 
independent occasions. Data represents mean ± SD (***p<0.0001). Statistical 
analysis was performed using a one-way ANOVA with Bonferonni post-test to 
compare all groups to each other. 
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Quantitative PCR was employed as a more sensitive assay, which would provide 
the capacity to distinguish between total and live cells. The premise of this 
approach was to take away the inherent bias of colony counting as a means of 
viable cell counting. The improved sensitivity of qPCR is demonstrated here, due 
to the ability to detect the presence of bacteria and yeast within the DC group 
(Fig 4.5), which previously remained undetected by CFU analysis.  
For both total bacteria (Fig 4.5A) and live bacteria (Fig 4.5B), the number of 
bacteria was significantly lower in both the BR and DC groups when compared to 
the untreated control, a pattern that was observed on all 5 days. However, no 
significant differences were seen between the BR and DC groups on any of the 
days, for either total or live cells. This indicated that both treatments are equally 
effective at reducing cell numbers, as the total cells remaining by day 5 for BR 
and DC were 2.07 x 106 and 3.48 x 106 CFE/mL, respectively, and live cells were 
1.25 x 105 and 2.39 x 105 CFE/mL respectively.  
The number of yeasts isolated for the discs shows a similar pattern to that of the 
bacteria, in that in comparison to the untreated control there was significantly 
less yeast in both the BR and DC groups. This result was true for day 1 to day 5 
and could be observed for both total yeasts (Fig 4.5C) and live yeasts (Fig 4.5D). 
Again, as with the bacteria, no significant differences were found between the 
two treatment groups for either total of live cells. The intermittent BR treatment 
and daily DC treatment reduced the total yeast numbers, by 2 log10, to 3.62 x 104 
and 5.67 x 104 CFE/mL, respectively, by day 5, and from 2.8 x 106 CFE/ml on the 
untreated control on day 1. Both treatments were even more effective at reducing 
the number of live cells which saw a 3 log10 reduction for both groups with the 
BR group, reduced to 8.89 x 102 CFE/mL, and the DC group to 3.48 x102 CFE/ml, 
when compared to the untreated control on day 1, 1.89 x 105 CFE/mL. Thus, 
although a considerable number of microbes, both live and dead remain on the 
discs post cleansing, the treatments employed are significantly effective given the 
extensive reduction in the overall microbial burden.  
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Figure 4.5: Daily CFE counts of total and live bacteria and yeasts post 
treatment. 
Following treatment, each PMMA disc was sonicated before 50 μM of PMA was 
added and exposed to a 650 W halogen light source for 5 min to allow photo 
activation. Samples containing no PMA were also included to account for total 
biomass. DNA was extracted from each sample using the Qiagen DNA extraction 
kit, for quantification of each species using SYBR® GreenER™ based qPCR to 
determine the number of total and live cells remaining following treatment for 
quantification of total (A) and live (B) bacteria and total (C) and live yeast (D). 
All testing was carried out in triplicate and on three independent occasions. Data 
represents mean ± SD (*p<0.05, **p<0.01, ***p<0.0001). Statistical analysis was 
performed using a one-way ANOVA with Bonferonni post-test to compare all groups 
to each other. 
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4.4.3 Individual species contribution to denture biofilms during 
combinational treatment 
The number of total and live cells were quantified for each individual species and 
compared across treatment groups (Fig 4.6). Any changes in the individual species 
contribution to each biofilm were investigated over the 5 day time course, for 
both treatments and untreated controls. Initially the total cell count was 
quantified and converted into a percentage of the overall biofilm, to determine 
the contribution of each species. Interestingly the untreated control saw a number 
of changes over the 5 days. Streptococcus species began as the most predominant 
species on day 1 (49.2%) which peaked at day 3 (59.9%), before taking a dramatic 
decline, contributing only 15.96% by day 5 (Fig 4.7Ai-ii). A. naeslundii, tended to 
fluctuate more, beginning at 35.6% on day 1, but returning to a similar level by 
day 5 (39.6%). V. dispar, however, saw a steady increase from 11.9% to 40.9% on 
day 5. As for C. albicans (0.18%), R. dentocariosa (0.33%), and L. zeae (1.76%), 
they all declined by day 5, yet L. casei saw a small increase in its overall 
contribution (1.21%). Moreover, in terms of the treatments, the BR group, as with 
the UN group, saw streptococcus species remain as the majority species (68.4%), 
with levels declining steadily until day 4 (22.7%), before taking a sharp increase 
on day 5 (46.5%). A. naeslundii increased, overtaking streptococci as the most 
predominant species, which peaked on day 4 (70.7%) before settling at 47.9% on 
day 5. V. dispar levels remained low in comparison to the control, decreasing from 
4.2% to 1.9% by day 5. The remaining species saw dynamic fluctuations, but levels 
remained relatively steady overall.  
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Figure 4.6: Impact of denture cleansing regimens on individual bacterial 
species within denture biofilms. 
Complex 9 species biofilms were grown on PMMA for 7 days and were treated as 
described previously. Biofilms were treated with PMA and DNA extracted as 
previously described, for quantification of each species using SYBR® GreenER™ 
based qPCR to determine the number of total and live cells remaining following 
treatment. CFE counts were enumerated for A. naeslundii total (A) and live (B) 
cells, Streptococcus total (C) and live (D) cells, V. dispar total (E) and live (F) 
cells, R. dentocariosa total (G) and live (H) cells, L. casei total (I) and live (J) cells 
and L. zeae total (K) and live (L) cells. Untreated controls were also included. All 
testing was carried out in triplicate and on three independent occasions. Data 
represents mean ± SD (*p<0.05, **p<0.01, ***p<0.0001). Statistical analysis was 
performed using a one-way ANOVA with Bonferonni post-test to compare all groups 
to each other. 
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Daily combinational treatments demonstrated similar levels and pattern to the 
intermittent treatment, in terms of C. albicans, V. dispar, R. dentocariosa, L.zeae 
and L. casei, all showing small fluctuations across the 5 day treatment, but 
remaining relatively stable (Fig 4.7Av-vi). Again, as previous streptococcal species 
and A. naeslundii are the primary components of the DC biofilm, however this 
time A. naeslundii begins (68%) and ends (75.2%) as the largest contributor, but 
not before declining on day 2 (37.7%). Streptococcal species on the other hand 
saw a fluctuation on days 2 and 3, before gradually declining by day 5 (18.1%).  
When focusing solely on the live cells, the denture biofilm composition was 
significantly altered from that of the total groups, for both treatments and the 
untreated control. For the untreated control (Fig 4.7Bi-ii), V. dispar made up the 
majority of the live cells on day 1 (42.8%), and was at its highest on day 4 (55.4%). 
The streptococcal species were the second most abundant on day 1 (24.4%), which 
seemed to plateau until day 4, before increasing considerably at day 5 (43.4%). A. 
naeslundii showed an initial increase, peaking at day 3 (27.3%), but gradually 
declined by day 5 (14.7%). Interestingly, R. dentocariosa which initially comprised 
11.9% of the biofilm, dramatically declined to 0.01% by day 5. C. albicans, L. casei 
and L. zeae, all contributed less that 1% each to the biofilm, and all three 
gradually declined further over the 5 days. As for intermittent cleansing (Fig 
4.7Biii-iv), A. naeslundii was the most abundant on day 1 (73.9%), before falling 
to 32.8% by day 5. As A. naeslundii gradually fell the streptococcal species 
overtook, showing a considerable increase from 10.7% to 48% from day 1 to day 5, 
respectively. 8.1% of the biofilm was composed of V. dispar, falling to 2.2% by day 
4 but climbing back up to 13% at day 5. As with the untreated control, R. 
dentocariosa fell noticeably, yet L. casei had a sizable increase going from 0.6% 
to 5.1%. The BR+DC group had a similar composition to that of the BR group on 
day 1 in terms of A. naeslundii (77.6%) and streptococcus (11.6%), yet despite 
some fluctuations A. naeslundii remained the dominant species by day 5 (74.2%), 
whilst streptococcus species comprised 21.1% (Fig 4.7Bv-vi)
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Figure 4.7: Compositional analysis of denture biofilms post treatment regimens 
for total and live cells. 
Multispecies complex biofilms were grown on PMMA for 7 days, as previously 
described. Following maturation, biofilms were washed and either treated daily 
with brushing and denture cleansing (BR + DC) or brushed daily with the addition 
of a DC on day 1 and 5 only (BR). Biofilms were treated with PMA and DNA 
extracted as previously described, for quantification of each species using SYBR® 
GreenER™ based qPCR to determine the number of total and live cells remaining 
following treatment. The composition of the biofilms following combinational 
treatment was determined using species-specific primers for the total number of 
cells for untreated biofilms (Ai-ii), (BR) biofilms (Aiii-iv) and (BR + DC) biofilms 
(Av-vi). The composition of live cells within each biofilm were also determined 
for the untreated biofilms (Bi-ii), (BR) biofilms (Biii-iv) and (BR + DC) biofilms (Bv-
vi). All testing was carried out in triplicate and on three independent occasions.  
4.4.4 Effect of combinational treatment on denture biofilm 
architecture   
In order to visualise changes in the biofilms growing on PMMA discs, scanning 
electron microscopy (SEM) was carried out. Images were taken of UN, BR and 
BR+DC biofilms on day 1, 3 and 5 DC using x 2500 magnification (Fig 4.8). On day 
1, the untreated controls have a thick biofilm with only small patches of PMMA 
visible. The biofilms are complex, with many C. albicans yeast cells visible, which 
are surrounded by cocci shaped bacteria, which will be primarily streptococci and 
V. dispar, based on the CFE data. Many rod shaped bacteria can be observed, 
which based on their abundance, will primarily be A. naeslundii, chains of 
Lactobacillus are also present. For both treatments, the biomass is visibly 
reduced, as well as fewer yeast cells, yet some candidal hyphae are present. 
Streptococci are the predominant bacteria, with some rods interspersed. 
By day 3, the biomass of the untreated control had increased considerably, with 
virtually none of the PMMA disc surface visible. As on day 1, streptococcal species 
are the most predominant, with the classic streptococcus chains present. 
Furthermore the increase in V. dispar by day 3 is likely to also be contributing 
towards the cocci shaped bacteria. Many rods are visible, however they seem to 
be located deeper within the biofilm but are being masked by the more abundant 
cocci adhering to them at the surface. Nonetheless, both the BR and BR+DC 
treatments removed the majority of the biofilm, with only a few clusters of 
streptococci dispersed across the surface.  
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On day 5, the final treatment day, the untreated control had abundant biomass, 
but shows an increased number of rods which reflects the large increase in 
Actinomyces from the quantitative data. However, the thickness and complexity 
of the biofilm makes it more difficult to differentiate between individual species 
as mainly only the microbes on the surface are visible. Again, both treatments 
effectively reduce the biomass, leaving very few cells on the surface. However, 
bacteria can be seen colonising deep within cracks and crevices on the PMMA discs 
which have had treatment, which may not be accessible during treatment. 
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Figure 4.8: Daily combinational treatment impacts biofilm architecture by 
reducing total biomass and live cells. 
Multispecies biofilms were grown on PMMA for 7 days, and treated as previously 
described. Biofilms were then processed and viewed on a JEOL-JSM 6400 scanning 
electron microscope and images assembled using Photoshop software. All images 
are shown at 2500× magnifications and are representative of the sample. Scale 
bars represent 10 μm. Note the pores within the PMMA as denoted by the arrows.  
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4.5 Discussion 
Biofilm models of disease are becoming more utilised in terms of research as they 
are an effective way to model disease and investigate pathogenesis and potential 
treatments, when in vivo experiments are not possible (Millhouse et al., 2014, 
Camelo-Castillo et al., 2015, van der Waal et al., 2016). Oral disease is an area of 
research in which biofilm models have played a key role, particularly in 
understanding the pathogenesis of periodontal disease (Millhouse et al., 2014, Bao 
et al., 2014). Disease of the oral cavity is more often than not associated with 
teeth, however, approximately one fifth of the population are edentulous, yet are 
still affected (Shulman et al., 2004). Wearing dentures is predominantly the main 
cause of oral disease in the edentulous (Gendreau and Loewy, 2011), nevertheless, 
there is a distinct lack of research into the microbiology behind denture related 
disease. Therefore, using data from chapter 2 which investigated the microbiome 
of dentures, an in vitro biofilm model was developed, which truly reflected the 
microbial composition of denture plaque.  With this model, using sensitive 
molecular techniques, we have been able to model and monitor the microbial 
composition of denture biofilms and how they change over time and adapt 
following therapeutic treatments, based on recent work from our laboratory 
(Sherry et al., 2016). Furthermore, newer techniques such as live/dead PCR have 
enabled us to gain a more detailed insight into the individual species susceptibility 
to antimicrobials.  
Given that over 700 bacterial species have been identified with in the oral cavity 
(Chen et al., 2010), selecting the species to include in the model proved 
challenging. However, the advancement of NGS has allowed us to gain a more in 
depth understanding of microbiomes. The previous chapters provided us with the 
information of the most predominant genus present within denture plaque; this 
however meant that we were faced with the problem of which species from each 
genus to include in the model. Based on previous oral biofilm models from our 
laboratory (Millhouse et al., 2014, Shahzad et al., 2015, Sherry et al., 2013), and 
previous literature into human oral microbiome studies (Chen et al., 2010), we 
selected eight bacterial species to be cultured alongside C. albicans. Only species 
from the top 5 most abundant genus were included as a cut off of 5% was instated, 
otherwise too many species would be included in model, which could quickly 
become unmanageable. Having to limit the number of microbes which we include 
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within the model is indeed a caveat, as it may be implied that the model has too 
many species missing to truly reflect the denture microbiome. However, in order 
to maintain manageability and accuracy of experiments, a limit had to set; 
particularly given that over 700 OTU’s were identified in some samples. 
Unlike previous biofilm models prepared by our group, this model was not grown 
under anaerobic conditions, as our biofilms were still able to grow effectively with 
high biomass and viability in 5% CO2. This is likely because the anaerobic bacteria 
included were A. naeslundii and V. dispar, both of which are facultative 
anaerobes, and the model included no strict anaerobes such as Prevotella 
intermedia or Porphyromonas gingivalis, in contrast to models of dental plaque 
developed by our group. Furthermore, based on this study, both A. naeslundii and 
V. dispar did not appear to be restricted in their growth, despite not growing 
under their optimal conditions, as they were frequently the most predominant 
species within the biofilms.  
Previous work by our lab investigated the effectiveness of different denture 
cleansing regimens on reducing biofilm biomass and viability, and discovered that 
a daily combinational treatment of both brushing and using a denture cleanser 
was most effective (Sherry et al., 2016). However, the biofilm model used in this 
study was based on an 11 species biofilm with various orally important 
microorganisms, including C. albicans. Whilst the data from this study is extremely 
useful, the biofilm model is not truly reflective of denture plaque, as it includes 
bacterial species that are pathogenic in nature such as, P. gingivalis, P. 
intermedia and A. actinomycetemcomitans. Thus, there is a need for a more 
accurate denture biofilm model when testing treatments directed specifically at 
denture plaque.  
A 5 day treatment regimen looking at the effectiveness of daily combinational 
treatment with brushing and cleansing compared to intermittent cleansing was 
carried out. The initial CFU analysis indicated that daily cleansing completely 
removed all the aerobes, anaerobes and yeasts residing on the discs after daily 
cleansing, yet the intermittent cleansing saw re-growth on days 2-5, these findings 
are in agreement with previous studies carried out by our group (Ramage et al., 
2012, Sherry et al., 2016). Furthermore, qPCR analysis of the same samples 
highlighted the inaccuracy of CFU analysis. The more sensitive qPCR assay was 
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able to detect bacterial DNA for daily and intermittent cleansing treatments 
where CFU analysis indicated there were no cells remaining. This emphasises the 
need for molecular analysis to become the gold standard technique used in 
microbiological analysis.  
The accuracy of the molecular CFE data allows us to gain a clearer understanding 
of the efficiency of the treatments used. In comparison to the untreated control, 
both treatments significantly reduced the number of microbes on the denture. 
However, determining which treatment is more effective is problematic as they 
appear to be equally successful. Nonetheless, the data indicates that many 
microbes still remain on the denture surface, a large proportion of which are still 
alive, and therefore they have the potential to proliferate and form a biofilm. 
Based on the SEM images for the treatments very few microbes can be observed 
on the denture surface, however, the denture surface is uneven and covered in 
cracks and crevices which both C. albicans and bacteria have been shown to 
colonise. These crevices therefore may provide protection during the treatments 
and are likely to be the source of a large proportion of the remaining viable cells.  
Using species-specific primers, we were able to investigate how each species 
responded to each of the treatments. For the untreated control there was an 
interesting shift in the composition across the 5 days, despite being left 
untouched. In terms of the total cells, the streptococci and A. naeslundii remained 
the predominant species. Of particular interest was the significant increase in V. 
dispar from day 1 to 5, this in combination with the A. naeslundii meant that by 
day 5 the total cell count was made up of 80.56% of anaerobic bacteria. This was 
also reflected in the live cell analysis, whereby V. dispar comprises the majority 
of the biofilm. Although V. dispar and A. naeslundii are generally associated with 
being commensals (Avila et al., 2009), they have the potential to create an 
anaerobic environment which may encourage the growth of other more pathogenic 
anaerobes, such as P. gingivalis or A. actinomycetemcomitans (Darveau et al., 
2012, Henderson et al., 2003).  Some may argue that this will not happen as many 
of these pathogenic bacteria are associated with dentate individuals, and that 
they disappear from the oral cavity after the removal of teeth (Danser et al., 
1995, Danser et al., 1997). However, studies by Sachedo et al (2008) have 
demonstrated the presence of such bacteria in edentulous individuals (Sachdeo et 
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al., 2008). In addition to this, large proportions of denture wearers have partial 
dentures and thus will have natural teeth remaining (GlaxoSmithKline, 2010). 
The biofilm composition after both intermittent and daily cleansing treatments 
looks quite different to the untreated control. Unsurprisingly streptococci and A. 
anaeslundii comprise a minimum of 90% of the total cells and at least 80% of the 
live cells for every day of treatment. This finding is predictable given that 
streptococci and Actinomyces species are attributed to being amongst the primary 
colonisers of the oral cavity (Nyvad and Kilian, 1987, Sbordone and Bortolaia, 
2003, Whittaker et al., 1996). Therefore, after the treatments remove the 
majority of cells, the biofilm will have to re-establish itself again.  
Given that denture related microbiological studies predominantly focus on the 
role of Candida species (Coco et al., 2008a, Pereira-Cenci et al., 2008, Gendreau 
and Loewy, 2011), a surprising outcome from this study is how little C. albicans 
actually contributes to the overall biofilm. In the untreated biofilm, C. albicans 
comprises less than 1% of the biofilm and gradually contributes less and less as the 
biofilm matures over the 5 days, suggesting that if left for longer, it may disappear 
completely. Similarly low levels are also found for both treatments. This therefore 
begs the question, has the role of Candida in denture plaque been overestimated? 
Nevertheless, just because it only contributes to a small proportion of the biofilm, 
is not to say that it has no effect. For example P. gingivalis comprises less than 
1% of a periodontal biofilm model yet is considered the keystone pathogen in the 
disease (Malcolm et al., 2016). Furthermore, looking at the SEM images, the 
biofilm would appear to be abundant in Candida yeast cells. However, in terms of 
scale they may appear more abundant than they are, but not when accounted for 
as individual cells. Moreover, there is a distinct lack of visible hyphae in the 
biofilm, as C. albicans cells can be seen principally in its yeast form. In its hyphal 
form Candida has been known to form a synergistic relationship with certain 
bacteria, particularly Streptococci and Actinomyces (Diaz et al., 2012b, Grimaudo 
et al., 1996, Arzmi et al., 2015). These bacteria can adhere to the hyphae, which 
provides biofilm stability by forming a scaffold and also aids their ability to invade 
cells (Schlecht et al., 2015). However, the lack of hyphae may be explained by 
the presence of Lactobacillus, as these microbes are noted for having a strong 
antagonistic relationship, inhibiting C. albicans adherence, proliferation and 
hyphal formation (Manzoni et al., 2006, Morales and Hogan, 2010, Krasner et al., 
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1956, Boris and Barbes, 2000). Interestingly though, in our denture microbiome 
study we showed a positive correlation between the abundance of Candida and 
Lactobacillus within denture plaque (Bilhan et al., 2009) (Chapter 2 section 3.4.5). 
Therefore, the relationship between these microbes is clearly complex, and their 
interactions with one another perhaps vary depending on the circumstances. Most 
studies investigating the bi-direction relationship between these tend to focus on 
their interactions in the vagina, which may be completely different to how they 
interact on the denture. 
Based on the evidence from this study, the advantages of using molecular methods 
over standard culture methods in terms of microbial detection and quantification 
are apparent. Nonetheless, despite the numerous advantages of molecular 
technologies such as qPCR, it does have its limitations. The primary reason being 
cost, as molecular qPCR is an expensive process to carry out, also it requires 
expert handling and involves a more complex data analysis. In terms of live/dead 
PCR propidium monoazide (PMA) is extremely toxic and has to be handled with 
care. Furthermore, as it relies on penetration of the cell membrane of dead cells 
to function, and therefore there is the argument that microbial cells that died for 
reasons other than a disrupted cell membrane are not accounted for. Moreover, 
the process can be more laborious and time consuming than standard cell viability 
assays such as 2,3 bis(2-methoxy-4-nitro-5sulfo-phenyl)-2H-tetrazolium-5-
carboxanilide (XTT) and alamar blue. Nevertheless, with every technique there 
are caveats, however the significant improvements in accuracy provided by these 
techniques surpasses their disadvantages.  
In this study we have been able to develop a biofilm model that truly represents 
denture plaque using data from a previous study looking at the microbiome of 
dentures. One of the main findings from this study is the inaccuracy of culture-
based methods when quantifying biofilms, which emphasises the need for 
molecular based methods to be used in its place. From this research, we concluded 
that both combinational treatments employed in this study significantly reduced 
both the biomass and viability of these biofilms, with both treatments just as 
proficient as one another. Therefore, given the lack of differences between 
treatments, this suggests that intermittent cleansing may be the most economical 
choice. Nonetheless, even with treatments, there were some microbes left 
residing on the PMMA disc surface and within the cracks and crevices. 
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Furthermore, the accuracy of this model has allowed us to see how the biofilm 
composition changes over time when left untreated, and it appears that as time 
passes the biofilm becomes more anaerobic. However, whether more anaerobic 
means more pathogenic requires a longitudinal study of increasing length. Of note, 
the contribution of Candida to the overall biofilm is very small, raising the 
question: ‘has the role of this microbe been over estimated in denture plaque?’ 
Therefore, this study emphasises the importance of placing more focus on the role 
of bacteria and bacterial/candida interactions in denture related disease.  
 
CHAPTER FINDINGS 
CFU analysis is considerably less effective at quantifying biofilms than molecular 
CFE analysis using qPCR. 
Intermittent cleansing and daily cleansing both significantly reduce the biomass 
and viability of denture biofilms. 
Both treatments were found to be equally effective. 
When left untreated the denture biofilm takes on a predominantly anaerobic 
composition 
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5 Dentures act as a reservoir for respiratory 
pathogens
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5.1 Introduction 
Internationally, more than 810 million people are aged 60 years or over, which is 
expected to reach two billion by 2050 (22% of the entire global population) 
(Guzmán et al., 2012). Delivery of systemic and oral healthcare will face greater 
challenges with this ever-increasing elderly population. Obvious links between 
oral and systemic disease have been described, for example with rheumatoid 
arthritis, cardiovascular disease and respiratory infection (Farquharson et al., 
2012, Pizzo et al., 2010). Several of these elderly individuals will experience a 
general decline in oral health, which for some may translate to complete or partial 
edentulousness. Currently it is estimated that approximately 20% of the US and 
UK population wear some form of removable denture (Coulthwaite and Verran, 
2007, Shulman et al., 2004). Dentures can encourage the growth of denture plaque 
in the form of biofilms, which are complex polymicrobial group comprised of 
bacteria and yeasts. The unique architecture of the biofilm and the rough surface 
topography of the denture, with its cracks and crevices, act as a physical barrier 
to provide protection for the microorganisms against the effects of the host 
immune system and chemotherapeutic agents (Verran et al., 2014). The close 
proximity of the denture plaque biofilm to the respiratory tract represents a 
reservoir of potential opportunistic respiratory pathogens. Consequently, the risk 
of denture wearers aspirating opportunistic pathogens from the denture into their 
lungs is increased.  
 
Pneumonia is the principal cause of death associated with infection in patients 
older than 65, costing the national health service (NHS) in excess of £440 million 
annually (Guest and Morris, 1997). Aspiration pneumonia is a form of respiratory 
infection with potentially life threatening consequences associated with entry of 
contaminated foreign material such as gastric or oropharyngeal contents, 
including food debris, dental and/or denture plaque, and saliva into the lungs. 
Poor oral hygiene may further contribute to the development of AP (Quagliarello 
et al., 2005). What is more, it has been discovered that aspiration of 
oropharyngeal contents is a common occurrence in healthy individuals, as 
approximately 45% aspirate material into the lungs during sleep, but in whom 
normal immune functions provide protection (Gleeson et al., 1997). The 
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deterioration of the immune system with age, known as immunosenescence, 
increases their risk of developing pneumonia as the elderly are likely to be less 
effective at clearing the invading pathogen. In addition, other risk factors that 
may contribute towards developing AP, such as dysphagia and chronic obstructive 
pulmonary disease (COPD), are more common in the elderly, thus putting this sub-
population at an increased risk of infection (El-Solh, 2011a). Failure to clean a 
denture adequately leads to an accumulation of plaque, with the denture surface 
capable of carrying up to 1011 microbes per milligram (Nikawa et al., 1998). Dental 
plaque composition has been well characterised and many of the oral bacteria 
identified have been linked with systemic infections (Inaba and Amano, 2010). 
There is adequate evidence to substantiate a relationship between dental plaque 
and respiratory infection, principally amongst the dependant elderly and 
hospitalised patients (Muller, 2014, Russell et al., 1999). Nevertheless, there still 
remains a gap in our understanding of the direct implications of denture plaque in 
the development of respiratory disease.  
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5.2 Aims 
The aims of this chapter were to undertake a comprehensive targeted evaluation 
of putative respiratory pathogens residing upon dentures using a targeted 
quantitative molecular approach. The following key questions were investigated: 
 Do respiratory pathogens colonise dentures? 
 If respiratory pathogens do colonise dentures, how abundant are they 
within the denture plaque? 
 Is there a relationship between denture stomatitis and prevalence of 
respiratory pathogens found on dentures? 
The data represented in this chapter has been published in: 
 
The data presented in this chapter has been presented at the following 
conferences: 
 
L. O’Donnell, C. Nile, K. Smith, V. Hannah, L. Cross, D. Robertson, G. Ramage. 
The Oral Cavity acts as a Reservoir for Staphylococcus aureus: Implications for 
Systemic Infections from Prosthetic Dental Appliances, ECCMID, Barcelona, Spain, 
May, 2014. 
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5.3 Materials and Methods 
5.3.1 DNA extraction of denture sonicate 
Denture sonicate samples were collected and processed as previously described 
(section 2.3.2). One ml of the denture sonicate, which had been stored in 
RNAlater™ was removed and used for DNA extraction. The denture sonicates were 
centrifuged for 10 minutes at 10,000 g. DNA was extracted from individual denture 
sonicate samples using the QIAmp mini DNA extraction kit (QIAgen). The 
supernatant was discarded and the pellet was re-suspended in 180 μl of ATL buffer 
supplemented with 20 μl of proteinase K. From this point onwards the DNA 
extraction process was carried out as previously described (section 4.3.2.4.1). DNA 
was quantified using the NanoDrop™ ND-1000 spectrophotometer (Labtech) as 
described in (section 4.3.2.4.2). 
 
5.3.2 Identification of respiratory pathogens on dentures 
DNA samples extracted from the denture sonicate were screened using qPCR for 
the presence of nine of well know respiratory pathogens, which included: 
Staphylococcus aureus, Moraxella catarrhalis, Streptococcus pneumoniae, 
Streptococcus pyogenes, Haemophilus influenzae B, Pseudomonas aeruginosa, 
Legionella pneumophila, Klebsiella pneumoniae and Chlamydophila pneumoniae.  
5.3.3 Microbial culture of respiratory pathogens 
Laboratory strains of the respiratory pathogens were selected for use in this study. 
Staphylococcus aureus ATCC 25923 and Moraxella catarrhalis ATCC 43617 were 
grown and maintained at 37°C on CBA plates (Oxoid) in aerobic conditions. 
Streptococus pneumoniae ATCC 6303 and Streptococcus pyogenes ATCC 12344 
were maintained at 37°C in 5% CO2 on CBA plates. Haemophilus influenzae B ATCC 
10211, Pseudomonas aeruginosa PA14 and Legionella pneumophila ATCC 33154 
were grown on chocolate agar (E and O labs), LB agar and charcoal agar (E and O 
labs), respectively, in 5% CO2 at 37 °C. Klebsiella pneumoniae DSM 12059 was 
maintained on MacConkey agar (E and O labs) under anaerobic conditions (85% N2, 
10% CO2 and 5% H2, [Don Whitley Scientific Limited, Shipley, UK]).  
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Overnight broths were prepared for each bacterial species. A single colony of S. 
aureus, S. pneumoniae, S. pyogenes and Moraxella catarrhalis was inoculated into 
10 mL of BHI broth (Sigma-Aldrich). H. infulenzae B and K. pneumoniae were 
grown in tryptic soy broth (TSB) (Sigma-Aldrich) and P. aeruginosa was maintained 
in lysogeny broth (LB) (Sigma-Aldrich). L. pneumophila was grown in Legionella 
BYCE growth supplemented broth (Oxoid). Cultures were grown for 24 to 48 h at 
37°C as necessary, washed by centrifugation and resuspended in PBS (Sigma-
Aldrich). All cultures were standardised and adjusted to a final working 
concentration of 1 x 108 cells/mL in PBS.  
5.3.4 Preparation of respiratory pathogen standard curves 
Preparations of standard curves used within this chapter were carried out with 
the help and support of Dr Karen Smith. Serial two-fold dilutions of the 1 x 108 
cells/mL cultures were prepared. Each dilution was centrifuged for 10 min a 
10,000 g. The supernatant was removed, making sure to avoid disturbing the 
pellet. Pellets were re-suspended in proteinase K extraction buffer and incubated 
at 55oC for 20 min. DNA was extracted using the QIAmp mini DNA extraction kit 
(Qiagen,) as previously described (section 4.3.2.4.1). DNA quality and quantity 
was then quantified by NanoDrop® (ThermoScientific).  
5.3.5 Detection of respiratory pathogens in denture plaque using 
qPCR 
Primers were either taken from published literature or designed using the web-
based GenScript real-time PCR primer design software 
(https://www.genscript.com/ssl-bin/app/primer). Primer sequences were 
checked for specificity to each target organism using the NIH-BLAST database. PCR 
amplification efficiencies of all primer sets were optimised prior to gene 
expression analysis, with efficiencies ranging from 90-110%. Details of the 
oligonucleotide primers (Eurogentec, Southampton, UK) used in this study are 
listed in Table 5.1. 200 ng of DNA was used in a mastermix containing SYBR® 
GreenER™ (Life Technologies), UV-treated RNase-free water and forward/reverse 
primers (10 μM). qPCR was carried out using the step one plus real-time PCR unit 
(Applied Biosciences), as previously described (section 4.3.2.4.4), under the 
following conditions; 50oC for 2 min, 95oC for 2 min followed by 40 cycles of 95oC 
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for 3s and 60oC for 30 s. Data analysis was carried out using StepOne software 
V2.3, (Life Technologies). Baseline threshold values of the samples were adjusted 
to correspond with the equivalent standard curve; Ct values were then used to 
approximate the number of corresponding CFE’s based on standard curves created 
from serial two-fold dilutions of each bacterial species.  
 
5.3.6 IL-8 ELISA 
Clarified saliva samples were diluted 1:5 in assay buffer (PBS, 0.5% BSA, 0.1% 
Tween20). IL-8 [Invitrogen, Paisley, UK], was used according to manufacturer’s 
instructions. Capture antibody (1 μg/mL) was prepared in NA2HCO3 and 100 μL 
added to each well of a Nunc™ Maxisorp® flat bottomed microtitre plate [Fisher, 
Loughborough, UK]. Plates were sealed and incubated overnight at 4oC. Contents 
were then discarded and washed with 300 μL of wash buffer of PBS containing 500 
μL Tween 20 /L. Plates were then blocked with 300 μL of assay buffer containing 
0.5 % bovine serum albumin (BSA) for 1 hour at room temperature to block non-
specific binding. After incubation, contents were discarded and 100 μL of each 
sample loaded in duplicate as well as standards of known concentrations ranging 
from 2000 – 31.25 pg/mL. At this time detection antibody was diluted to 0.04 
μg/mL in assay buffer and added to each well containing sample or standard. 
Plates were then sealed and incubated for 2 h at room temperature on a shaking 
platform at 700 rpm. Following incubation the contents of the plate were 
discarded and 100 μL of detection antibody diluted to 0.04 μg/mL in assay buffer 
added to each well before a further incubation of 2 h at room temperature at 700 
rpm. Next, the plate was washed and 50 μL of a 1/2500 dilution of streptavidin-
HRP in assay buffer was added to each well for a further 30 min incubation shaking 
at 700 rpm. Finally, the supernatants were discarded and 100 μL of TMB [R&D 
Systems, Abingdon, UK] was added to each well and incubated in the dark for 30 
min before addition of 100 μL 1 mM hydrochloric acid (HCL) to stop the reaction. 
Absorbance was read using a plate reader [FLUOstar Omega BMG Labtech, VA, 
USA] at 405 nm with a 650 nm wavelength correction. A standard curve was 
constructed by plotting the mean absorbance for each standard against the 
appropriate protein concentration and the R-squared calculated using a computer 
program [Omega analysis software, VA, USA]. Results were calculated using a 4-
parameter curve fit to determine the concentration of protein release in samples 
tested. All samples were tested in duplicate. 
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5.3.7 Statistical analysis 
Graph production, data distribution and statistical analysis were performed using 
GraphPad Prism (version 4; La Jolla, CA, USA) or IBM SPSS statistics (version 21; 
Chicago, Il, USA). Since continuous data including real-time qPCR determination 
of bacterial cell numbers on dentures did not conform to a normal distribution the 
Man-Whitney U-test was used for comparisons between the different denture 
wearer subsets. The Spearman bivariate correlation analysis was used to 
determine relationships between the Newton Grade of inflammation and bacterial 
numbers.  
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Table 5.1: Respiratory pathogen primers used for qPCR.  
Species Type strain Media/Conditions Gene Primer sequence Amplicon 
Size 
S. aureus DSMZ 1104 BHI, aerobic SAR0134 F – ATTTGGTCCCAGTGGTGTGGGTAT 
R – GCTGTGACAATTGCCGTTTGTCGT 
143 
MRSA  BHI, aerobic MecA F – AACCACCCAATTTGTCTGCC 
R – TGATGGTATGCAACAAGTCGTAAA 
135 
H. influenzae 
B 
DSMZ 11969 MHB + 0.4% 
haemophilus test 
medium, 5% CO2 
GryB F–CTTACGCTTCTATCTCGGTGATTAATAA 
R – TGTTCGCCATAACTTCATCTTAGC 
138 
P. aeruginosa PA14 LB, aerobic RpoD F – GGGCGAAGAAGGAAATGGTC 
R – CAGGTGGCGTAGGTGGAGAA 
178 
S. pneumoniae DSMZ 14377 BHI, 5% CO2 CspA F – ACGCAACTGACGAGTGTGAC 
R – GATCGCGACACCGAACTAAT 
352 
M. catarrhalis DSMZ 11994 BHI, aerobic OmpCD F – ACACGCAACTCTTGACGAAG 
R – CTGAGCCTGTCATTGAGGAA 
180 
S. pyogenes DSMZ 20565 BHI, 5% CO2 SpeB F – TGC TAAAGTCGCTACGGTTG 
R – GAATTGATGGCTGATGTTGG 
148 
C. 
pneumoniae 
ATCC VR-
1360D DNA 
NA MomP F – 
TTACTTAAAGAAACGTTTGGTAGTTCATTT 
R – TAAACATTTGGGATCGCTTTGAT 
154 
K. 
pneumoniae 
DSMZ 12059 TSB, anaerobic PhoE F – AGAATTCAGATTCCCAACGG 
R – ACAAGAACGCGAACAAACTG 
167 
L. 
pneumophila 
DSMZ 25038 YEB with BCYE 
supplement, 5% CO2 
Mip F – CAATGTCAACAGCAATGGCTGCAAC 
R – CTCATAGCGTCTTGCATGCCTTTAGCC 
160 
16S   16S F – ACTCCTACGGGAGGCAGCAGT 
R- TATTACCGCGGCTGCTGGC 
198 
MRSA: Methicillin –resistant Staphylococcus aureus, BHI: Brain heart infusion, MHB: Mueller Hinton broth, NA: Not applicable,TSB: 
Tryptic soy broth, YEB:Yeast extract broth, BCYE: Buffered charcoal yeast extract. 
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5.4 Results 
5.4.1 Detection of respiratory pathogens 
In order to determine if dentures could act as a reservoir for respiratory 
pathogens, DNA was extracted from the denture sonicate, and assessed for the 
presence of nine pathogens associated with respiratory infection. The dentures of 
84 patients (64.6%) carried potential respiratory pathogens. The following six were 
identified by qPCR using species specific primers (Table 5.1): S. aureus, S. 
pneumoniae, P. aeruginosa, H. influenzae B, S. pyogenes and M. catarrhalis.  
 
S. aureus was the most prevalent, with 67 patients (51.2%) being shown to carry 
this pathogen. Of these 67 patients, re-testing using primers specific for the mecA 
gene demonstrated that two (3%) dentures were colonised with MRSA.  H. 
influenzae B (15.3%), P. aeruginosa (11.5%), S. pneumoniae (6.9%), S. pyogenes 
(0.8%) and M. catarrhalis (0.8%) were also detected within denture plaque of our 
patients (Table 5.2). Fifty-eight patients (44.6%) had dentures colonised by a 
single pathogen, 24 patients (18.5%) were colonised by two pathogens, and two 
patients (1.5%) were colonised by three. None of the samples were shown to be 
positive for L. pneumophila, C. pneumoniae or K. pneumoniae. 
 
5.4.2 Quantifying respiratory pathogens 
Standard curves of the six respiratory pathogens detected were prepared for each 
bacteria (Figure 5.1); R2 values ranged from 0.91 to 0.99. Table 5.2 shows the 
mean CFE counts of each organism detected on dentures. In terms of overall 
proportion of denture plaque, P. aeruginosa was found to be the most abundant 
respiratory pathogen, with a mean count of 4.3 x 106 CFE when present. This was 
followed by S. pneumoniae and S. aureus, which were detected at relatively high 
levels of 2.5 x 105 CFE/denture and 1.3 x 105 CFE/denture, respectively. 
Conversely, H. influenzae B, S. pyogenes and M. catarrhalis, where present, were 
all detected at levels lower than 105 CFE/denture. The total number of bacteria 
residing on dentures shown to harbour respiratory pathogens was calculated using 
the 16S gene, with mean quantities ranging between 7.97 x 109 – 4.5 x 1010 
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CFE/denture. As a proportion of the overall plaque, P. aeruginosa was most 
abundant contributing to 0.015% of the total. The remaining pathogens all 
contributed to less than 0.001% of the complete plaque sample. 
 
Table 5.2: Prevalence and quantity of respiratory pathogens colonising 
dentures. 
Species Positive 
Samples 
Prevalence 
(%) 
Average 
CFE 
Average 
Total 16S 
CFE 
Proportion 
of 16S (%) 
S. aureus* 67 51.2 1.3x105 4.5x1010 2.8x10-4 
H. influenzae 
B 
20 15.3 2.4x104 1.7x1010 1.4x10-4 
P. aeruginosa 15 11.5 4.3x106 3.34x1010 1.5x10-2 
S. 
pneumoniae 
9 6.9 2.5x105 4.4x1010 6.3x10-4 
M. catarrhalis 1 0.8 2x103 7.97x109 2.5x10-5 
S. pyogenes 1 0.8 3.7x104 3.2x1010 1.2x10-4 
C. 
pneumoniae 
ND** ND ND ND ND 
K. 
pneumoniae 
ND ND ND ND ND 
L. 
pneumophila 
ND ND ND ND ND 
* Two S. aureus samples were found to be MRSA positive. 
**ND = Not detected 
CFE: colony forming equivalent  
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Figure 5.5.1:  Standard curves of each of the respiratory pathogens detected 
on dentures. 
DNA from known concentrations of S. aureus (i), H. influenzae B (ii), P. aeruginosa 
(iii), S. pneumoniae (iv), M. catarrhalis (v), S. pyogenes (vi) and 16S (vii) were 
used for qPCR and their equivalent Ct used for the preparation of a standard curve. 
Unknown bacterial counts could then be quantified by extrapolating from the 
appropriate curve. Each DNA dilution was assessed in duplicate for each of the 
primer sets. 
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5.4.3 Oral inflammation, hygiene and respiratory pathogens 
The relationship between DS and presence of respiratory pathogens was 
investigated. In relation to DS, we determined the prevalence of respiratory 
pathogens amongst healthy and diseased patients, based on clinical presentation 
using Newton’s classification, as previously classified (section 2.3.1) (Table 5.3). 
The overall prevalence of these was similar between the healthy (85.2%) and 
diseased (89.8%) groups. However, individual species variation was more evident, 
as upon the dentures of patients with oral inflammation there appeared to be 
greater numbers of S. pneumoniae (p=0.060), though no statistically significant 
differences were observed. 
  
Therefore, the relationship between oral inflammation and salivary Interleukin-8 
levels were investigated as a means to determine whether salivary IL-8 was a 
potential biomarker of inflammation grade in DS patients. IL-8 levels were found 
to be significantly higher in denture wearers with inflammation [Median: 291.4 
(min: 2.07,max: 2821) v 532.3 (min:94.68, max: 3301), p<0.001] (Fig 5.2) and 
positively correlated with the Newton’s inflammation grade (rho=0.315, p<0.01). 
Therefore, henceforth, salivay IL-8 levels were employed as a surrogate marker 
of inflammation severity in DS patients. Taking this approach, no significant 
correlations were identified between salivary IL-8 levels and denture CFE levels 
of individual bacteria.  
 
Data taken from patient clinical information sheets and a self-reported oral health 
questionnaire assessed the oral hygiene of patients with and without respiratory 
pathogens colonising their dentures. Interleukin-8 levels were significantly higher 
in denture wearers with poor oral hygiene (p<0.01) and were found to have a 
positive correlation with poor oral hygiene (rho=325, p<0.001). Whether the 
denture wearers left their dentures in overnight did not appear to alter salivary 
IL-8 concentrations. Interestingly, only 68% of patients with respiratory pathogens 
were classed as having good oral hygiene compared to 81% of those without 
respiratory pathogens. However, having better oral hygiene did not appear to alter 
significantly the proportion of dentures carrying particular bacteria or the 
numbers of those bacteria on dentures. Sleeping with the denture in situ was also 
more common amongst respiratory pathogen positive individuals (58%), when 
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compared to those without (49%). A greater proportion of dentures that were left 
in patients’ mouths overnight were found to carry S. pneumoniae, and an 
increased median number of S. pneumoniae were detected on those dentures 
(p=0.041 and p=0.038, respectively). In contrast, the proportion of dentures 
positive for P. aeruginosa and quantities of P. aeruginosa found on dentures that 
were left in overnight was lower than dentures that were removed (p=0.038 and 
p=0.04, respectively). 
 
 
Table 5.3: Prevalence of respiratory pathogens in plaque of patients with 
healthy palatal mucosa and those with denture stomatitis. 
 
 Healthy Denture stomatitis  
Species Patients Prevalence (%) Patients Prevalence (%) 
S. aureus 40 49.4 27 55.1 
H. influenzae B 16 19.8 4 8.2 
P. aeruginosa 10 12.3 5 10.2 
S. pneumoniae 3 3.7 6 12.2 
M. catarrhalis ND* ND 1 2.0 
S. pyogenes ND ND 1 2.0 
C. pneumoniae ND ND ND ND 
K. pneumoniae ND ND ND ND 
L.  pneumophila ND ND ND ND 
MRSA ND ND 2 4.1 
OVERALL 69 85.2 44 89.8 
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Figure 5.5.2: Salivary IL-8 levels are elevated in denture stomatitis sufferers. 
Salivary levels of IL-8 were compared between healthy and diseased individuals. 
Data represents median (** p<0.01). Statistical analysis was performed using a 
Mann Whitney test as data did not conform to a normal distribution.  
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5.5 Discussion 
Advancements in healthcare in the last 100 years have led to an increasing 
population of elderly individuals. Pneumonia is the 4th leading cause of death 
globally, accounting and thus this ageing population, particularly those aged 65 
and over, and are at a greater risk of developing the disease (Guest and Morris, 
1997). A large proportion of these cases of pneumonia can be attributed to oral 
bacteria emanating from the oropharynx (Andrews and Steen, 2013). 
Approximately 70% of UK adults older than 75 years old wear dentures, which are 
colonised by complex biofilm consortia. These individuals are at an increased risk 
of developing a life-threatening infection as a result of putative respiratory 
pathogens residing upon their denture (Iinuma et al., 2014). Moreover, a recent 
study showed that patients who wear their denture overnight double their risk of 
pneumonia. In this chapter, for the first time, qPCR has been employed to assess 
the pathogenic potential of denture plaque in terms of respiratory infection from 
a large cohort of denture wearers. This study reports a 65% prevalence rate of 
individuals carrying significant quantities of respiratory pathogens on their 
dentures. This was independent from existing oral disease status, indicating that 
even denture wearers with good oral hygiene and healthy palatal mucosa, may 
harbour respiratory pathogens on their dentures. 
 
Biofilms, by their nature, are complex aggregates of microorganisms, and difficult 
to remove homogenously from the denture. To this end we used a mild sonication 
technique previously used in our studies of indwelling prostheses (Coco et al., 
2008a, Tunney et al., 1998). This method was shown to adequately remove the 
biofilm from the surface of the denture. Given the dense and complex microbial 
population of the oral cavity, the presence of similar genera and species is 
problematic for accurate quantitative microbial counts on selective agars (Sumi 
et al., 2002). Therefore, we adopted an alternative specific non-culture based 
method of a qPCR-based approach to identify a panel of defined respiratory 
pathogens. This technique enabled us to rapidly and specifically assess the 
presence and quantity of defined respiratory pathogens. Moreover, this targeted 
molecular approach provided the ability to screen accurately for specific 
microorganisms in complex samples. Similar technology has been employed in 
studies of dental plaque, but has been restricted to conventional PCR only (Abe 
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et al., 2001, Zuanazzi et al., 2010). While there are numerous putative respiratory 
pathogens, our study focussed on nine key bacterial pathogens widely implicated 
in respiratory infections. We found that almost 65% of patients’ dentures carried 
one or more of the pathogens from our panel. This finding is similar to a recent 
study reporting that 64% of the healthy patient group contained respiratory 
pathogens, this was however was a culture based approach, and only nine patients 
were screened in this study (Przybylowska et al., 2014). We are limited in our 
comparisons as, to our knowledge; this is the first study to use a quantitative 
molecular based approach to investigate the presence of respiratory pathogens on 
dentures.  
 
qPCR has proven to be  an vital tool, as this study demonstrated a high prevalence 
of S. aureus (51.2%), yet in another study, which was primarily culture based, of 
the 50 patients only 10% carried S. aureus on their dentures (Sumi et al., 2002). 
This inconsistency can be attributed to the improved detection abilities of qPCR 
as in our parallel study using standard microbial culture S. aureus was detected in 
only 20% of samples (data not shown). H. influenza was also detected in 15.3%, 
whereas Sumi and colleagues (2002) were unable to detect this organism at all. 
Dentures from 6.9% of our patients carried S. pneumoniae, which is considerably 
lower than the 63% prevalence reported by Abe and colleagues (2001). 
Nevertheless, this discrepancy is likely to be caused by the non-specific nature of 
the primers in Abe and colleagues study (Abe et al., 2001). As based on the findings 
from our denture microbome data we showed that streptococcal species make up 
on average 23.5% of the overall denture plaque composition, thus using non-
specific primers will likely detect other streptococci given their high abundance. 
We used the cspA gene specifically, instead of the generic primers, to minimise 
detection of closely related streptococcal species. Together, these organisms 
were detected in relatively low abundance in relation to total bacterial flora (<6 
x 10-4 %), suggesting that these bacteria occupy limited niches upon the denture 
surface. P. aeruginosa however, comprised 0.015% of the total denture 
microbiome, which may be associated with its resistance to standard mechanical 
and chemical cleaning methods when grown on denture acrylic (Paranhos et al., 
2009).  
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We were interested to know if having DS put the individual at greater risk of 
respiratory pathogen colonisation of denture plaque. Previous studies have shown 
that DS sufferers have poorer denture hygiene with higher microbial colonisation 
(Budtz-Jorgensen et al., 1975, Coco et al., 2008a), which supports our finding of 
higher inflammation levels in those with poor hygiene. However, our results 
revealed a similar prevalence of respiratory pathogens between healthy and 
diseased individuals (89.2% and 85.8% respectively), suggesting that DS does not 
increase the likelihood of respiratory pathogen colonisation.  In spite of  previous 
studies showing higher prevalence of AP in patients who do not follow adequate 
dental hygiene measures (Bassim et al., 2008), and that targeted oral hygiene 
measures can reduce the incidence of AP in at risk groups (van der Maarel-Wierink 
et al., 2013). This study detected no difference in the prevalence of respiratory 
pathogen carriage in those with and without signs of DS, signifying that the 
presence of the denture was enough risk in itself.   
 
The high detection rate of S. aureus residing on dentures is concerning, given the 
emergence of drug resistant strains. Two patients in this study were found to be 
positive for the MRSA mecA gene (1.5%). Our prevalence rate is low, yet is 
comparable to a previous study conducted in Scotland in which found that 5% of 
denture wearers carried MRSA in their oral cavity (Kulak et al., 1997). However, 
the prevalence of MRSA in the general population is on average lower than that of 
the institutionalised or hospitalised elderly (14.8%) (Abe et al., 2001).  This may 
be cause for concern as many over-the-counter oral hygiene antimicrobials are 
ineffective against MRSA biofilms (Smith et al., 2013). Sleeping with a denture in 
situ is a habit practised by a large proportion of the patients in this study (55%). 
S. pneumoniae in particular was shown to be significantly more abundant on 
dentures, which were kept in their owner’s mouths overnight. Aspiration of 
oropharyngeal contents most commonly occurs when the individual is sleeping, 
thus these patients are putting themselves at an increased risk of developing 
infection. This is particularly important given that currently 20-30% of S. 
pneumoniae worldwide are multidrug resistant (Lynch and Zhanel, 2005). 
Furthermore, 11.5% of patients carried P. aeruginosa, a disreputable cause of life-
threatening pneumonia for intensive care patients with, a mortality rate of 44.5% 
(Tumbarello et al., 2013). Oropharyngeal P. aeruginosa isolates have also been 
shown to have a high rate of antibiotic resistance (Oostdijk et al., 2010). 
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Moreover, soaking dentures in water overnight is commonplace, thus this may be 
an unintentional source of contamination, so some form of disinfectant such as 
hypochlorite should be included such as hypochlorite alongside for non-metal 
containing prostheses. This is important given that studies have indicated the 
presence of P. aeruginosa in water and its capacity to form biofilms in plumbing 
systems (Loveday et al., 2014). 
 
In summary, this study has shown that dentures are a reservoir for respiratory 
pathogens in the oral cavity, thus increasing the risk of developing AP. This study 
has utilised a robust qPCR based method of sampling the denture microflora which 
has been characterised by comparison of the data to date derived from culture 
independent techniques.  We have shown that there is a high prevalence of 
putative respiratory pathogens on the dentures of ambulatory adults, a finding 
that could explain the source of infection in some cases of AP.  Adoption of 
routine, oral hygiene practices including mechanical cleaning, and the use of 
antiseptic cleansing agents could help to reduce the risk of respiratory infection 
among the elderly population (Ramage et al., 2012).  However, ultimately what is 
required to definitively associate dentures with increased risk of pneumonia are 
more longitudinal studies reporting the clinical outcomes of the patients being 
followed, but with a specific focus on the role of dentures. Although other studies 
have demonstrated the presence of respiratory pathogens on dentures, these 
studies focus on a single time point, and fail to follow up on the patient.  
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CHAPTER FINDINGS 
Dentures act as a reservoir for respiratory pathogens, increasing the risk of 
developing aspiration pneumonia. 
S. aureus was found to be the most prevalent pathogen colonising dentures, and 
where detected, P. aeruginosa the most abundant. 
No association between the presence of respiratory pathogens on dentures and 
denture stomatitis was determined.
  
   
 
6 Discussion
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6.1 Introduction 
DS is a disease for which there is currently a limited understanding of the 
aeitiopathogenesis. This is primarily because studies investigating this disease 
focus heavily on fungal infection by the pathogenic Candida spp. of yeasts, 
consequently neglecting the role of bacteria also residing on dentures. In addition, 
arguably there has been a disproportionate level of investigation focussed on 
periodontal microbiology. Despite this, and perhaps as a catalyst, there been a 
recent realisation that DS is in fact a polymicrobial disease. Here fungi and 
bacteria interact synergistically to survive in complex biofilms, with the 
inadvertent consequence of enhanced fungal pathogenicity. Understanding a 
disease of this nature is complex, and has to be investigated methodically, 
beginning with the aetiological agent(s). ‘What are the aetiological agent(s) of 
DS?’ is a fundamental question, because if we do not know the cause then we 
cannot begin to understand the pathogenic mechanisms behind it, and in turn 
begin to manage it clinically.  
The central problem associated with DS research is the microbial composition of 
denture plaque has yet to be elucidated in depth. The novelty of the work 
described herein lies in the fact that it was the first to use advanced next 
generation sequencing methods to examine the composition of denture plaque in 
both healthy and diseased individuals. This has allowed us to begin to understand 
the aeitiopathogenesis of DS in greater detail and provides a platform for further 
research into the development of ways of improving clinical management of DS 
patients.  
6.2 Is the denture microbiome relevant?  
The human microbiome refers to the collection of genes and genomes of members 
of the microbiota found in the human body (Turnbaugh et al., 2007). The 
microbiome at specific locations within the body are generally studied opposed to 
looking at the human microbiome as a complete entity, such as the oral or gut 
microbiome per se (Chen et al., 2010). Microbiome analysis is able to give a global 
representation of the microbial communities at the site of investigation due to 
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advances in sequencing technology. Other technologies, including microbial 
culturing, standard qPCR, DNA-DNA hybridisation, all provide valuable 
information, yet really only offer a biased snapshot of the microbial communities 
present. Uncultivable bacteria are recognised as one of the key problems 
associated with less advanced sequencing techniques, as these bacteria are 
generally not detected during conventional screening (Diaz-Sanchez et al., 2013). 
This means that microbes that may play a potentially significant role in the 
pathogenesis of a particular disease are missed. Next generation, high throughput, 
sequencing on the other hand is able to detect these bacteria, and depending on 
the sequencing platform used, can identify them down to species level. The 
importance of microbiome studies cannot be underestimated as recent evidence 
strongly indicates that, in the near future, we will be able to use individual 
microbiota profiles in clinical practice as a biomarker of the patients' health (Cenit 
et al., 2014). Moreover, there is potential to use this technology in order to predict 
if an individual is more at risk of developing a certain disease, though clearly 
further pioneer studies are required to take this forward.  
In terms of the oral cavity this study has addressed the point that whilst the dental 
microbiome has been well characterised, in comparison the denture microbiome 
has been relatively unexplored. However, the relevance of studying the denture 
microbiome comes from the vast number of people that wear some form of 
denture prosthesis. With approximately one fifth of adults wearing a denture, 
there is an elevated likelihood that they will experience denture-related disease 
at some point. Some individuals will be fortunate and have no issues with their 
denture, yet others will continue to be plagued by recurrent problems of a 
chronic, and often debilitating nature. DS is the primary disease associated with 
denture microbiology, with prevalence rates of up to 70% (section 1.2.3). 
However, other diseases are associated with denture microbiology, including 
angular chelitis, a common inflammatory condition affecting the corners of the 
mouth (Skinner et al., 2005). Denture wearers are within the high risk group for 
this disease, with approximately 7 per 1000 people affected; a figure which 
increases 3-fold in denture wearers (Shulman et al., 2004, MacEntee et al., 1998). 
Samples taken from infected areas principally isolate C. albicans, S. aureus and 
herpes simplex virus (Skinner et al., 2005).  
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These are just some examples of the local implications that can be caused by 
denture microbiology, yet what is now becoming a more heavily focused area of 
research are the potential systemic implications. The links between denture 
plaque and respiratory infection has been a primary focus within this body of 
research (chapter 5). The successful identification of numerous well-known 
respiratory pathogens colonising dentures was reported herein, and this combined 
with the high number of people that sleep overnight wearing their dentures and 
the rate of aspiration of oropharyngeal contents, significantly increases their risk 
of developing serious pulmonary infection. Nonetheless, the potential systemic 
implications of dentures are more than just respiratory infection, as oral bacteria 
have been implicated in other diseases such as endocarditis (Carmona et al., 
2002). Furthermore, a knock on effect of denture related disease is malnutrition, 
a consequence of inflamed oral mucosa, resulting in an inability to comfortably 
wear dentures, and thus the individual cannot properly consume foods (Prakash 
et al., 2012).  
Given the numerous local and systemic consequences that could be related back 
to the microbiology of a denture, the relevance of understanding the denture 
microbiome and the pathogenesis behind disease cannot be overstated. However, 
what these implications ultimately translate to a high cost to the NHS. For that 
reason, more time and money should be invested in denture research to find a 
more targeted treatment for denture related disease, which consequently should 
have a knock on effect in terms of local and systemic consequences, ultimately 
reducing the cost and burden to the NHS.  
6.3 Current and potential treatments 
Disappointingly, it has become apparent that there still remains a clear lack of 
evidence for the most appropriate denture cleansing strategy. The most recent 
guidelines for care and maintenance of complete dentures suggested that removal 
of the “bacterial biofilm” is of the upmost importance in order to sustain good oral 
and systemic health and prevent DS (Felton et al., 2011). In addition to removal of 
the denture biofilm, the guidelines also advocate reduction and maintenance of 
low microbial levels on the denture, either with daily soaking and brushing with an 
effective, non-abrasive cleanser, which should only be performed extra-orally and 
thoroughly rinsed thereafter, following manufacturers instructions (Felton et al., 
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2011). The type of brush and cleanser used are of critical importance, as 
mechanical cleansing augmented with dentifrices have been shown to induce 
abrasions causing physical defects on the denture acrylic, leading to enhanced 
bacterial adhesion through altered surface topography (Charman et al., 2009, 
Mainieri et al., 2011, Sorgini et al., 2012, Verran et al., 2014). Moreover, the 
frequency of cleansing has an important bearing (Apratim et al., 2013), as in vitro 
and in vivo studies have reported that the sporadic use of denture cleansers allows 
build up of mature denture plaque (Apratim et al., 2013, Lucena-Ferreira et al., 
2014, Ramage et al., 2012), which while responsive to a range of treatment options 
still leaves behind residual live cells, even with agents such as sodium hypochlorite 
(Jose et al., 2010). In fact, some studies have suggested that C. albicans may be 
favoured for selection due to its thick cell wall and hardy protective chitin layer 
(Lucena-Ferreira et al., 2014). However, in contrast, this study demonstrated that 
daily cleansing may not be critical, as there were no significant differences in the 
quantity of bacteria or fungi colonising denture discs when a denture cleanser was 
used daily or intermittently. Nonetheless, daily brushing was required to dislodge 
the biofilm mass. Collectively, these studies suggest a drive towards a consensus 
approach to managing denture cleansing, which has still to be forthcoming.   
 
Although current cleansing methods are effective in killing cells and disrupting the 
denture biofilm structure, the biofilm quickly reforms as live cells still remain and 
the process begins all over again. As demonstrated in this study, significant number 
of live cells remained even after daily cleansing and brushing. Thus, an alternative 
approach to denture cleansing is required; perhaps a more targeted solution. 
Biofilm formation in itself is an effective protective mechanism from 
antimicrobials, protecting cells within by blocking access of antimicrobial drugs. 
The ECM produced by the biofilm has been shown to play an important role in the 
protection against antimicrobials (Rajendran et al., 2013), therefore, targeting a 
key component of the ECM involved in protection could result in a more effective 
treatment. For example, extracellular DNA (eDNA) is a known component of 
bacterial and fungal biofilms and the use of DNAse in conjunction with antifungals, 
such as amphoterecin B, has been shown to effectively enhance biofilm disruption 
(Rajendran et al., 2014). This presents a possible option for the use of DNAse in 
combination with standard denture cleansers, which may target other cells buried 
deep within the denture biofilm being protected by the ECM. Nonetheless, whilst 
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this treatment approach shows potential, it should be kept in mind that C. albicans 
species are heterogenic by nature in terms of eDNA release, thus the effectiveness 
of this treatment is strain dependant (Rajendran et al., 2014). Moreover, given 
that Candida spp. are outnumbered by approximately 10 fold by bacteria, then 
their role also needs to be considered and factored into new therapeutics.  
 
This in turn raises another problem regarding treatment methods, as the 
microbiome of each individual is unique, and whilst the majority of species may 
be similar, the strains are not necessarily. This indicates that the most logical 
solution is patient specific treatment. With the advances in NGS technology, a 
patient’s microbiome can be sequenced within hours. However, most of these 
platforms have not yet advanced to a level in which chair-side sequencing is 
possible. One of the more recent platforms to be introduced is the Ion Torrent™ 
system. Ion Torrent™ technology directly translates chemically encoded 
information (DNA bases [A, C, G, T]) into digital information on a semiconductor 
chip (Merriman and Rothberg, 2012). The result is a sequencing technology that is 
simpler, faster, more cost effective and scalable than any other technology 
available, putting it within the reach of any lab or clinic, however remote. 
Currently, using this technology the process from sample collection to data takes 
around 4 hours, and no doubt as NGS technologies continue to advance this time 
will decrease. Obviously further research is required, however, chair/bed-side 
diagnosis with targeted patient specific treatment, would appear to be the 
direction of the future (Quick et al., 2016).  
 
6.4 The Relevant Use of a Model 
The term model is used rather liberally in science, though their use in the study 
of disease is without question if fit for purpose. Oral biofilm models have been 
used by several groups to study microbial interactions as well as biofilm-host 
interactions (Millhouse et al., 2014, Park et al., 2014, Guggenheim et al., 2001, 
Periasamy and Kolenbrander, 2009). The majority of these biofilm models are 
based around periodontal disease. These models have included both defined and 
undefined consortia of bacteria. Undefined consortia are considered in vivo 
models as samples are taken directly from the patient and the biofilms are grown 
directly from these samples. Whilst these types of models have the advantage of 
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accurately representing the microbiome of periodontal plaque, the investigator 
remains blind to the microbes that are present in the biofilm, thus there are 
usually problems with reproducibility of results. In addition, a sample taken 
directly from the patient is likely to contain numerous bacterial genera, making 
studying the intricate microbial interactions extremely complex. Therefore, using 
NGS methods to identify the microbes found within the biofilm allows for the 
selection of the key microbes to include within an in vitro biofilm model. These 
offer many advantages over in vivo biofilm models, most notably being ethical and 
cost considerations. Furthermore, they also offer the advantage of being a 
controlled reproducible environment, which allows for detailed studies of real 
time changes in both the biofilm and host responses, and how they interact. The 
sequential addition of bacteria, and indeed fungi, during the growth of multi-
species biofilms allows their development in a manner that reflects that of natural 
denture plaque.  
Biofilm model studies are necessary for research into health, disease and 
therapeutics both in the oral cavity and beyond (Millhouse et al., 2014). The initial 
study highlighting the important role that biofilm models could play in future 
studies of antimicrobial resistance and chemotherapeutics was carried out by 
Nickel and colleagues (1985) when investigating P. aeruginosa biofilms, where  
they found that in its planktonic form the cells were 1000-fold more susceptible 
to the antibiotic tobramycin than in its biofilm form (Nickel et al., 1985). As for 
Candida spp., countless studies have demonstrated the enhanced resistance of 
these fungi to several of the ‘gold standard’ antifungal agents including: 
amphoterecin B, fluconazole, caspofungin and nystatin in their biofilm form 
(Hawser and Douglas, 1995, Chandra et al., 2001). Furthermore, in terms of oral 
bacteria, these findings also apply to S. gordonii, P. gingivalis, F. nucleatum and 
A. actinomycetemcomitans, where antibacterial resistance increased between 
100-1000 fold upon treatment with doxycycline or chlorohexadine (Park et al., 
2014). Moreover, they also emphasised the importance of interspecies interactions 
on influencing antimicrobial sensitivity, by showing that multispecies biofilms 
were 100-1000 fold more resistant to the antimicrobials than single species. The 
overuse of antibiotics has led to the emergence of resistant organisms, which 
means alternate treatments need to be developed (Gillam and Turner, 2014). 
Biofilm models therefore provide a relatively inexpensive platform upon which 
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potential new treatments can be tested. Moreover, these models can give an 
insight into more than just the microbial interactions. They can also be adapted 
to give insight into the host response. These biofilm models are also easily 
adaptable in that the components can easily be swapped to create a model most 
relevant to a particular disease of interest. 
6.5 Clinical implications and future work 
This body of work has investigated the composition of the denture, dental and 
mucosal microbiome of a denture wearer using NGS. The data obtained has been 
used to investigate differences in the microbiome composition between health 
and disease and subsequently develop a biofilm model representative of denture 
plaque. Although differences were detected in terms of diversity between the 
healthy and DS denture microbiome, minimal changes were detected in terms of 
composition. However, it was the presence of natural dentition that had the most 
significant impact on altering the microbiome.  
The clinical implications of this research have the potential to be vast. As what 
this study has done is given an in depth insight into the microbiome of dentures 
and the oral cavity of denture wearers by showing us ‘what is there’, which is the 
first key step in allowing us to begin to understand the complex microbe-microbe 
interactions; as well as host-microbe interactions. The subsequent development 
of the denture biofilm model has further provided us with the platform whereby 
we can begin to investigate these intricate interactions. With such a model we are 
better equip to begin to understand this disease at both the host and microbial 
level. With this, there should hopefully come the development of potential 
therapeutics so that DS can be classed as an easily treatable and manageable 
disease. Furthermore, the identification of numerous respiratory pathogens as a 
component of denture plaque, regardless of health or disease should serve as a 
warning for the potential systemic implications. The aim of this investigation was 
not to scaremonger and say that patients will develop pneumonia if they have 
these pathogens on their dentures. However, what would ideally result from this 
study is increased awareness of the importance of good denture and oral hygiene, 
and the implementation of strict oral hygiene regimes in hospitals and long term 
care facilities nationally.  The benefits of oral hygiene regimens have already been 
shown to reduce incidences of pneumonia, thus given that the NHS currently 
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spends £400 million annually treating patients with pneumonia, the potential 
impact in terms of alleviating burden and cost to the NHS could be massive. 
Going forward it would be particularly interesting to investigate how the host 
responds to the presence of these biofilms by setting up a co-culture model with 
the biofilm and host cells, as described previously (Millhouse et al., 2014). The 
biofilm could be cultured alongside different cell types including host tissue 
epithelial cells and immune cells to investigate if, and how, the biofilm is able to 
modulate the host response. This setup would allow us to begin to assess the 
mechanisms by which biofilms differentially modulate host immune responses, 
focusing separately on either the biofilm or host cells. For example, RNA 
extraction from either microbial or host cells could allow for gene expression 
analysis by which significant genes being up or down regulated can be identified. 
Mutant strains deficient in these key genes could then either be included within 
the model to assess the role and importance of the gene. Furthermore, the 
inclusion or removal of certain species of bacteria or fungi from the biofilm would 
help evaluate their contribution to the modulation of host responses and help 
understand the role of health and disease-associated bacteria in oral biofilms.  
This thesis has provided an in depth analysis of denture plaque, whilst providing 
important data to the evidence base. However, it only represents a snapshot of 
the microbiome from a single point in time. This work could, and will, be taken 
further with a more longitudinal study in which biofilm development and the 
associated compositional changes can be observed over time. Moreover, this kind 
of study would also present the opportunity to test new antimicrobial treatments, 
and assess their effectiveness and the impact on microbiome composition and 
viability over time in vivo.  
The next logical step would therefore involve a clinical trial to test these 
hypotheses. Currently, a clinical trial which will test the antimicrobial efficacy of 
a new denture cleanser will shortly be undertaken within our clinics. Patients will 
be given either daily or weekly treatments and the microbiome composition 
assessed at several time points over the course of three weeks, using a variety of 
methods including NGS, qPCR and CFU analysis. This work should hopefully reveal 
important information, regarding the species that are more resistant to 
treatment, thus revealing new targets for more targeted chemotherapeutics. 
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6.6 Summary 
CHAPTER FINDINGS 
The key findings presented in this chapter are as follows: 
The bacterial microbiome composition of denture wearers is not consistent 
throughout the mouth and varies depending on sample site.  
The presence of natural teeth has a significant impact on the overall microbial 
composition.  
Evidence suggests that the compositional changes responsible for disease 
progression are occurring at the mucosa. 
CFU analysis is considerably less effective at quantifying biofilms than 
molecular CFE analysis using qPCR. 
When left untreated the denture biofilm takes on a predominantly anaerobic 
composition 
Dentures act as a reservoir for respiratory pathogens, increasing the risk of 
developing aspiration pneumonia. 
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Dental 
 Healthy DS 
Class Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinobacteria 17.25 16.04 64.16 1.04 >0.05 12.27 19.66 14.29 66.10 0.65 >0.05 16.71 
Bacilli 12.83 7.01 76.23 0.26 >0.05 17.51 13.57 6.23 96.88 0.26 >0.05 18.60 
Bacteroidia 12.63 5.97 48.44 0 >0.05 13.75 15.81 15.32 58.57 0 >0.05 14.84 
Betaproteobacteria 5.04 1.38 36.36 0 >0.05 8.17 3.85 0.39 32.34 0 >0.05 7.68 
Clostridia 23.69 21.17 51.43 0.65 >0.05 13.82 24.97 21.17 68.96 0.39 >0.05 12.61 
Coriobacteriia 0.24 0 1.69 0 >0.05 0.40 0.64 0.13 6.10 0 >0.05 1.28 
Epsilonproteobacteria 1.41 1.10 5.07 0 >0.05 1.22 1.85 1.43 5.84 0 >0.05 1.61 
Flavobacteriia 6.24 2.73 42.60 0 >0.05 8.95 3.91 1.69 19.61 0 >0.05 4.82 
Fusobacteriia 16.12 15.91 43.12 0.26 >0.05 11.63 12.33 10.78 33.12 0 >0.05 9.64 
Gammaproteobacteria 0.22 0.19 1.41 0 >0.05 0.63 0.13 0.27 1.15 0 >0.05 0.65 
Other 0.09 0 0.52 0 >0.05 0.15 0.28 0.26 0.65 0 >0.05 0.13 
Spirochaetes 0.70 0 5.46 0 >0.05 1.18 0.85 0.13 4.16 0 >0.05 1.27 
Synergistia  0.03 0 0.65 0 >0.05 0.11 0.22 0 3.77 0 >0.05 0.72 
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Dental 
 Healthy DS 
Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinomyces 5.10 2.79 33.12 0 >0.05 6.77 8.89 3.64 57.79 0 >0.05 12.74 
Bifidobacterium 0.16 0 3.64 0 >0.05 0.64 0.43 0 5.07 0 >0.05 1.25 
Campnophaga 5.84 2.67 41.82 0 >0.05 8.44 3.67 1.69 16.49 0 >0.05 4.40 
Campylobacter 1.41 1.10 5.07 0 >0.05 1.23 1.85 1.43 5.84 0 >0.05 1.61 
Corynebacterium 7.69 4.74 32.08 0 >0.05 8.77 5.44 1.95 27.92 0 >0.05 6.84 
Dialister 0.94 0 9.61 0 >0.05 2.07 0.86 0.39 6.23 0 >0.05 1.37 
Fusobacterium 6.02 3.77 26.8 0 >0.05 6.04 6.97 5.97 24.29 0 >0.05 5.99 
Halomonas 0.47 0 11.56 0 >0.05 2.03 0.07 0 0.65 0 >0.05 0.17 
Heamophilus 1.98 0.26 26.10 0 >0.05 4.81 1.84 0.13 14.10 0 >0.05 3.51 
Kingella 1.14 0.45 10.78 0 >0.05 2.15 2.07 0.13 31.30 0 >0.05 6.02 
Lactobacillus 4.26 0 75.06 0 >0.05 17.01 4.21 0 94.68 0 >0.05 17.80 
Leptotrichicia 10.11 0 1.04 0 >0.05 0.25 0.05 0 0.65 0 >0.05 3.44 
Moryella 10.09 5.84 33.64 0 >0.05 10.07 5.43 0 20.39 0 >0.05 0.14 
Nessieria 1.89 0.13 18.70 0 >0.05 4.12 0.97 2.99 18.44 0 >0.05 5.99 
Porphyromonas 0.48 0 4.16 0 >0.05 0.97 0.50 0 5.58 0 >0.05 0.12 
Prevotella 11.13 5.07 45.97 0 >0.05 12.90 13.53 11.30 45.71 0 >0.05 12.92 
Rothia 0.03 0 0.39 0 >0.05 0.08 0.31 0 3.51 0 <0.05 0.71 
Selenomonas 6.59 5.52 21.43 0 >0.05 6.54 6.01 3.25 34.16 0 >0.05 8.44 
Streptococcus 8.27 5.78 34.29 0 >0.05 9.15 8.36 4.54 37.27 0.26 >0.05 8.68 
Tanerella 0.43 0.06 3.90 0 >0.05 0.85 0.48 0 5.07 0 >0.05 1.23 
Treponema 0.70 0 5.46 0 >0.05 1.18 0.85 0.13 4.16 0 >0.05 1.27 
Veillonella 12.69 9.42 48.44 0.26 >0.05 12.76 14.89 14.16 68.83 0.39 >0.05 14.07 
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Denture 
 Healthy DS 
Class Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinobacteria 42.57 42.08 89.35 1.039 >0.05 24.73 42.76 38.96 88.57 16.88 >0.05 21.05 
Alphaproteobacteria 2.73 0 50.52 0 >0.05 8.23 0.94 0 15.58 0 >0.05 2.850 
Bacilli 32.44 28.96 94.49 0.39 >0.05 22.77 32.73 28.44 96.62 1.69 >0.05 25.01 
Bacteroidia 2.97 1.17 40.65 0 <0.05 6.15 5.18 2.86 30.78 0 <0.05 1.06 
Betaproteobacteria 2.44 1.04 18.05 0 >0.05 4.03 1.80 0.65 12.47 0 >0.05 3.02 
Clostridia 8.65 4.42 41.17 0.26 <0.05 8.79 11.24 10.52 36.75 0.13 >0.05 8.04 
Coriobacteriia 1.11 0.26 12.47 0 >0.05 2.26 1.28 0.52 14.55 0 >0.05 25.80 
Epsilonproteobacteria 0.06 0 1.56 0 >0.05 0.21 0.1 0 0.52 0 <0.05 0.15 
Flavobacteriia 0.14 0 0.78 0 >0.05 0.19 0.21 0 2.99 0 >0.05 0.56 
Fusobacteriia 0.99 0.39 11.04 0 >0.05 1.91 1.11 0.52 5.46 0 >0.05 1.32 
Gammaproteobacteria 5.71 0.13 70.52 0 >0.05 12.49 2.50 0.91 20.13 0 >0.05 4.50 
Other 0.01 0 0.52 0 >0.05 0.07 0.02 0 0.26 0 >0.05 0.06 
Sphingobacteriia 0.08 0 4.93 0 >0.05 0.61 0.02 0 0.65 0 >0.05 0.10 
Spirochaetes 0.01 0 0.26 0 >0.05 0.04 0.03 0 0.52 0 >0.05 0.09 
Synergistia 0.004 0 0.13 0 >0.05 0.02 0.04 0 0.91 0 >0.05 0.16 
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Denture 
 Healthy DS 
Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinomyces 26.49 18.31 86.88 0.26 p>0.05 25.16 27.71 21.30 83.25 0 p>0.05 22.32 
Atopbium 1.02 0.26 12.34 0 p>0.05 2.08 1.17 0.39 14.03 0 p>0.05 2.43 
Bifidobacterium 1.08 0 19.09 0 p>0.05 3.22 1.11 0.13 11.82 0 p>0.05 2.56 
Bradyrhizobium 1.88 0 38.96 0 p>0.05 6.44 0.63 0 11.17 0 p>0.05 2.03 
Campnophaga 0.06 0 0.52 0 p>0.05 0.14 0.18 0 2.58 0 p>0.05 0.50 
Campylobacter 0.06 0 1.56 0 p>0.05 0.21 0.10 0 0.52 0 p>0.05 0.15 
Cardiobacterium 0.02 0 0.26 0 p>0.05 0.06 0.02 0 0.26 0 p>0.05 0.06 
Corynebacterium 0.64 0.13 10.52 0 p>0.05 1.63 1.37 0.26 18.44 0 p>0.05 3.42 
Delftia 0.09 0 2.86 0 p>0.05 0.40 0.26 0 9.35 0 p>0.05 1.43 
Dialister 0.04 0 0.78 0 p>0.05 0.12 0.12 0 1.95 0 p>0.05 0.35 
Fusobacterium 0.14 0 1.82 0 p>0.05 0.31 0.25 0 1.30 0 p>0.05 0.37 
Halomonas 0.36 0 2.73 0 p>0.05 0.72 0.32 0 4.16 0 p>0.05 0.72 
Heamophilus 2.7 0.26 36.62 0 p>0.05 5.83 1.91 0.52 19.35 0 p>0.05 4.29 
Kingella 0.35 0 4.16 0 p>0.05 0.73 0.47 0 4.81 0 p>0.05 1.02 
Lactobacillus 7.28 0.91 95.19 0 p>0.05 16.31 7.36 1.69 84.94 0 p>0.05 15.46 
Leptotrichicia 0.85 0.26 9.22 0 p>0.05 1.69 0.86 0.39 4.81 0 p>0.05 1.14 
Moryella 0.72 0.26 8.18 0 p>0.05 1.46 0.71 0.26 5.58 0 p>0.05 1.17 
Nessieria 1.27 0.13 16.62 0 p>0.05 3.32 0.53 0.13 8.70 0 p>0.05 1.44 
Porphyromonas 0.08 0 0.91 0 p>0.05 0.19 0.16 0 3.38 0 p>0.05 0.54 
Prevotella 2.81 1.17 39.61 0 P<0.01 5.97 4.85 2.86 29.87 0 p<0.01 6.75 
Pseudomonas 0.24 0 14.42 0 p>0.05 0.23 0.01 0 0.12 0 p>0.05 0.01 
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Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Rothia 11.09 4.03 67.27 0 p>0.05 14.4 8.57 5.32 54.03 0 p>0.05 10.81 
Scardovia 1.42 0 30.65 0 p>0.05 4.82 3.18 0.13 21.74 0 p>0.05 6.85 
Schwartzia 0.02 0 1.30 0 p>0.05 0.16 0.02 0 0.39 0 p>0.05 0.07 
Selenomonas 0.58 0 15.97 0 p>0.05 2.20 0.85 0.13 10.91 0 p>0.05 2.08 
Staphylococcus 0.06 0 3.18 0 p>0.05 0.39 0.02 0 0.39 0 p>0.05 0.06 
Streptococcus 23.19 19.48 80.91 0 p>0.05 19.42 23.97 15.58 86.62 0.65 p>0.05 22.25 
Tanerella 0.01 0 0.39 0 p>0.05 0.05 0.03 0 0.78 0 p>0.05 0.12 
Veillonella 6.40 3.12 41.17 0 P<0.05 7.69 7.53 6.62 27.40 0 P<0.05 5.32 
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Appendix IX: Pairwise comparisons of Bacterial 
Classes of Healthy and DS Mucosal Microbiome 
 220 
 
 
Mucosal 
 Good Poor 
Class Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinobacteria 17.56 13.13 51.30 0 <0.05 13.42 23.83 17.66 88.38 1.04 <0.05 16.43 
Alphaproteobacteria 0.70 0.26 4.29 0 >0.05 2.12 0.53 0.26 5.84 0 >0.05 1.18 
Bacilli 49.25 50.26 99.22 3.12 >0.05 26.12 40.24 40.00 89.00 4.03 >0.05 22.89 
Bacteroidia 4.85 2.79 27.27 0 <0.05 5.79 8.64 6.88 37.92 0 <0.05 8.27 
Betaproteobacteria 4.98 3.18 65.27 0 >0.05 12.71 4.48 2.60 14.29 0 >0.05 3.63 
Clostridia 8.17 4.55 35.84 0.26 <0.05 8.52 10.07 8.44 26.10 0.13 <0.05 6.59 
Coriobacteriia 0.57 0.13 4.68 0 >0.05 1.10 1.04 0.26 6.23 0 >0.05 1.58 
Epsilonproteobacteria 0.18 0.13 1.82 0 >0.05 0.31 0.33 0.19 1.56 0 >0.05 0.39 
Flavobacteriia 0.40 0.13 5.46 0 >0.05 0.90 0.45 0.13 3.34 0 >0.05 0.84 
Fusobacteriia 1.87 0.91 7.27 0 >0.05 2.03 1.07 0.52 7.27 0 >0.05 1.44 
Gammaproteobacteria 7.95 3.38 30.65 0.26 >0.05 8.17 8.45 4.94 59.22 0.30 >0.05 10.76 
Other 0.02 0 0.39 0 >0.05 0.06 0.06 0 0.39 0 >0.05 0.09 
Spirochaetes 0.03 0 0.65 0 >0.05 0.13 0.13 0 4.29 0 >0.05 0.85 
Synergistia 0.02 0 0.52 0 >0.05 0.11 0.11 0 6.1 0 >0.05 1.21 
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Appendix X: Pairwise comparisons of Bacterial 
Genera of Healthy and DS Mucosal Microbiome 
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Mucosal 
 Healthy DS 
Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinomyces 7.75 4.16 50.91 0 >0.05 9.95 8.78 5.46 72.99 0 >0.05 12.92 
Atopbium 0.52 0.13 3.98 0 >0.05 0.97 0.58 0.26 3.64 0 >0.05 0.91 
Bifidobacterium 0.64 0.13 15.54 0 >0.05 2.27 0.77 0.13 5.71 0 >0.05 1.42 
Campnophaga 0.39 0.13 4.54 0 >0.05 0.88 0.33 0 3.51 0 >0.05 0.67 
Campylobacter 0.18 0.13 1.82 0 >0.05 0.31 0.33 0.13 1.56 0 >0.05 0.40 
Corynebacterium 0.63 0.13 8.70 0 >0.05 1.43 0.13 0.26 11.30 0 >0.05 2.57 
Delftia 8.10 0 0.65 0 >0.05 0.15 0.11 0 1.69 0 >0.05 0.32 
Dialister 0.05 0 1.04 0 >0.05 0.16 0.13 0 1.56 0 >0.05 0.32 
Fusobacterium 0.25 0 2.47 0 >0.05 0.43 0.45 0.26 2.99 0 >0.05 0.65 
Halomonas 1.28 0.39 13.90 0 >0.05 2.85 0.68 0.39 7.01 0 >0.05 1.27 
Heamophilus 5.37 2.01 28.57 0 >0.05 7.29 5.71 5.59 26.01 0 >0.05 6.56 
Jathingobacterium 1.82 0.45 17.40 0 >0.05 3.57 0.05 0 1.56 0 >0.05 0.26 
Kingella 0.23 0 6.23 0 >0.05 0.88 0.13 0 1.43 0 >0.05 0.28 
Lactobacillus 3.40 0 65.97 0 >0.05 12.09 3.39 0.13 88.57 0 >0.05 14.94 
Leptotrichicia 0.96 0.32 7.27 0 >0.05 1.62 1.22 0.78 6.49 0 >0.05 1.39 
Moryella 0.70 0.19 8.96 0 >0.05 1.40 0.78 0.13 11.43 0 >0.05 2.02 
Nessieria 3.35 0.13 47.27 0 >0.05 7.92 3.48 0.78 35.71 0 >0.05 6.68 
Porphyromonas 0.23 0 2.08 0 >0.05 0.49 1.01 0.13 13.38 0 >0.05 2.38 
Prevotella 4.19 2.53 26.62 0 <0.05 5.82 6.85 5.84 23.12 0 <0.05 5.73 
Rothia 11.15 7.27 50.52 0.26 >0.05 11.10 8.02 5.20 42.27 0 >0.05 9.27 
Scardovia 0.15 0 5.07 0 >0.05 0.77 0.47 0 6.10 0 >0.05 0.14 
Selenomonas 1.41 0.26 16.36 0 >0.05 2.90 1.11 0.13 10.13  >0.05 2.25 
Staphylococcus 0.02 0 0.26 0 >0.05 0.06 0.02 0 0.39 0 >0.05 0.08 
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Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Streptococcus 39.14 35.78 87.66 2.73 >0.05 23.42 38.50 34.16 87.92 3.12 >0.05 24.62 
Tanerella 0.02 0 0.26 0 >0.05 0.06 0.11 0 1.82 0 >0.05 0.32 
Veillonella 4.79 3.44 25.58 0 >0.05 4.87 4.43 3.77 12.60 0 >0.05 3.16 
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Appendix XI: Pairwise comparisons of Bacterial 
Classes of Smokers and Non-smokers Dental 
Microbiome 
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Dental 
 Smoker Non-smoker 
Class Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinobacteria 25.43 24.55 66.10 4.81 >0.05 19.24 17.03 15.19 64.16 0.65 >0.05 13.42 
Bacilli 20.68 5.58 76.23 2.86 >0.05 2.86 11.75 6.62 96.88 0.26 >0.05 15.34 
Bacteroidia 12.36 13.12 35.84 0.65 >0.05 11.58 14.42 9.35 58.57 0 >0.05 14.75 
Betaproteobacteria 1.52 0.13 9.48 0 >0.05 2.93 5.05 1.17 36.36 0 >0.05 8.43 
Clostridia 19.71 16.23 41.04 0.91 >0.05 11.76 25.14 22.08 68.96 0.39 >0.05 13.25 
Coriobacteriia 0.52 0.06 2.72 0 >0.05 0.90 0.40 0 6.10 0 >0.05 0.94 
Epsilonproteobacteria 1.34 0.91 4.03 0 >0.05 1.25 1.66 1.30 5.84 0 >0.05 1.46 
Flavobacteriia 2.81 0.91 11.69 0 >0.05 3.99 5.61 2.86 42.60 0 >0.05 7.80 
Fusobacteriia 12.92 10.52 34.03 0.26 >0.05 12.17 14.65 14.03 43.12 0 >0.05 10.68 
Gammaproteobacteria 1.43 0.26 7.14 0 >0.05 2.32 3.21 0.91 26.10 0 >0.05 5.37 
Other 0.21 0.26 0.39 0 >0.05 0.16 0.17 0.13 0.65 0 >0.05 0.17 
Spirochaetes 0.68 0 4.16 0 >0.05 1.40 0.79 0.26 5.46 0 >0.05 1.19 
Synergistia 0.40 0 3.77 0 >0.05 0.18 0.06 0 1/04 0 >0.05 0.19 
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Appendix XII: Pairwise comparisons of Bacterial 
Genera of Smokers and Non-smokers Dental 
Microbiome 
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Dental 
 Healthy DS 
Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinomyces 12.16 4.47 57.79 0 >0.05 18.13 5.84 2.86 35.32 0 >0.05 7.58 
Bifidobacterium 0.38 0 2.73 0 >0.05 0.87 0.27 0 5.07 0 >0.05 0.99 
Campnophaga 2.60 0.91 11.04 0 >0.05 3.77 5.27 2.73 41.82 0 >0.05 7.31 
Campylobacter 1.22 0.78 4.03 0 >0.05 1.25 1.69 1.30 5.84 0 >0.05 1.45 
Cardiobacterium 0.14 0 0.78 0 >0.05 0.29 0.44 0 5.58 0 >0.05 0.89 
Corynebacterium 6.49 2.73 21.82 0 >0.05 7.97 6.69 3.57 32.08 0 >0.05 8.03 
Dialister 0.46 0.13 2.47 0 >0.05 0.75 1.01 0.06 9.61 0 >0.05 1.91 
Fusobacterium 4.20 3.64 12.21 0 >0.05 4.27 6.84 5 26.88 0 >0.05 6.22 
Halomonas 0.13 0 0.65 0 >0.05 0.23 0.32 0 11.56 0 >0.05 1.65 
Heamophilus 1.32 0.13 7.14 0 >0.05 2.23 2.04 0.26 26.10 0 >0.05 4.54 
Kingella 0.30 0.13 1.56 0 >0.05 0.48 1.84 0.26 31.30 0 >0.05 4.77 
Lactobacillus 13.12 0 75.06 0 >0.05 28.76 2.36 0 94.68 0 >0.05 13.35 
Leptotrichicia 9.09 1.18 33.64 0 >0.05 11.30 7.70 4.41 31.95 0 >0.05 8.16 
Megasphera 0.18 0 0.78 0 >0.05 0.32 0.55 0 5.46 0 >0.05 1.14 
Moryella 0.08 0 0.65 0 >0.05 0.20 0.09 0 1.04 0 >0.05 0.21 
Nessieria 0.90 0 8.70 0 >0.05 2.74 1.57 0.13 18.70 0 >0.05 4.03 
Porphyromonas 1.03 0 5.58 0 >0.05 2.06 0.39 0 3.51 0 >0.05 0.78 
Prevotella 9.14 10.78 17.01 0.52 >0.05 7.43 12.82 7.79 45.97 0 >0.05 13.62 
Rothia 0.13 0.06 0.52 0 >0.05 0.18 0.16 0 3.51 0 >0.05 0.54 
Schwartzia 0.36 0.06 2.56 0 >0.05 0.61 0.53 0 3.56 0 >0.05 1.12 
Selenomonas 4.67 1.30 24.29 0 >0.05 7.39 6.64 3.38 34.16 0 >0.05 7.45 
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Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Streptococcus 5.81 3.18 18.18 0 >0.05 6.38 8.78 5.46 37.27 0.26 >0.05 9.23 
Tanerella 0.56 0 3.87 0 >0.05 1.27 0.43 0 5.07 0 >0.05 0.99 
Treponema 0.68 0 4.16 0 >0.05 1.40 0.79 0.26 5.46 0 >0.05 1.19 
Veillonella 12.32 12.27 29.74 0.39 >0.05 9.06 13.96 11.30 68.83 0.26 >0.05 14.02 
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Appendix XIII: Pairwise comparisons of Bacterial 
Classes of Smokers and Non-smokers Denture 
Microbiome 
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Denture 
 Smokers Non-smokers 
Class Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinobacteria 46.30 44.16 88.57 6.36 >0.05 22.91 41.94 38.96 89.35 1.04 >0.05 23.61 
Alphaproteobacteria 3.52 0 50.52 0 >0.05 11.54 1.74 0 33.25 0 >0.05 5.18 
Bacilli 31.74 24.29 81.95 6.23 >0.05 22.58 32.79 30.00 96.62 0.39 >0.05 24.16 
Bacteroidia 3.90 1.17 40.65 0 >0.05 9.35 3.81 1.69 30.78 0 >0.05 5.86 
Betaproteobacteria 2.08 0.65 0 15.71 >0.05 3.86 2.21 0.91 18.05 0 >0.05 3.68 
Clostridia 8.54 4.16 23.25 0.65 >0.05 7.94 9.89 7.14 41.17 0.13 >0.05 8.66 
Coriobacteriia 0.66 0 3.12 0 >0.05 1.03 1.32 0.39 14.55 0 >0.05 2.59 
Epsilonproteobacteria 0.18 0.13 1.56 0 >0.05 0.36 0.05 0 0.52 0 >0.05 0.12 
Flavobacteriia 0.12 0 0.52 0 >0.05 0.17 0.13 0 2.08 0 >0.05 0.28 
Fusobacteriia 0.64 0.26 3.25 0 >0.05 0.86 0.51 0.13 7.14 0 >0.05 1.16 
Gammaproteobacteria 1.70 1.04 4.49 0 >0.05 1.97 1.04 4.97 70.52 0 >0.05 11.21 
Other 0.01 0 0.13 0 >0.05 0.03 0.01 0 0.52 0 >0.05 0.07 
Sphingobacteriia 0.01 0 0.13 0 >0.05 0.03 0.06 0 4.94 0 >0.05 0.52 
Spirochaetes 0.03 0 0.52 0 >0.05 0.03 0.01 0 0.26 0 >0.05 0.01 
Synergistia 0.08 0 0.91 0 >0.05 0.23 0.01 0 0.13 0 >0.05 0.03 
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Appendix XIV: Pairwise comparisons of Bacterial 
Genera of Smokers and Non-smokers Denture 
Microbiome 
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Denture 
 Smoker Non-smoker 
Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinomyces 26.73 18.70 83.25 1.68 >0.05 24.48 27.03 19.61 86.88 0 >0.05 24.02 
Atopbium 27.03 19.61 86.88 0 <0.001 24.02 1.18 0.39 14.03 0 <0.001 2.39 
Bifidobacterium 0.29 0 1.82 0 >0.05 0.55 1.26 0.13 19.09 0 >0.05 3.23 
Bradyrhizobium 2.50 0 38.96 0 >0.05 8.90 1.15 0 25.97 0 >0.05 4.04 
Campnophaga 0.08 0 0.52 0 >0.05 0.14 0.11 0 2.60 0 >0.05 0.36 
Campylobacter 0.18 0.13 1.56 0 >0.05 0.36 0.05 0 0.52 0 >0.05 0.11 
Cardiobacterium 0.01 0 0.13 0 >0.05 0.03 0.02 0 0.26 0 >0.05 0.06 
Corynebacterium 0.21 0.13 0.91 0 >0.05 0.27 1.08 0.13 18.44 0 >0.05 2.74 
Delftia 0.01 0 0.13 0 >0.05 0.03 0.19 0 9.35 0 >0.05 1.05 
Dialister 0.01 0 0.13 0 >0.05 0.03 0.08 0 1.95 0 >0.05 0.26 
Fusobacterium 0.25 0 1.30 0 >0.05 0.40 0.17 0 1.82 0 >0.05 0.32 
Halomonas 0.35 0 2.73 0 >0.05 0.70 0 0.34 4.16 0 >0.05 0.72 
Heamophilus 1.01 0.39 3.90 0 >0.05 1.27 2.67 0.52 36.62 0 >0.05 5.73 
Jathingobacterium 0.11 0 0.52 0 >0.05 0.17 0.16 0 4.68 0 >0.05 0.65 
Kingella 0.36 0 3.90 0 >0.05 0.97 0.40 0 4.81 0 >0.05 0.83 
Lactobacillus 3.49 0.58 24.94 0 >0.05 7.25 8.07 1.56 95.19 0 >0.05 17.04 
Leptotrichicia 0.83 0.32 3.90 0 >0.05 1.16 0.86 0.26 9.22 0 >0.05 1.55 
Moryella 0.86 0.13 5.56 0 >0.05 1.51 0.68 0.26 8.18 0 >0.05 1.31 
Nessieria 1.24 0.13 15.71 0 >0.05 3.61 0.92 0.13 16.62 0 >0.05 2.55 
Prevotella 3.73 1.17 39.61 0 >0.05 9.09 36 1.69 29.87 0 >0.05 5.66 
Rothia 18.13 12.21 67.27 0.26 >0.05 19.25 5.37 3.90 53.12 0 >0.05 10.76 
Scardovia 0.37 0 2.86 0 >0.05 0.79 2.5 0.13 30.15 0 >0.05 6.27 
Selenomonas 0.14 0 1.43 0 <0.01 0.36 0.81 0.13 15.97 0 <0.01 2.35 
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Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Streptococcus 26.98 21.43 65.71 4.35 >0.05 18.73 22.76 16.10 86.62 0 >0.05 20.87 
Veillonella 6.73 4.16 20.39 0.39 >0.05 6.19 6.87 4.94 41.17 0 >0.05 6.99 
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Appendix XV: Pairwise comparisons of Bacterial 
Classes of Smokers and Non-smokers Mucosal 
Microbiome 
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Mucosal 
 Smoker Non-smoker 
Class Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinobacteria 16.45 12.34 44.81 3.12 >0.05 11.01 21.74 17.66 83.38 0 >0.05 16.94 
Alphaproteobacteria 1.41 0.52 5.84 0 >0.05 1.80 0.46 0.26 4.03 0 >0.05 0.71 
Bacilli 47.09 42.99 81.43 10.39 >0.05 23.10 45.29 44.42 99.22 3.12 >0.05 25.70 
Bacteroidia 8.18 5.33 27.27 0 >0.05 8.99 5.96 4.29 37.92 0 >0.05 6.61 
Betaproteobacteria 6.83 4.09 22.60 0.13 >0.05 7.36 6.02 2.47 65.97 0 >0.05 10.88 
Clostridia 8.81 5.52 30.65 1.17 <0.05 8.68 8.96 7.01 35.84 0 <0.05 7.67 
Coriobacteriia 0.59 0.26 3.51 0 >0.05 0.91 0.80 0.13 6.23 0 >0.05 1.41 
Epsilonproteobacteria 0.32 0.06 1.82 0 >0.05 0.54 0.22 0.13 1.56 0 >0.05 0.30 
Flavobacteriia 1.68 0.84 6.49 0 >0.05 2.01 1.34 0.65 7.27 0 >0.05 1.69 
Fusobacteriia 7.82 6.03 28.96 0.26 >0.05 7.44 8.23 4.55 59.22 0.26 >0.05 9.68 
Gammaproteobacteria 7.82 6.03 28.96 0.26 >0.05 7.44 8.23 4.55 59.22 0.26 >0.05 9.68 
Other 0.03 0 0.13 0 >0.05 0.06 0.02 0 0.39 0 >0.05 0.08 
Spirochaetes 0.04 0 0.52 0 >0.05 0.13 0.16 0 4.29 0 >0.05 0.62 
Synergistia 0.07 0 1.17 0 >0.05 0.29 0.21 0 6.1 0 >0.05 0.86 
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Appendix XVI: Pairwise comparisons of Bacterial 
Genera of Smokers and Non-smokers Mucosal 
Microbiome 
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Mucosal 
 Smoker Non-smoker 
Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinomyces 4.23 3.12 16.62 0 >0.05 4.40 9.05 5.58 72.99 0 >0.05 12.04 
Atopbium 0.39 0.26 1.82 0 >0.05 0.51 0.58 0.13 3.90 0 >0.05 1.01 
Bifidobacterium 1.65 0.13 15.84 0 >0.05 3.97 0.48 0.13 5.70 0 >0.05 1.05 
Campnophaga 0.32 0 3.51 0 >0.05 0.87 0.38 0.13 4.55 0 >0.05 0.79 
Campylobacter 0.32 0.06 1.82 0 >0.05 0.54 0.22 0.13 1.56 0 >0.05 0.30 
Corynebacterium 0.50 0.13 3.77 0 >0.05 1.03 1.02 0.13 11.30 0 >0.05 2.13 
Delftia 0.16 0 0.91 0 >0.05 0.25 0.09 0 1.69 0 >0.05 0.23 
Dialister 0.03 0 0.13 0 >0.05 0.06 0.09 0 1.56 0 >0.05 0.26 
Fusobacterium 0.42 0.19 1.56 0 >0.05 0.54 0.30 0.13 2.98 0 >0.05 0.52 
Halomonas 2.58 0.65 13.90 0 >0.05 4.53 0.69 0.39 8.05 0 >0.05 1.32 
Heamophilus 3.95 0.52 28.57 0 >0.05 7.15 5.86 2.86 26.49 0 >0.05 6.91 
Jathingobacterium 2.89 0.26 15.06 0 >0.05 4.78 0.50 0 4.29 0 >0.05 0.92 
Kingella 0.11 0 1.43 0 >0.05 0.63 0.21 0 6.23 0 >0.05 0.75 
Lactobacillus 5.37 0.26 65.97 0 >0.05 16.49 2.95 0 88.57 0 >0.05 12.47 
Leptotrichicia 1.19 0.13 6.49 0 >0.05 1.86 1.04 0.52 7.27 0 >0.05 1.46 
Moryella 0.75 0.13 8.96 0 >0.05 2.20 0.73 0.13 11.43 0 >0.05 1.53 
Nessieria 2.18 0.13 20.65 0 >0.05 5.22 3.68 0.39 47.27 0 >0.05 7.82 
Porphyromonas 1.35 0.13 13.38 0 >0.05 3.29 0.37 0 3.25 0 >0.05 0.77 
Prevotella 6.34 4.03 26.62 0 >0.05 7.44 5.02 4.16 23.12 0 >0.05 5.31 
Pseudomonas 0.32 0 3.38 0 >0.05 0.93 0.84 0 57.27 0 >0.05 6.79 
Rothia 9.35 6.75 39.09 0.52 >0.05 9.56 10.01 6.62 30.52 0 >0.05 10.71 
Scardovia 0.23 0 2.47 0 >0.05 0.61 0.37 0 6.10 0 >0.05 1.00 
Selenomonas 0.89 0.06 7.67 0 >0.05 2.02 1.38 0.39 16.36 0 >0.05 2.78 
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Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Staphylococcus 0.03 0 0.26 0 >0.05 0.09 0.01 0 0.39 0 >0.05 0.06 
Streptococcus 39.29 33.12 78.96 9.09 >0.05 22.56 38.79 35.97 87.92 2.73 >0.05 24.19 
Tanerella 0.06 0 0.65 0 >0.05 0.16 0.06 0 1.82 0 >0.05 0.23 
Veillonella 5.10 4.48 17.27 0 >0.05 4.84 4.54 3.64 25.58 0 >0.05 4.13 
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Appendix XVII: Pairwise comparisons of Bacterial 
Classes of Good and Poor Hygiene Denture 
Microbiome 
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Denture 
 Good Poor 
Class Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinobacteria 43.49 42.47 81.35 1.04 >0.05 24.66 40.81 38.96 83.51 2.21 >0.05 19.99 
Alphaproteobacteria 1.76 0 50.52 0 <0.05 7.19 2.57 0.13 27.27 0 <0.05 5.42 
Bacilli 32.17 28.70 96.49 1.69 >0.05 28.37 33.38 29.48 96.62 0.39 >0.05 23.36 
Bacteroidia 3.52 1.43 40.65 0 >0.05 6.69 4.57 2.60 26.23 0 >0.05 6.22 
Betaproteobacteria 2.19 0.91 18.05 0 >0.05 3.66 2.17 0.65 15.71 0 >0.05 3.73 
Clostridia 9.41 6.17 41.17 0.26 >0.05 8.81 10.25 11.36 28.57 0.13 >0.05 8.06 
Coriobacteriia 1.10 0.39 12.47 0 >0.05 2.07 1.40 0.32 14.55 0 >0.05 2.96 
Epsilonproteobacteria 0.09 0 1.56 0 >0.05 0.22 0.07 0 0.52 0 >0.05 0.15 
Flavobacteriia 0.15 0 2.08 0 >0.05 0.30 0.17 0 2.99 0 >0.05 0.52 
Fusobacteriia 0.97 0.45 5.84 0 >0.05 1.26 1.18 0.26 11.04 0 >0.05 2.40 
Gammaproteobacteria 4.96 1.20 70.52 0 >0.05 11.54 3.29 0.84 26.10 0 >0.05 6.32 
Other 0.01 0 0.26 0 >0.05 0.04 0.02 0 0.52 0 >0.05 0.09 
Sphingobacteriia 0.07 0 4.94 0 >0.05 0.57 0.02 0 0.65 0 >0.05 0.11 
Spirochaetes 0.02 0 0.52 0 >0.05 0.07 0.02 0 0.26 0 >0.05 0.05 
Synergistia 0.02 0 0.91 0 >0.05 0.11 0.02 0 0.52 0 >0.05 0.02 
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Appendix XVIII: Pairwise comparisons of Bacterial 
Genera of Good and Poor Hygiene Denture 
Microbiome 
 242 
 
Denture 
 Good Poor 
Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinomyces 29.88 21.30 86.88 0.26 >0.05 25.31 20.66 17.01 69.74 0 >0.05 19.71 
Atopbium 1.04 0.39 12.34 0 >0.05 1.99 1.15 0.26 14.03 0 >0.05 2.68 
Bifidobacterium 0.83 0.13 13.12 0 >0.05 2.18 1.65 0.13 19.09 0 >0.05 4.18 
Bradyrhizobium 1.21 0 38.96 0 >0.05 5.47 1.76 0 23.77 0 >0.05 4.51 
Campnophaga 0.09 0 1.95 0 >0.05 0.27 0.13 0 2.60 0 >0.05 0.45 
Campylobacter 0.08 0 1.56 0 >0.05 0.20 0.06 0 0.52 0 >0.05 0.14 
Cardiobacterium 0.02 0 0.26 0 >0.05 0.06 0.02 0 0.26 0 >0.05 0.06 
Corynebacterium 1.08 0.13 18.44 0 >0.05 2.76 0.59 0.13 10.78 0 >0.05 1.85 
Delftia 0.06 0 2.86 0 >0.05 0.34 0.36 0 9.35 0 >0.05 1.62 
Dialister 0.07 0 1.95 0 >0.05 0.27 0.06 0 0.78 0 >0.05 0.18 
Fusobacterium 0.18 0 1.30 0 >0.05 0.31 0.20 0 1.82 0 >0.05 0.40 
Halomonas 0.32 0 2.73 0 >0.05 0.63 0.37 0 4.16 0 >0.05 0.88 
Heamophilus 2.66 0.58 36.62 0 >0.05 5.49 1.77 0.13 20.13 0 >0.05 4.77 
Jathingobacterium 0.17 0 4.68 0 >0.05 0.59 0.09 0 0.91 0 >0.05 0.22 
Kingella 0.46 0 4.82 0 >0.05 0.90 0.27 0 4.16 0 >0.05 0.76 
Lactobacillus 6.18 0.91 95.19 0 >0.05 15.12 9.78 1.95 84.94 0 >0.05 17.47 
Leptotrichicia 0.79 0.32 5.84 0 >0.05 1.15 0.98 0.26 9.22 0 >0.05 2.05 
Moryella 0.75 0.26 8.18 0 >0.05 1.39 0.63 0.13 5.58 0 >0.05 1.23 
Nessieria 1.01 0.13 16.62 0 >0.05 2.63 0.90 0 15.71 0 >0.05 3.02 
Prevotella 3.34 1.43 39.61 0 >0.05 6.51 4.25 2.40 25.84 0 >0.05 5.99 
Rothia 9.99 6.75 54.03 0 >0.05 11..95 10.29 3.57 67.27 0 >0.05 15.49 
Scardovia 0.99 0 16.75 0 >0.05 2.6 4.59 0.32 30.65 0 >0.05 9.08 
Selenomonas 0.71 0.13 15.97 0 >0.05 2.24 0.64 0.13 10.91 0 >0.05 1.96 
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Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Staphylococcus 0.01 0 0.39 0 >0.05 0.05 0.11 0 3.31 0 >0.05 0.53 
Streptococcus 24.14 18.77 80.91 1.04 >0.05 21.27 23.10 19.29 86.62 0.39 >0.05 18.93 
Tanerella 0.02 0 0.78 0 >0.05 0.10 0.01 0 0.13 0 >0.05 0.03 
Veillonella 6.60 4.29 41.17 0 >0.05 6.81 7.40 5.26 27.40 0 >0.05 6.96 
 244 
 
Appendix XIX: Pairwise comparisons of Bacterial 
Classes for Cleaning Frequency at the Denture 
Microbiome 
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Denture 
 Once Twice 
Class Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinobacteria 47.50 48.83 89.35 1.04 >0.05 23.73 39.67 35.83 88.70 1.69 >0.05 22.59 
Alphaproteobacteria 1.32 0 12.21 0 >0.05 2.97 2.45 0 50.52 0 >0.05 8.14 
Bacilli 25.06 18.57 81.95 0.91 <0.01 20.19 37.14 32.34 96.62 0.91 <0.01 24.50 
Bacteroidia 4.75 1.56 30.78 0 >0.05 7.09 3.3 1.69 40.65 0 >0.05 6.16 
Betaproteobacteria 2.40 0.78 15.71 0 >0.05 3.54 2.05 0.91 18.05 0 >0.05 3.75 
Clostridia 8.77 5.84 30.52 0.26 >0.05 7.70 10.24 7.14 41.17 0.13 >0.05 9.04 
Coriobacteriia 1.19 0.39 7.53 0 >0.05 1.98 1.2 0.39 14.55 0 >0.05 2.6 
Epsilonproteobacteria 0.08 0 0.52 0 >0.05 0.14 0.07 0 1.56 0 >0.05 0.21 
Flavobacteriia 0.11 0 0.78 0 >0.05 0.16 0.18 0 2.99 0 >0.05 0.47 
Fusobacteriia 1.24 0.39 11.04 0 >0.05 2.06 0.91 8.18 0.39 0 >0.05 1.42 
Gammaproteobacteria 7.31 1.30 70.52 0 >0.05 15.42 2.67 1.04 20.13 0 >0.05 3.40 
Other 0.02 0 0.52 0 >0.05 0.08 0.01 0 0.26 0 >0.05 0.05 
Sphingobacteriia 1.58 0 38 0 >0.05 7.43 33.50 33.50 66 1 >0.05 45.95 
Spirochaetes 0.04 0 0.91 0 >0.05 0.16 0.01 0 0.15 0 >0.05 0.02 
Synergistia 0.04 0 0.67 0 >0.05 0.11 0.01 0 0.13 0 >0.05 0.03 
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Appendix XX: Pairwise comparisons of Bacterial 
Genera for Cleaning Frequency at the Denture 
Microbiome 
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Denture 
 Once Twice 
Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinomyces 31.24 2.27 83.25 0.26 >0.05 25.51 24.36 17.53 86.88 0 >0.05 22.50 
Atopbium 1.11 0.39 7.53 0 >0.05 1.85 1.06 0.26 14.03 0 >0.05 2.43 
Bifidobacterium 1.03 0.13 11.69 0 >0.05 2.23 1.14 0.14 19.09 0 >0.05 3.35 
Bradyrhizobium 0.48 0 7.27 0 >0.05 1.51 1.94 0 38.96 0 >0.05 6.42 
Campnophaga 0.05 0 0.39 0 >0.05 0.09 0.14 0 2.60 0 >0.05 0.42 
Campylobacter 0.08 0 0.59 0 >0.05 0.14 0.07 0 1.56 0 >0.05 0.21 
Cardiobacterium 0.02 0 0.26 0 >0.05 0.06 0.02 0 0.26 0 >0.05 0.05 
Corynebacterium 0.76 0.13 7.40 0 >0.05 1.42 1.03 0.13 18.44 0 >0.05 2.99 
Delftia 0.37 0 9.35 0 >0.05 1.53 0.02 0 0.39 0 >0.05 0.07 
Dialister 0.09 0 1.95 0 >0.05 0.34 0.06 0 0.78 0 >0.05 0.16 
Fusobacterium 0.19 0 1.82 0 >0.05 0.41 0.18 0 1.17 0 >0.05 0.29 
Halomonas 0.35 0 4.16 0 >0.05 0.80 0.33 0 2.73 0 >0.05 0.66 
Heamophilus 2.88 0.39 36.62 0 >0.05 7.05 2.07 0.32 19.09 0 >0.05 3.82 
Jathingobacterium 0.09 0 0.78 0 >0.05 0.19 0.19 0 4.68 0 >0.05 0.62 
Kingella 0.46 0 4.16 0 >0.05 0.89 0.36 0 4.81 0 >0.05 0.84 
Lactobacillus 5.01 0.65 37.40 0 >0.05 9.19 8.72 1.69 95.19 0 >0.05 18.80 
Leptotrichicia 1.05 0.26 9.22 0 >0.05 1.81 0.73 0.26 7.14 0 >0.05 1.25 
Moryella 0.83 0.26 6.23 0 >0.05 1.44 0.64 0.26 8.18 0 >0.05 1.28 
Nessieria 1.20 0.13 15.71 0 >0.05 3.07 0.84 0.13 16.62 0 >0.05 2.54 
Prevotella 4.50 1.56 29.87 0 >0.05 6.85 3.09 1.43 39.61 0 >0.05 6 
Rothia 10.86 6.36 67.27 0.13 >0.05 14.33 9.62 3.90 53.12 0 >0.05 12.37 
Scardovia 1.22 0 21.95 0 >0.05 3.63 2.68 0.13 30.65 0 >0.05 6.69 
Selenomonas 0.77 0 15.97 0 >0.05 2.72 0.65 0.13 10.91 0 >0.05 1.73 
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Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Staphylococcus 0.02 0 0.39 0 >0.05 0.07 0.05 0 3.12 0 >0.05 0.38 
Streptococcus 18.78 12.99 65.71 0.39 >0.05 17.48 26.36 21.43 86.62 0.39 >0.05 21.76 
Tanerella 0.01 0 0.13 0 >0.05 0.03 0.03 0 0.78 0 >0.05 0.11 
Veillonella 5.87 4.94 19.87 0.13 >0.05 7.45 7.45 4.63 41.17 0 >0.05 7.74 
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Classes for Sleeping with or without a Denture in 
situ at the Denture Microbiome 
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Denture 
 Yes No 
Class Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinobacteria 44.67 38.96 89.35 1.04 >0.05 26.12 40.57 42.08 88.57 2.21 >0.05 22.03 
Alphaproteobacteria 1.52 0 33.25 0 >0.05 5.37 2.17 0 50.52 0 >0.05 7.58 
Bacilli 24.31 21.30 86.88 0.91 <0.01 19.84 37.15 34.61 82.86 0.39 <0.01 22.01 
Bacteroidia 6.25 2.6 40.65 0 <0.05 8.83 2.16 1.49 12.34 0 <0.05 2.51 
Betaproteobacteria 1.47 0.39 18.05 0 <0.05 3.02 3.13 1.36 17.66 0 <0.05 4.37 
Clostridia 14.88 14.94 9.14 0.26 <0.001 9.14 5.57 4.87 21.43 0.26 <0.001 4.88 
Coriobacteriia 1.68 0.65 14.55 0 >0.05 2.80 0.91 0.26 12.47 0 >0.05 2.1 
Epsilonproteobacteria 0.13 0 1.56 0 <0.05 0.26 0.03 0 0.26 0 <0.05 0.66 
Flavobacteriia 0.17 0 2.99 0 >0.05 0.45 0.14 0 2.08 0 >0.05 0.34 
Fusobacteriia 1.73 1.04 11.04 0 <0.001 2.21 0.46 0.26 4.42 0 <0.001 0.74 
Gammaproteobacteria 3.46 1.78 59.48 0 >0.05 9.21 4.77 1.82 37.01 0 >0.05 7.36 
Other 0.01 0 0.26 0 >0.05 0.04 0.02 0 0.52 0 >0.05 0.08 
Sphingobacteriia 0.09 0 4.94 0 >0.05 0.63 0.01 0 0.13 0 >0.05 0.03 
Spirochaetes 0.02 0 0.52 0 >0.05 0.08 0.01 0 0.13 0 >0.05 0.04 
Synergistia 0.03 0 0.91 0 >0.05 0.11 0.01 0 0.13 0 >0.05 0.02 
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Denture 
 Yes No 
Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinomyces 31 23.44 83.25 0 <0.05 23.58 21.55 10.58 86.88 0.39 <0.05 23.70 
Atopbium 1.23 0.39 14.03 0 >0.05 2.33 0.88 0.13 12.34 0 >0.05 2.07 
Bifidobacterium 0.89 0.13 11.69 0 >0.05 2.16 1.36 0.13 19.09 0 >0.05 3.80 
Bradyrhizobium 1.35 0 25.97 0 >0.05 4.69 1.43 0 38.96 0 >0.05 5.82 
Campnophaga 0.12 0 2.60 0 >0.05 0.35 0.09 0 1.95 0 >0.05 0.31 
Campylobacter 0.11 0 1.56 0 >0.05 0.23 0.03 0 0.26 0 >0.05 0.06 
Cardiobacterium 0.03 0 0.26 0 >0.05 0.06 0.02 0 0.26 0 >0.05 0.05 
Corynebacterium 1.01 0.13 10.78 0 >0.05 2.31 0.82 0.13 18.44 0 >0.05 2.78 
Delftia 0.09 0 2.86 0 >0.05 0.39 0.25 0 9.35 0 >0.05 1.39 
Dialister 0.08 0 1.95 0 >0.05 0.29 0.05 0 0.78 0 >0.05 0.16 
Fusobacterium 0.22 0 1.82 0 >0.05 0.40 0.13 0 0.78 0 >0.05 0.22 
Halomonas 0.34 0 4.16 0 >0.05 0.75 0.34 0.06 2.73 0 >0.05 0.69 
Heamophilus 1.48 0.39 20.13 0 <0.05 3.78 3.59 0.78 36.62 0 <0.05 6.63 
Jathingobacterium 0.12 0 1.56 0 >0.05 0.27 0.19 0 4.66 0 >0.05 0.70 
Kingella 0.36 0 4.16 0 >0.05 0.85 0.45 0.13 4.81 0 >0.05 0.87 
Lactobacillus 8.23 1.04 95.16 0 >0.05 19.15 6.07 0.19 42.34 0 >0.05 10.08 
Leptotrichicia 1.24 0.58 9.22 0 <0.001 1.80 0.32 0.13 3.64 0 <0.001 0.60 
Moryella 1.03 0.26 8.18 0 >0.05 1.69 0.32 0.13 1.30 0 >0.05 0.39 
Nessieria 0.35 0.13 8.70 0 <0.01 1.19 1.82 0.26 16.62 0 <0.01 3.84 
Prevotella 4.80 1.62 39.61 0 >0.05 7.92 2.03 1.43 12.21 0 >0.05 2.46 
Rothia 6.08 2.21 40.26 0 <0.001 8.45 14.06 8.38 67.27 0.13 <0.001 15.46 
Scardovia 2.19 0 30.65 0 >0.05 5.92 2.02 0 29.74 0.13 >0.05 5.57 
Selenomonas 1.07 0.13 15.97 0 >0.05 2.78 0.19 0.06 1.16 0 >0.05 0.30 
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Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Staphylococcus 0.06 0 3.12 0 >0.05 0.40 0.02 0 0.39 0 >0.05 0.07 
Streptococcus 19.57 13.64 86.62 0 <0.05 18.59 28.79 25.65 80.91 0 <0.05 21.92 
Tanerella 0.04 0 0.78 0 >0.05 0.13 0.02 0 0.13 0 >0.05 0.02 
Veillonella 8.67 6.36 41.17 0 <0.01 7.77 4.39 3.05 20.39 0 <0.01 4.30 
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Microbiome 
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Mucosal 
 Good Poor 
Class Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinobacteria 20.60 14.42 83.38 0 >0.05 17.70 21.06 18.18 61.56 1.04 >0.05 13.14 
Alphaproteobacteria 0.56 0.26 5.84 0 >0.05 1.11 0.75 0.39 3.24 0 >0.05 0.97 
Bacilli 47.48 43.64 99.22 3.12 >0.05 27.20 42.44 44.74 89.09 9.48 >0.05 20. 50 
Bacteroidia 6.14 3.90 37.92 0 >0.05 7.69 6.77 6.04 22.08 0 >0.05 6.06 
Betaproteobacteria 5.74 2.08 47.92 0.13 >0.05 9.22 6.90 3.83 65.97 0.13 >0.05 12.04 
Clostridia 8.21 6.36 30.65 1.17 <0.05 7.23 10.17 8.57 35.84 0.13 <0.05 8.71 
Coriobacteriia 0.59 0.13 3.89 0 >0.05 1.03 1.06 0.26 6.23 0 >0.05 1.70 
Epsilonproteobacteria 0.23 0.13 1.82 0 >0.05 0.38 0.26 0.19 1.30 0 >0.05 0.31 
Flavobacteriia 0.38 0.13 5.46 0 >0.05 0.88 0.50 0.13 3.64 0 >0.05 0.86 
Fusobacteriia 1.21 0.65 6.89 0 >0.05 1.55 1.73 0.91 7.27 0 >0.05 2.03 
Gammaproteobacteria 8.50 6.03 59.22 0.26 >0.05 10.02 7.56 3.57 30.65 0.39 >0.05 7.93 
Other 0.02 0 0.39 0 >0.05 0.06 0.04 0 0.39 0 >0.05 0.09 
Spirochaetes 0.11 0 2.60 0 >0.05 0.40 0.20 0 4.29 0 >0.05 0.76 
Synergistia 0.10 0 2.21 0 >0.05 0.36 0.33 0 6.10 0 >0.05 1.21 
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 Appendix XXIII: Pairwise comparisons of Bacterial 
Genera of Good and Poor Hygiene Mucosal 
Microbiome 
 257 
 
Denture 
 Good Poor 
Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinomyces 7.93 0 72.99 4.54 >0.05 12.40 8.57 0.23 40.39 6.10 >0.05 8.87 
Atopbium 0.53 0.13 3.90 0 >0.05 0.96 0.57 0.19 3.38 0 >0.05 0.92 
Bifidobacterium 0.50 0 15.84 0 <0.01 2.15 1.03 0.26 5.71 0 <0.01 1.56 
Campnophaga 0.31 0.13 4.55 0 >0.05 0.76 0.47 0.13 3.51 0 >0.05 0.85 
Campylobacter 0.23 0.13 1.82 0 >0.05 0.38 0.26 0.19 1.30 0 >0.05 0.31 
Corynebacterium 1.01 0.13 11.30 0 >0.05 2.35 0.73 0.26 4.29 0 >0.05 1.10 
Delftia 0.14 0 0.91 0 >0.05 0.19 0.11 0 1.69 0 >0.05 0.31 
Dialister 0.06 0 1.56 0 >0.05 0.22 0.11 0 1.04 0 >0.05 0.27 
Fusobacterium 0.26 0 2.47 0 >0.05 0.43 0.45 0.26 2.99 0 >0.05 0.65 
Halomonas 0.79 0.26 8.05 0 >0.05 1.48 1.47 0.06 13.90 0 >0.05 3.35 
Heamophilus 5.50 3.77 26.10 0 >0.05 6.61 5.52 1.62 28.57 0 >0.05 7.66 
Jathingobacterium 0.68 0 12.60 0 >0.05 1.84 1.83 0.19 17.40 0 >0.05 4.06 
Kingella 0.06 0 0.78 0 <0.01 0.13 0.23 0.13 1.43 0 <0.01 0.34 
Lactobacillus 3.45 0 88.57 0 >0.05 14.73 3.32 0.39 57.14 0 >0.05 10.36 
Leptotrichicia 0.95 0.39 6.49 0 >0.05 1.32 1.25 0.45 7.27 0 >0.05 1.85 
Moryella 0.65 0.13 8.96 0 >0.05 1.41 0.89 0.26 11.43 0 >0.05 2.05 
Nessieria 4.06 0.39 47.27 0 >0.05 8.71 2.27 0.26 20.65 0 >0.05 4.24 
Porphyromonas 0.64 0 13.38 0 >0.05 1.92 0.39 0 2.99 0 >0.05 0.74 
Prevotella 4.89 2.60 26.62 0 >0.05 5.95 5.89 4.81 20.75 0 >0.05 5.36 
Rothia 10.21 5.84 50.52 0 >0.05 11.87 9.33 8.12 29.61 0.26 >0.05 7.57 
Scardovia 0.04 0 0.52 0 >0.05 0.10 0.75 0.13 6.10 0 >0.05 1.45 
Selenomonas 1.04 0.13 9.22 0 >0.05 1.72 2.07 0.52 16.36 0 >0.05 3.42 
Staphylococcus 0.02 0 0.26 0 >0.05 0.06 0.02 0 0.39 0 >0.05 0.08 
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Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Streptococcus 40.57 35.97 87.92 2.73 >0.05 26.26 36.00 33.83 80.78 7.27 >0.05 18.78 
Tanerella 0.07 0 1.82 0 >0.05 0.25 0.05 0 0.65 0 >0.05 1.14 
Veillonella 4.57 3.77 13.90 0 >0.05 3.51 4.78 3.25 25.58 0 >0.05 5.35 
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Mucosal 
 Once Twice 
Class Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinobacteria 19.80 15.19 51.30 0 >0.05 12.65 21.20 16.95 83.38 0.39 >0.05 17.50 
Alphaproteobacteria 0.52 0.26 4.03 0 >0.05 0.95 0.68 0.26 5.84 0 >0.05 1.10 
Bacilli 40.17 38.44 99.22 4.56 >0.05 21.15 48.08 55.19 94.94 3.12 >0.05 26.52 
Bacteroidia 8.86 7.27 37.92 0 >0.05 8.86 5.26 3.90 27.27 0 >0.05 5.89 
Betaproteobacteria 7.38 2.60 47.90 0 >0.05 11.69 5.62 3.12 65.97 0 >0.05 9.66 
Clostridia 10.62 8.44 26.23 0 >0.05 7.95 8.17 6.30 35.84 0.13 >0.05 1.40 
Coriobacteriia 0.75 0.26 3.90 0 >0.05 1.16 0.77 0.13 6.23 0 >0.05 7.70 
Epsilonproteobacteria 0.28 0.13 1.30 0 >0.05 0.35 0.23 0.13 1.82 0 >0.05 0.35 
Flavobacteriia 0.39 0 3.34 0 >0.05 0.76 0.43 0.13 5.46 0 >0.05 0.92 
Fusobacteriia 1.49 0.91 6.50 0 >0.01 1.61 1.36 0.65 7.27 0 >0.01 1.82 
Gammaproteobacteria 9.21 4.68 59.22 0.26 >0.05 12.24 7.68 4.87 30.65 0.26 >0.05 7.65 
Other 0.03 0 0.13 0 >0.05 0.06 0.02 0 0.39 0 >0.05 0.08 
Spirochaetes 0.13 0 2.60 0 >0.05 0.51 0.14 0 4.30 0 >0.05 0.59 
Synergistia 0.12 0 1.17 0 >0.05 0.35 0.22 0 6.10 0 >0.05 0.93 
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Appendix XXVI: Pairwise comparisons of Bacterial 
Genera for Cleaning Frequency at the Mucosal 
Microbiome 
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Mucosal 
 Once Twice 
Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinomyces 8.53 5.58 50.76 0 >0.05 10.69 7.97 3.25 72.99 0 >0.05 9.87 
Atopbium 0.62 0.26 3.90 0 >0.05 1.05 0.51 0.13 3.51 0 >0.05 0.89 
Bifidobacterium 0.76 0.26 5.71 0 >0.05 1.35 0.66 0.13 15.94 0 >0.05 2.20 
Bradyrhizobium 0.33 0 3.51 0 >0.05 0.74 0.39 0.13 4.54 0 >0.05 0.83 
Campnophaga 0.28 0.13 1.30 0 >0.05 0.35 0.23 0.13 1.82 0 >0.05 0.35 
Campylobacter 0.86 0.13 8.31 0 >0.05 1.90 0.93 0.13 11.30 0 >0.05 2.03 
Corynebacterium 0.86 0.1 8.31 0 >0.05 1.90 0.93 0.13 11.30 0 >0.05 2.03 
Delftia 0.16 0 1.67 0 >0.05 0.33 0.08 0 0.91 0 >0.05 0.17 
Dialister 0.10 0 1.56 0 >0.05 0.30 0.07 0 1.04 0 >0.05 0.20 
Fusobacterium 0.32 0.13 1.56 0 >0.05 0.41 0.33 0.06 2.99 0 >0.05 0.57 
Halomonas 1.11 0.26 13.90 0 >0.05 2.82 1.02 0.39 13.90 0 >0.05 2.12 
Heamophilus 4.44 2.08 28.57 0 >0.05 6.19 5.99 2.86 26.49 0 >0.05 7.29 
Jathingobacterium 1.06 0 17.40 0 >0.05 3.33 1.13 0 15.06 0 >0.05 2.70 
Kingella 0.11 0 1.43 0 >0.05 0.28 0.23 0 6.23 0 >0.05 0.82 
Lactobacillus 3.54 0.13 65.97 0 >0.05 12.67 3.33 0 88.57 0 >0.05 13.57 
Leptotrichicia 1.13 0.78 6.49 0 >0.05 1.41 1.03 0.39 7.27 0 >0.05 1.59 
Moryella 1.05 0.52 11.43 0 >0.05 2.23 0.60 0.13 8.96 0 >0.05 1.34 
Nessieria 5.16 0.26 47.27 0 >0.05 11.51 2.61 0.39 21.17 0 >0.05 4.42 
Porphyromonas 1.06 0 13.38 0 >0.05 2.63 0.32 0 3.12 0 >0.05 0.68 
Prevotella 6.78 6.10 23.12 0 >0.05 6.15 4.58 2.79 26.62 0 >0.05 5.44 
Rothia 10.14 6.62 50.52 0 >0.05 11.33 9.78 6.62 42.47 0 >0.05 10.14 
Scardovia 0.06 0 0.52 0 >0.05 0.13 0.41 0 6.10 0 >0.05 1.13 
Selenomonas 1.03 0.32 9.22 0 >0.05 2.15 1.42 0.26 16.36 0 >0.05 2.87 
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Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Staphylococcus 0.01 0 0.26 0 >0.05 0.05 0.02 0 0.39 0 >0.05 0.08 
Streptococcus 32.61 31.43 87.92 2.86 >0.05 18.69 41.71 41.95 87.66 0 >0.05 23.37 
Tanerella 0.04 0 0.65 0 >0.05 0.13 0.07 0 1.82 0 >0.05 0.25 
Veillonella 6.21 4.81 25.28 0 >0.05 5.56 3.94 3.38 17.27 0 >0.05 3.32 
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Appendix XXVII: Pairwise comparisons of Bacterial 
Classes for Sleeping with or without a Denture in 
situ at the Mucosal Microbiome 
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Mucosal 
 Yes No 
Class Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinobacteria 17.35 15.97 41.43 0 >0.05 10.62 22.02 16.23 83.38 1.04 >0.05 18.30 
Alphaproteobacteria 0.73 0.26 5.84 0 >0.05 1.27 0.54 0.26 3.25 0 >0.05 0.79 
Bacilli 45.88 43.77 99.22 4.55 >0.05 25.29 44.93 45.58 83.70 9.48 >0.05 25.41 
Bacteroidia 8.96 6.95 37.92 0 <0.05 1.33 4.51 3.90 15.19 0 <0.05 0.71 
Betaproteobacteria 4.30 2.60 16.23 0 >0.05 4.65 9.04 3.25 65.97 0.13 >0.05 14.91 
Clostridia 10.67 7.39 35.84 0 <0.05 8.76 7.21 6.36 20.91 0.13 <0.05 5.73 
Coriobacteriia 1.11 0.39 6.23 0 <0.05 1.63 0.45 0.13 3.51 0 <0.05 0.80 
Epsilonproteobacteria 0.35 0.19 1.82 0 <0.05 0.44 0.15 0.13 0.91 0 <0.05 0.20 
Flavobacteriia 0.36 0.13 3.64 0 >0.05 0.63 0.49 0.13 5.46 0 >0.05 1.14 
Fusobacteriia 1.81 1.17 7.27 0 <0.01 1.82 1.07 0.26 6.88 0 <0.01 1.71 
Gammaproteobacteria 7.78 5.58 30.65 0.26 >0.05 7.14 9.17 2.21 9.22 0.39 >0.05 11.28 
Other 0.03 0 0.39 0 >0.05 0.08 0.02 0 0.39 0 >0.05 0.07 
Spirochaetes 0.20 0 4.29 0 >0.05 0.78 0.09 0 1.30 0 >0.05 0.26 
Synergistia 0.24 0 6.10 0 >0.05 0.98 0.18 0 3.25 0 >0.05 0.65 
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Appendix XXVIII: Pairwise comparisons of Bacterial 
Genera for Sleeping with or without a Denture in situ 
at the Mucosal Microbiome 
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Mucosal 
 Yes No 
Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Actinomyces 8.21 5.58 50.91 0 >0.05 9.15 8.10 3.25 72.99 0 >0.05 13.80 
Atopbium 0.71 0.26 3.90 0 >0.05 1.09 0.30 0 2.86 0 >0.05 0.59 
Bifidobacterium 0.83 0.13 15.84 0 >0.05 2.37 0.49 0.13 5.71 0 >0.05 1.10 
Campnophaga 0.32 0.13 3.51 0 >0.05 0.59 0.44 0 4.55 0 >0.05 1.04 
Campylobacter 0.32 0.13 3.51 0 >0.05 0.59 0.46 0 4.55 0 >0.05 1.03 
Corynebacterium 0.59 0.13 5.20 0 >0.05 1.14 1.39 0.26 11.30 0 >0.05 2.75 
Delftia 0.11 0 0.91 0 >0.05 0.19 0.09 0 1.69 0 >0.05 0.29 
Dialister 0.11 0 1.56 0 >0.05 0.30 0.06 0 1.04 0 >0.05 0.18 
Fusobacterium 0.33 0.13 1.56 0 >0.05 0.42 0.32 0.13 2.99 0 >0.05 0.65 
Halomonas 1.08 0.32 13.90 0 >0.05 2.37 0.97 0.52 13.90 0 >0.05 2.32 
Heamophilus 5.24 2.27 26.49 0 >0.05 6.84 5.91 2.99 28.57 0 >0.05 7.23 
Jathingobacterium 1.03 0 15.06 0 >0.05 2.79 1.23 0.13 17.40 0 >0.05 3.08 
Kingella 0.12 0 1.43 0 >0.05 0.27 0.30 0 6.23 0 >0.05 1.05 
Lactobacillus 3.44 0.13 88.57 0 >0.05 14.44 3.34 0 65.97 00 >0.05 11.40 
Leptotrichicia 1.28 0.71 7.27 0 <0.05 1.60 0.75 0.13 6.49 0 <0.05 1.37 
Moryella 0.98 0.39 11.43 0 >0.05 2.06 0.37 0 2.60 0 >0.05 0.66 
Nessieria 2.26 0.32 13.64 0 >0.05 2.54 5.10 0.39 47.27 0 >0.05 10.73 
Porphyromonas 0.69 0 13.38 0 >0.05 1.96 0.33 0 2.99 0 >0.05 0.72 
Prevotella 6.19 4.22 26.62 0 >0.05 6.56 3.88 2.86 15.06 0 >0.05 3.90 
Rothia 12.87 7.27 50.52 0.65 <0.05 12.57 6.69 5.65 28.70 0 <0.05 6.30 
Scardovia 0.47 0 6.10 0 >0.05 1.30 0.17 0 1.82 0 >0.05 0.37 
Selenomonas 1.81 0.45 16.36 0 >0.05 3.26 0.52 0.13 4.68 0 >0.05 0.89 
Staphylococcus 0.02 0 0.39 0 >0.05 0.07 0.02 0 0.26 0 >0.05 0.07 
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Genus Mean Median Max Min P value SD Mean Median Max Min P value SD 
Streptococcus 38.83 35.78 87.92 2.72 >0.05 23.25 38.97 32.08 82.34 3.12 >0.05 24.89 
Tanerella 0.06 0 0.65 0 >0.05 0.13 0.08 0 1.82 0 >0.05 0.31 
Veillonella 4.61 3.51 25.58 0 >0.05 4.36 4.69 3.77 17.27 0 >0.05 4.14 
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